SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2023

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from               to               

 

Commission file number 001-40747

 

 

 

authID Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   46-2069547

(State or other jurisdiction of

incorporation or organization)

  (I.R.S. Employer
Identification No.)

 

1580 North Logan Street, Suite 660, Unit 51767,

Denver, CO 80203 

(Address of principal executive offices) (zip code)

 

516-274-8700

(Registrant’s telephone number, including area code)

 

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
Common Stock par value $0.0001 per share   AUID   The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.

 

Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller reporting company
  Emerging growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 

 

Yes ☐ No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.

 

Class   Outstanding at November 6, 2023
Common Stock, par value $0.0001   7,874,962 shares
Documents incorporated by reference:   None

 

 

 

 

 

TABLE OF CONTENTS

 

    Page No.
PART I – FINANCIAL INFORMATION    
     
Item 1. Financial Statements.   1
     
Condensed Consolidated Balance Sheets as of September 30, 2023 (unaudited) and December 31, 2022   1
     
Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2023 and 2022 (unaudited)   2
     
Condensed Consolidated Statements of Comprehensive Loss for the Three and Nine Months Ended September 30, 2023 and 2022 (unaudited)   3
     
Condensed Consolidated Statements of Stockholders’ Equity for the Three and Nine Months Ended September 30, 2023 and 2022 (unaudited)   4
     
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2023 and 2022 (unaudited)   5
     
Notes to Unaudited Condensed Consolidated Financial Statements   6-23
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.   24-29
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk.   29
     
Item 4. Controls and Procedures.   30
     
PART II – OTHER INFORMATION    
     
Item 1. Legal Proceedings.   31
     
Item 1A. Risk Factors.   31
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.   33
     
Item 3. Defaults Upon Senior Securities.   33
     
Item 4. Mine Safety Disclosures.   33
     
Item 5. Other Information.   33
     
Item 6. Exhibits.   34

 

i

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

 

This report includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Words such as, but not limited to, “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “targets,” “likely,” “aim,” “will,” “would,” “could,” and similar expressions or phrases identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and future events and financial trends that we believe may affect our financial condition, results of operation, business strategy and financial needs.

 

You should read thoroughly this report and the documents that we refer to herein with the understanding that our actual future results may be materially different from and/or worse than what we expect. We qualify all of our forward-looking statements by these cautionary statements including those made in this report, in Part I. Item 1A. Risk Factors also appear in our Annual Report on Form 10-K for the year ended December 31, 2022 and our other filings with the Securities and Exchange Commission. Some examples of risk factors which may affect our business are as follows:

 

  our lack of significant revenues, positive cash flow and history of losses,
     
  market acceptance of our products and competition;
     
  our ability to attract and retain customers for existing and new products;

 

  our ability to effectively maintain and update our technology and product and service portfolio;

 

  our reliance on third party software and developers;

 

  breaches of network or IT security and presentation attacks;

 

  our ability to hire and retain key personnel and additional talent;
     
  our ability to raise capital under acceptable terms;
     
  our ability to maintain listing of our common stock on the Nasdaq Capital Market;
     
  our ability to adequately protect our intellectual property, or the loss of some of our intellectual property rights through costly litigation or administrative proceedings;
     
  our ability to operate in non-US markets;
     
  the impact of the Covid-19 Pandemic;
     
  the impact of the wars in Ukraine and the Middle East;
     
  stock price and market volatility and the risk of securities litigation;
     
  legislation and government regulation; and
     
  general economic conditions, inflation and access to capital.

 

Other sections of this report include additional factors which could adversely impact our business and financial performance. New risk factors emerge from time to time and it is not possible for our management to predict all risk factors, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Except for our ongoing obligations to disclose material information under the Federal securities laws, we undertake no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events. These forward-looking statements speak only as of the date of this report, and you should not rely on these statements without also considering the risks and uncertainties associated with these statements and our business.

 

OTHER PERTINENT INFORMATION

 

Unless specifically set forth to the contrary, when used in this report the terms “authID” the “Company,” “we,” “our,” “us,” and similar terms refer to authID Inc., a Delaware corporation and its subsidiaries.

 

On June 26, 2023 the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporations to effect a one-for-eight (1-for-8) reverse split which became effective on July 7, 2023 (See Note 8 “Shareholders’ Equity”).

 

The information which appears on our website www.authID.ai is not part of this report.

 

ii

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS.

 

authID INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   September 30,   December 31, 
   2023   2022 
   (unaudited)     
ASSETS        
Current Assets:        
Cash  $3,811,014   $3,237,106 
Accounts receivable, net   48,832    261,809 
Other current assets, net   474,178    729,342 
Deferred contract costs   66,300    
-
 
Current assets held for sale   
-
    118,459 
Total current assets   4,400,324    4,346,716 
           
Other Assets   
-
    250,383 
Intangible Assets, net   370,409    566,259 
Goodwill   4,183,232    4,183,232 
Non-current assets held for sale   
-
    27,595 
Total assets  $8,953,965   $9,374,185 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current Liabilities:          
Accounts payable and accrued expenses  $989,538   $1,154,072 
Deferred revenue   103,052    81,318 
Current liabilities held for sale   
-
    13,759 
Total current liabilities   1,092,590    1,249,149 
Non-current Liabilities:          
Convertible debt   220,309    7,841,500 
Accrued severance liability   325,000    
-
 
Total liabilities   1,637,899    9,090,649 
           
Commitments and Contingencies (Note 10)   
 
    
 
 
           
Stockholders’ Equity:           
Common stock, $0.0001 par value, 250,000,000 shares authorized; 7,874,962 and 3,179,789 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively   786    318 
Additional paid in capital   163,613,111    140,257,448 
Accumulated deficit    (156,310,215)   (140,130,159)
Accumulated comprehensive income   12,384    155,929 
Total stockholders’ equity   7,316,066    283,536 
Total liabilities and stockholders’ equity  $8,953,965   $9,374,185 

 

See notes to condensed consolidated financial statements. 

 

1

 

 

authID INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
                 
Revenues:                
Verified software license  $42,369   $30,023   $114,269   $116,925 
Legacy authentication services   1,020    
-
    4,118    144,559 
Total revenues, net   43,389    30,023    118,387    261,484 
                     
Operating Expenses:                    
General and administrative   2,965,344    3,914,432    5,712,303    11,583,798 
Research and development   749,705    1,620,492    1,666,638    4,689,515 
Depreciation and amortization   60,416    213,049    212,450    673,882 
Total operating expenses   3,775,465    5,747,973    7,591,391    16,947,195 
                     
Loss from continuing operations   (3,732,076)   (5,717,950)   (7,473,004)   (16,685,711)
                     
Other Income (Expense):                    
Other income (expense)   29,511    (42,148)   30,671    (38,908)
Interest expense, net   (13,138)   (437,301)   (1,095,320)   (931,205)
Conversion expense   
-
    
-
    (7,476,000)   
-
 
Loss on debt extinguishment   
-
    
-
    (380,741)   
-
 
Other income (expense), net   16,373    (479,449)   (8,921,390)   (970,113)
                     
Loss from continuing operations before income taxes   (3,715,703)   (6,197,399)   (16,394,394)   (17,655,824)
Income tax benefit (expense)   
-
    7,052    (3,255)   (1,048)
Loss from continuing operations   (3,715,703)   (6,190,347)   (16,397,649)   (17,656,872)
                     
Gain (loss) from discontinued operations   (1,915)   43,645    1,524    (363,385)
Gain (loss) on sale of discontinued operations   
-
    (188,247)   216,069    (188,247)
Total gain (loss) from discontinued operations   (1,915)   (144,602)   217,593    (551,632)
Net loss   $(3,717,618)  $(6,334,949)  $(16,180,056)  $(18,208,504)
                     
Net Loss Per Share - Basic and Diluted                    
Continuing operations
  $(0.47)  $(2.00)  $(3.05)  $(5.80)
Discontinued operations
  $(0.00)  $(0.05)  $0.04   $(0.18)
Weighted Average Shares Outstanding - Basic and Diluted:
   7,874,962    3,102,745    5,376,821    3,044,151 

 

See notes to condensed consolidated financial statements.

  

2

 

 

authID INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited)

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
Net Loss  $(3,717,618)  $(6,334,949)  $(16,180,056)  $(18,208,504)
Foreign currency translation (loss) gain   12,592    (37,383)   (143,545)   (72,431)
Comprehensive loss  $(3,705,026)  $(6,372,332)  $(16,323,601)  $(18,280,935)

 

See notes to condensed consolidated financial statements.

 

3

 

 

authID INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited) 

 

                   Accumulated     
           Additional       Other     
   Common Stock   Paid-in   Accumulated   Comprehensive     
   Shares   Amount   Capital   Deficit   Income   Total 
Balances, December 31, 2022   3,179,789   $318   $140,257,448   $(140,130,159)  $155,929   $283,536 
Stock-based compensation   -    
-
    (22,949)   
-
    
-
    (22,949)
Shares issued in lieu of interest   111,516    11    387,567    
-
    
-
    387,578 
Warrants for services with securities purchase agreement   -    
-
    438,000    
-
    
-
    438,000 
Conversion of convertible debt into common stock   2,348,347    235    15,331,776    
-
    
-
    15,332,011 
Conversion of credit facility borrowings into common stock   245,634    24    899,976    
-
    
-
    900,000 
Sale of common stock for cash, net of offering costs   1,989,676    198    6,321,293    
-
    
-
    6,321,491 
Net loss   -    
-
    
-
    (16,180,056)   
-
    (16,180,056)
Foreign currency translation   -    
-
    
-
    
-
    (143,545)   (143,545)
Balances, September 30, 2023   7,874,962   $786   $163,613,111   $(156,310,215)  $12,384   $7,316,066 
                               
Balances, June 30, 2023 (as Revised - see Note 8)   7,874,962   $786   $162,155,308   $(152,592,597)  $(208)  $9,563,289 
Stock-based compensation   -    
-
    1,519,952    
-
    
-
    1,519,952 
Incremental offering costs   -    
-
    (62,149)   
-
    
-
    (62,149)
Net loss   -    
-
    
-
    (3,717,618)   
-
    (3,717,618)
Foreign currency translation   -    
-
    
-
    
-
    12,592    12,592 
Balances, September 30, 2023   7,874,962   $786   $163,613,111   $(156,310,215)  $12,384   $7,316,066 
                               
Balances, December 31, 2021   2,926,655   $293   $126,583,738   $(115,899,939)  $211,486   $10,895,578 
Stock-based compensation   -    
-
    6,726,871    
-
    
-
    6,726,871 
Sale of common stock for cash, net of offering costs   132,940    13    3,146,927    
-
    
-
    3,146,940 
Common stock issued with convertible debt   3,562    1    91,756    
-
    
-
    91,757 
Common stock issued for working capital facility   12,500    1    302,999    
-
    
-
    303,000 
Shares issued in lieu of interest   23,964    2    473,810    
-
    
-
    473,812 
Warrants for services with the issuance of convertible debt   -    
-
    449,474    
-
    
-
    449,474 
Cashless stock option exercise   23,139    2    (2)   
-
    
-
    
-
 
Cashless warrant exercise   172    
-
    
-
    
-
    
-
    
-
 
Warrant exercise for cash   4,584    1    66,002    
-
    
-
    66,003 
Convertible note converted into common stock   1,689    1    49,999    
-
    
-
    50,000 
Net loss   -    
-
    
-
    (18,208,504)   
-
    (18,208,504)
Foreign currency translation   -    
-
    
-
    
-
    (72,431)   (72,431)
Balances, September 30, 2022   3,129,205   $314   $137,891,574   $(134,108,443)  $139,055   $3,922,500 
                               
Balances, June 30, 2022   3,113,580   $311   $135,325,005   $(127,773,494)  $176,438   $7,728,260 
Shares issued in lieu of interest   9,352    1    222,804    
-
    
-
    222,805 
Stock-based compensation   -    
-
    2,227,764    
-
    
-
    2,227,764 
Warrant exercise for cash   4,584    1    66,002    
-
    
-
    66,003 
Convertible note converted into common stock   1,689    1    49,999    
-
    
-
    50,000 
Net loss   -    
-
    
-
    (6,334,949)   
-
    (6,334,949)
Foreign currency translation   -    
-
    
-
    
-
    (37,383)   (37,383)
Balances, September 30, 2022   3,129,205   $314   $137,891,574   $(134,108,443)  $139,055   $3,922,500 

 

See notes to condensed consolidated financial statements. 

 

4

 

 

authID INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

   Nine Months Ended 
   September 30, 
   2023   2022 
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss  $(16,180,056)  $(18,208,504)
Adjustments to reconcile net loss with cash flows from operations:          
Depreciation and amortization expense   212,450    674,836 
Provision for doubtful collection of other receivable   150,000    
-
 
Stock-based compensation   (22,949)   6,726,871 
Warrants for services with securities purchase agreement   438,000    
-
 
Shares issued in lieu of interest   387,578    473,812 
Amortization of debt discounts and issuance costs   693,420    403,244 
(Gain) loss from sale of discontinued operation   (216,069)   188,247 
Conversion expense   7,476,000    
-
 
Loss on debt extinguishment   380,741    
-
 
Changes in operating assets and liabilities:          
Accounts receivable   212,977    (9,234)
Deferred contract costs   (66,300)   
-
 
Other assets   66,676    (161,884)
Accounts payable and accrued expenses   (178,428)   235,050 
Deferred revenue   21,734    (102,074)
Other accrued liabilities   290,000    
-
 
Adjustments relating to discontinued operations   110,064    226,586 
Net cash flows from operating activities   (6,224,162)   (9,553,050)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Proceeds from sale of discontinued operations, net of selling costs   

91,751

    146,728 
Cash disposed of from the sale of a discontinued operation   
-
    (299,505)
Purchase of property and equipment - discontinued operations   
-
    (16,159)
Purchase of property and equipment   
-
    (7,981)
Purchase of intangible assets   (16,601)   (6,311)
Net cash flows from investing activities   75,150   (183,228)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from sale of common stock, net of offering costs   6,321,492    3,146,940 
Credit facility drawdown, net of issuance costs   543,760    
-
 
Proceeds from issuance of convertible note payable, net of issuance costs   
-
    7,992,841 
Proceeds from exercise of warrants   
-
    66,003 
Cash paid for working capital facility   
-
    (300,000)
Payments on notes payable - discontinued operations   
-
    (1,579)
Principal payments on capital lease obligation - discontinued operations   
-
    (10,582)
Net cash flows from financing activities   6,865,252    10,893,623 
           
Effect of Foreign Currencies   (145,035)   (78,019)
           
Net Change in Cash   571,205    1,079,326 
Cash, Beginning of the Period   3,237,106    5,767,276 
Cash, Beginning of the Period - Discontinued Operations   2,703    270,707 
Cash, End of the Period - Discontinued Operations   
-
    (11,342)
Cash, End of the Period  $3,811,014   $7,105,967 
           
Supplemental Disclosure of Cash Flow Information:          
Cash paid for interest - discontinued operations  $364   $8,779 
Cash paid for income taxes  $3,255   $2,193 
Cash paid for income taxes - discontinued operations  $1,254   $4,493 
           
Schedule of Non-cash Investing and Financing Activities:          
Conversion of convertible note payable and accrued interest to common stock  $7,856,011   $6,232,340 
Conversion of credit facility borrowings into common stock  $900,000   $
-
 
Warrants for consulting services with the sale of common stock  $438,000   $
-
 
Cashless option and warrant exercises  $
-
   $67 
Settlement of accounts payable with issuance of common stock  $
-
   $349,376 
Reclass from other assets to intangible assets  $
-
   $8,270 

 

See notes to condensed consolidated financial statements. 

 

5

 

 

authID INC. AND SUBSIDIARIES 

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – BASIS OF PRESENTATION

 

In the opinion of Management, the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which we considered as necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The results of operations for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for future periods or the full year.

 

The condensed consolidated financial statements include the accounts of authID Inc. and its wholly-owned subsidiaries MultiPay S.A.S., ID Solutions, Inc., FIN Holdings Inc., Ipsidy Enterprises Limited and authID Gaming Inc. (collectively the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation.

 

Going Concern

 

As of September 30, 2023, the Company had an accumulated deficit of approximately $156.3 million. For the three and nine months ended September 30, 2023, the Company earned revenue from continuing operations of approximately $0.04 million and $0.12 million, used approximately $2.1 million and $6.2 million to fund its operations, and incurred a net loss of approximately $3.7 million and $16.2 million, respectively.

 

The continuation of the Company as a going concern is dependent upon financial support from the Company’s stockholders and noteholders, the ability of the Company to obtain additional debt or equity financing to continue operations, the Company’s ability to generate sufficient cash flows from operations, successfully locating and negotiating with other business entities for potential acquisition, and acquiring new clients to generate revenues and cash flows.

 

During the nine months ended September 30, 2023, the Company has secured additional financing of approximately $6.4 million net, which provides funding for its current operations as it continues to invest in its product, people, and technology. Although there is no guarantee, the Company projects that the investments will lead to revenue expansion thereby reducing liquidity needs. However, in order to further implement its business plan and satisfy its working capital requirements, the Company will need to raise additional capital. There is no guarantee that the Company will be able to raise additional equity or debt financing at acceptable terms, if at all.

 

There is no assurance that the Company will ever be profitable. These unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. As there can be no assurance that the Company will be able to achieve positive cash flows (become cash flow positive) and raise sufficient capital to maintain operations, there is substantial doubt about the Company’s ability to continue as a going concern.

 

Reclassification

 

Certain prior year expenses have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the previously reported loss from continuing operations and management does not believe that this reclassification is material to the consolidated financial statements taken as a whole. Specifically, we reclassified certain expenses from general and administrative expenses to research and development expenses.

 

6

 

 

Net Loss per Common Share

 

The Company computes net loss per share in accordance with FASB ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the statement of operations. Basic EPS is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible notes and stock warrants, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and conversion of convertible notes. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive. The following potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and nine months ended September 30, 2023 and 2022 because their effect was antidilutive:

 

Security  2023   2022 
         
Convertible notes payable   8,278    325,188 
Warrants   488,018    163,045 
Stock options   1,685,570    1,212,202 
    2,181,866    1,700,435 

 

Revenue Recognition

 

Verified Software License – The Company recognizes revenue based on the identified performance obligations over the performance period for fixed consideration and / or variable fees generated that are earned on a usage fee based over time based on user monthly user or transaction volumes or on a monthly flat fee rate. We allocate the selling price in a contract which has multiple performance obligations based on the contract selling price that we believe represents a fair market price for the service rendered based on estimated standalone selling price.

 

The Company had contract liabilities of approximately $103,000 and $81,000 as of September 30, 2023 and December 31, 2022 respectively for certain revenue that will be earned in future periods. All deferred revenue contract liabilities as of September 30, 2023 are expected to be earned over the next twelve months.

 

Remaining Performance Obligations

 

As of September 30, 2023, the Company’s Remaining Performance Obligation (RPO) was $1.87 million, of which $0.10 million is held as deferred revenue and $1.77 million is related to other non-cancelable contracted amounts. The Company expects approximately 34% of the RPO to be recognized as revenue in the twelve months ending September 30, 2024 based on contractual commitments and expected usage patterns. However, the amount and timing of revenue recognition are generally dependent upon customers’ future consumption, which is inherently variable at customers’ discretion. Furthermore, the Company does not have historical information to estimate the recognition of revenue due to its current operations and has approximated such amount based on discussions with the contracted parties.

 

Deferred Contract Costs – We defer the portion of sales commission that is considered a cost of obtaining a new contract with a customer and amortize these deferred costs over the period of benefit. We expense the remaining sales commissions as incurred. The following table summarizes deferred contract cost activity for the nine months ended September 30, 2023:

 

   Deferred 
   Contract Costs 
     
Carrying Value at December 31, 2022  $
-
 
Additions   66,300 
Amortization   
-
 
Carrying Value at September 30, 2023  $66,300 

 

Legacy Authentication Services – The Company historically has sold certain legacy software licenses to customers and revenue is recognized when delivery occurs, and all other revenue recognition criteria have been met. During both quarters ended September 30, 2023 and 2022, the Company provided annual software maintenance support services relating to previously licensed software on a stand-ready basis. These fees were billed in advance and recognized ratably over the requisite service period as revenue.

 

Revenue Accounting Pronouncement – In June 2016, the Financial Accounting Standards Board issued Accounting Standards Update No. 2016-13, “Financial Instruments – Credit Losses (Topic),” which replaces the current incurred loss impairment methodology for most financial assets with the current expected credit lost, or CECL, methodology. The series of new guidance amends the impairment model by requiring entities to use a forward-looking approach based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. The Company adopted the new standard effective January 1, 2023, which did not have a material impact to the consolidated financial statements.

 

7

 

 

NOTE 2 – OTHER CURRENT ASSETS AND OTHER ASSETS

 

Other current assets consisted of the following at September 30, 2023 (unaudited) and December 31, 2022:

 

   September 30,   December 31, 
   2023   2022 
         
Prepaid insurance  $295,188   $244,215 
Prepaid third party services   155,052    135,405 
Unamortized credit facility fees   
-
    199,156 
Other   23,938    150,566 
   $474,178   $729,342 

 

Other assets consisted of the following at September 30, 2023 (unaudited) and December 31, 2022:

 

   September 30,   December 31, 
   2023   2022 
         
Unamortized working capital facility fees  $
           -
   $248,945 
Other   
-
    1,438 
   $
-
   $250,383 

 

8

 

 

NOTE 3 – INTANGIBLE ASSETS, NET (OTHER THAN GOODWILL)

 

The Company’s intangible assets primarily consist of acquired and developed software that is being amortized over their estimated useful lives as indicated below. The following is a summary of activity related to intangible assets for the nine months ended September 30, 2023 (unaudited):

 

   Acquired and         
   Developed         
   Software   Patents   Total 
             
Useful Lives   5 Years    10 Years      
                
Carrying Value at December 31, 2022  $435,595   $130,664   $566,259 
Acquisition of intangible assets   16,601    
-
    16,601 
Amortization   (200,100)   (12,351)   (212,451)
Carrying Value at September 30, 2023  $252,096   $118,313   $370,409 

  

The following is a summary of intangible assets as of September 30, 2023 (unaudited):

 

   Acquired and         
   Developed         
   Software   Patents   Total 
Cost  $4,492,872    164,614   $4,657,486 
Accumulated amortization   (4,240,776)   (46,301)   (4,287,077)
Carrying Value at September 30, 2023  $252,096   $118,313   $370,409 

 

Amortization expense totaled approximately $212,450 and $642,000 for the nine months ended September 30, 2023, and 2022, respectively.

 

Future expected amortization of intangible assets is as follows:

 

2023 (Remainder of the Year)  $51,458 
2024   171,414 
2025   67,111 
2026   19,776 
2027   9,776 
Thereafter   50,874 
   $370,409 

 

There is no impairment indicator identified for impairment of the Company’s intangible assets and goodwill as of September 30, 2023.

  

9

 

 

NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consisted of the following as of September 30, 2023 (unaudited) and December 31, 2022:

 

   September 30,   December 31, 
   2023   2022 
         
Trade payables  $426,723   $623,130 
Accrued payroll and related obligations   113,494    145,837 
Other accrued expenses   449,321    385,105 
   $989,538   $1,154,072 

 

On February 14, 2023, the Company’s Board of Directors resolved to implement a revised budget for 2023 in order to reduce expenses and cash requirements and as part of such revised budget decided to re-balance staffing levels to better align with the evolving needs of the Company (the “Labor Reduction Plan”). Under the Labor Reduction Plan, 12 employees and 6 contractors have left the Company. The Company has also given termination notice to certain vendors and contractors that provide services to the Company. For the nine months ended September 30, 2023, the Company incurred approximately $0.8 million of severance expenses, of which $0.4 million was paid and $0.1 million was included in the Accounts payable and accrued expenses and the remaining $0.3 million was accrued for in Other liabilities as a long term liability on the unaudited Condensed Consolidated Balance Sheets as of September 30, 2023.

 

NOTE 5 – WORKING CAPITAL FACILTIY

 

On March 21, 2022, the Company entered into a Credit Facility Agreement (the “Original Facility Agreement”) with Stephen J. Garchik (“Garchik”), who is a shareholder of the Company, pursuant to which Garchik agreed to provide to the Company a $10.0 million unsecured standby line of credit facility that could be drawn down in several tranches, subject to certain conditions described in the Original Facility Agreement. Pursuant to the Original Facility Agreement, the Company paid Garchik a Facility Commitment Fee of 12,500 shares of our common stock upon the effective date of the Original Facility Agreement.

 

On March 8, 2023, the Company entered into an Amended and Restated Facility Agreement (“A&R Facility Agreement”) with Garchik, pursuant to which the Company and Garchik amended and restated the Original Facility Agreement in its entirety, to replace the credit facility contemplated by the Original Facility Agreement with (i) an initial credit facility to the Company in an amount of $900,000 and (ii) the parties to use their reasonable best efforts after the Initial Funding to negotiate the terms of a subsequent credit facility in the aggregate amount of $2,700,000 (the “Subsequent Funding”).

 

On March 9, 2023, pursuant to the A&R Facility Agreement, the Company entered into a promissory note (the “Initial Promissory Note”) in favor of Garchik, pursuant to which Garchik loaned the amount of $900,000 (the “Principal Amount”) to the Company. In connection with the Company and Garchik entering into the Initial Promissory Note, each of the principal United States based subsidiaries of the Company agreed to, for the benefit and security of Garchik, guarantee the payment and performance all of the Company’s obligations under the Initial Promissory Note and the Guaranty. The Company and Garchik also entered into the Release Agreement, pursuant to which the Company and Garchik mutually agreed to release any and all rights to make a claim against the other and any existing claims against the other arising out of or relating to the Original Facility Agreement.

 

The Company wrote-off approximately $410,000 of the issuance costs related to the Original Credit Facility and capitalized $426,000 issuance costs related to the A&R Facility Agreement as of March 31, 2023.

 

On May 25, 2023, the Company and Garchik agreed to cancel the Initial Promissory Note, terminate the A&R Facility Agreement and Guaranty and satisfy and offset the outstanding balance of the Initial Promissory Note, plus accrued and unpaid interest in the aggregate amount of $929,250 against the purchase price of certain shares of common stock of the Company. See Note 8 “Shareholders’ Equity”. All remaining unamortized debt issuance costs of approximately $381,000 related to the Initial Promissory Note and the A&R Facility Agreement were recorded as a loss on debt extinguishment for the nine months ended September 30, 2023.

  

10

 

 

NOTE 6 – CONVERTIBLE NOTES PAYABLE

 

On March 21, 2022, the Company entered into a Securities Purchase Agreement (“SPA”) with certain accredited investors, including certain directors of the Company or their affiliates (the “Note Investors”), and, pursuant to the SPA, sold to the Note Investors Senior Secured Convertible Notes (the “Convertible Notes”) with an aggregate initial principal amount of approximately $9.2 million and a conversion price of $29.60. The Convertible Notes were sold with an aggregate cash origination fee of approximately $200,000, and we issued a total of approximately 3,563 shares of our common stock to the Note Investors as an additional origination fee. The Convertible Notes accrue interest at the rate of 9.75% per annum, which is payable in cash or, for some or all of the first five interest payments, in shares of our common stock at the Company’s option, on the last day of each calendar quarter before the maturity date and on the maturity date. The maturity date of the Convertible Notes is March 31, 2025.

 

During the quarter ended September 30, 2022, a holder of a Convertible Note converted the full principal amount of $50,000 and accrued interest of $406 into 1,706 shares of our common stock.

 

During the quarter ended September 30, 2022, the Company issued 9,335 shares of common stock for approximately $223,000 of interest.

 

During the nine months ended September 30, 2023 and 2022, the Company issued 103,533 and 23,947 shares of common stock for approximately $358,000 and $474,000 of interest expense, respectively. The number of shares issued to each Note Investor was based on the VWAP of the common stock as of the relevant interest payment date, as defined in the Convertible Notes.

 

In connection with the issuance of the Convertible Notes, the Company issued 17,836 common stock warrants to a broker and its representatives with an estimated grant date fair value of approximately $449,000 which was recorded as a reduction in the carrying value of the Convertible Notes.

 

On May 23, 2023, the Company entered into an exchange agreement with certain holders (“Holders”) of the Convertible Notes of the Company, pursuant to which the Company agreed to issue 2,346,105 shares of common stock to the Holders in exchange for approximately $8.9 million (or approximately $7.9 million, net of debt issuance costs and discount) of the principal amount of Holders’ Convertible Notes at a price of $3.78 per share (or $4.12 if the Holder is a director, officer or insider of the Company). On June 7, 2023, the Company entered into a further Securities Purchase Agreement and Exchange Agreement with an accredited investor pursuant to which the Company agreed to issue 2,242 Exchange Shares in exchange for $13,000 of the principal amount of the Holder’s Convertible Note at a price of $5.80 per share. The Company also recognized an expense on conversion of convertible notes of approximately $7.5 million, representing the market value of the additional shares issued by the Company in exchange for the Convertible Notes, above the number of shares that the Holders would have received upon conversion at the original conversion price under the Convertible Notes.

 

On May 23, 2023, the Company solicited the consent of the Convertible Notes Holders to eliminate substantially all of the restrictive covenants and a related event of default in the Convertible Notes. The Company received consent from Holders representing over the necessary 66.67% of the outstanding principal amount under the Convertible Notes.

 

See Note 8 “Shareholders’ Equity”.

 

The following is a summary of the Convertible Notes payable outstanding as of September 30, 2023 (unaudited):

 

9.75% convertible notes due March 31, 2025  $245,000 
      
less:     
Unamortized debt issuance expense   (24,691)
   $220,309 

   

Future maturities of Convertible Notes payable as of September 30, 2023:

 

2025  $245,000 
   $245,000 

 

11

 

 

NOTE 7 – RELATED PARTY TRANSACTIONS

 

Convertible Notes Payable

  

On May 23, 2023, pursuant to an Exchange Agreement, Mr. Ken Jisser converted $100,000 of Convertible Notes payable and accrued interest of $1,463 into 24,628 shares of common stock.

 

On May 23, 2023, pursuant to an Exchange Agreement, Mr. Stephen J. Garchik, who is a shareholder of the Company, converted $1,000,000 of Convertible Notes payable and $14,625 of accrued interest into 264,831 and 3,874 shares of common stock, respectively. As a result of such exchange, the issuance of shares in satisfaction of the Credit Facility referred to below and the purchase of additional shares of common stock in May 2023, (See Note 8 “Shareholders’ Equity”), Mr. Garchik is now a holder of more than 10% of the outstanding shares of the Company’s common stock.

 

See Note 6 “Convertible Notes Payable” and Note 8 “Shareholders’ Equity”.

 

Issuance of Common Stock

 

On May 23, 2023, Messrs. Rhoniel Daguro, CEO, Ken Jisser, Michael Thompson, members of the Company’s Board of Directors and Joseph Trelin, the Chairman of the Board, each purchased 12,500 shares of Company’s common stock at a price of $50,000.

 

Credit Facility

 

On March 21, 2022 the Company entered into the Original Facility Agreement with Mr. Stephen Garchik, an accredited investor, who is both a current shareholder of the Company and a Note Investor, pursuant to which Mr. Garchik agreed to provide a $10.0 million unsecured standby line of credit facility that will rank behind the Convertible Notes and may be drawn down in several tranches, subject to certain conditions described in the Original Facility Agreement. Pursuant to the Original Facility Agreement, the Company agreed to pay Mr. Garchik the Facility Commitment Fee of 12,500 shares of our common stock upon the effective date of the Original Facility Agreement. Upon request by Mr. Garchik and until the full amount due under the Original Agreement is repaid in full, the Company agreed to provide for the nomination of one designee specified in writing by Garchik for appointment to our board directors and for subsequent election to our board of directors and to recommend such nominee for election to our board of directors. On April 18, 2022, Joseph Trelin, as Garchik’s designee under the Original Facility Agreement, was appointed as a member of the Board of Directors of the Company. By virtue of such right of nomination Mr. Garchik considered himself a “director by deputization”.

 

As described in Note 5 “Working Capital Facility”, the Original Facility Agreement was amended and restated effective March 8, 2023 pursuant to which amendment the amount of the facility was reduced to $3.6 million, an initial advance of $900,000 was made and subsequent advances under the A&R Facility Agreement are subject to various conditions including the granting of a security interest over substantially all the Company’s assets. Under the A&R Facility Agreement Garchik had a one-time right for the nomination of four designees specified in writing by Garchik for appointment to our board of directors. On March 9, 2023 Rhoniel Daguro, Ken Jisser, Michael Thompson and Thomas Szoke as Garchik’s designees under the A&R Facility Agreement, were appointed as members of the Board of Directors of the Company.

 

12

 

 

On May 25, 2023, the Company and Mr. Garchik agreed to cancel the Initial Promissory Note, terminated the A&R Facility Agreement and Guaranty and satisfied and offset the outstanding balance of the Note in the principal amount of $900,000 and $29,250 accrued and unpaid interest with the purchase price of 245,634 and 7,983 shares of common stock, respectively. See Note 5 “Working Capital Facility” and Note 8 “Shareholders’ Equity”.

 

Executive Officers’ Agreements

 

Effective March 23, 2023, Mr. Thomas Thimot resigned as the Company’s Chief Executive Officer.

 

On March 23, 2023, the Company and Rhoniel A. Daguro, a director of the Company, entered an Offer Letter pursuant to which Mr. Daguro agreed to serve as Chief Executive Officer of the Company in consideration of an initial annual salary of $400,000. Mr. Daguro will be eligible for an annual target bonus of up to $375,000 based on performance milestones. For the period ending March 31, 2024, a bonus amount of $75,000 shall be payable upon the Company achieving increments of $1,000,000 in total contract value of all customer agreements less claw backs (“Bookings”) up to an aggregate of $5,000,000 in Bookings. For subsequent years, Mr. Daguro and the Compensation Committee of the Board will mutually agree as to the performance targets to be achieved, to earn the annual bonus. On April 10, 2023, the Company provided Mr. Daguro with an initial grant of options to purchase 306,875 shares of common stock at the exercise price of $3.176 per share for a period of ten years vesting subject to achievement of performance and service conditions. On June 28, 2023, the Company made an additional grant of options to Mr. Daguro to acquire 183,125 shares of common stock at the exercise price of $5.48 for a period of ten years vesting subject to achievement of performance and service conditions.

 

The employment of Mr. Daguro is at will and may be terminated at any time, with or without formal cause. The Company also entered an Executive Retention Agreement with Mr. Daguro, pursuant to which the Company agreed to provide specified severance and bonus amounts and to accelerate the vesting on his equity awards upon termination upon a change of control or an involuntary termination, as each term is defined in the agreement. In the event of a termination upon a change of control or an involuntary termination, Mr. Daguro is entitled to receive an amount equal to 100% of his base salary, the actual bonus earned but unpaid for the previous year and any bonus that was earned but unpaid prior to the termination date. Further, upon termination upon a change of control or an involuntary termination, the Company will reimburse Mr. Daguro for the cost of continuation of health coverage for Mr. Daguro and his eligible dependents pursuant to COBRA until the earlier of 12 months following the termination date, the date Mr. Daguro and his dependents are eligible for health coverage from a new employer or the date Mr. Daguro and his eligible dependents are no longer eligible for COBRA.

 

On April 25, 2022, Hang Pham and the Company entered an Offer Letter pursuant to which Ms. Pham agreed to serve as Chief Financial Officer with a planned employment date commencing June 20, 2022. Ms. Pham receives an annual salary of $275,000. The Company agreed to provide a bonus of 40% of the base salary based on achievement of performance milestones, calculated and payable in accordance with the corporate milestones approved by the Board for the year 2022. For subsequent fiscal years the bonus shall be subject to performance targets to be mutually agreed with the Compensation Committee of the Board. In addition, Ms. Pham received a signing bonus in the amount of $25,000, which is fully refundable to the Company if Ms. Pham leaves her employment voluntarily or is terminated for cause prior to the first anniversary of the commencement of employment. Upon commencing employment, Ms. Pham was granted an option to acquire 43,750 shares of common stock at an exercise price of $19.28 with an exercise period of ten years subject to certain performance and market vesting requirements. On May 11, 2023, the Company entered a Retention Agreement with Ms. Pham, pursuant to which the Company agreed to provide specified retention bonus amounts subject to certain performance conditions in the aggregate amount of up to $240,625 and to accelerate the vesting on her equity awards upon termination. This Agreement replaces the previous Executive Retention Agreement dated April 25, 2022, which was terminated and a release granted in relation thereto. Ms. Pham resigned as Chief Financial Officer effective August 15, 2023.

 

13

 

 

On April 12, 2023, the Company entered an Offer Letter with Thomas R. Szoke, a director of the Company, pursuant to which Mr. Szoke agreed to serve as Chief Technology Officer in consideration of an initial annual salary of $250,000. Mr. Szoke received an initial signing bonus of $20,833 and will be eligible for an annual target bonus of up to $200,000 based on performance milestones. For the period ending March 31, 2024, a bonus amount of $40,000 shall be payable upon our company achieving increments of $1,000,000 in total contract value of all customer agreements less claw backs (“Bookings”) up to an aggregate of $5,000,000 in Bookings. For subsequent years, Mr. Szoke and the Compensation Committee of the Board will mutually agree as to the performance targets to be achieved, to earn the annual bonus. The vesting criteria of Mr. Szoke’s Stock Options to acquire 12,500 shares of common stock previously granted to Mr. Szoke on March 14, 2023 (the “Original Grant”) were amended pursuant to an Amended and Restated Stock Non-Statutory Option Agreement providing for vesting subject to achievement of performance and service conditions. All other terms of the Original Grant were not changed. On June 28, 2023, the Company made an additional grant of options to Mr. Szoke to acquire 50,000 shares of common stock at the exercise price of $5.48 per share for a period of ten years vesting subject to achievement of performance and service conditions.

 

The employment of Mr. Szoke is at will and may be terminated at any time, with or without formal cause. The Company also entered an Executive Retention Agreement with Mr. Szoke, pursuant to which the Company agreed to provide specified severance and bonus amounts and to accelerate the vesting on his equity awards upon termination upon a change of control or an involuntary termination, as each term is defined in the agreement. In the event of a termination upon a change of control or an involuntary termination, Mr. Szoke is entitled to receive an amount equal to 100% of his base salary, the actual bonus earned but unpaid for the previous year and any bonus that was earned but unpaid prior to the termination date. Further, upon termination upon a change of control or an involuntary termination, the Company will reimburse Mr. Szoke for the cost of continuation of health coverage for Mr. Szoke and his eligible dependents pursuant to COBRA until the earlier of 12 months following the termination date, the date Mr. Szoke and his dependents are eligible for health coverage from a new employer or the date Mr. Szoke and his eligible dependents are no longer eligible for COBRA.

 

On July 31, 2023, the Company and Edward Sellitto entered an Offer Letter pursuant to which Mr. Sellitto agreed to serve as Chief Financial Officer of the Company commencing August 15, 2023 in consideration of an annual salary of $250,000. Mr. Sellitto will be eligible for an annual target bonus of up to 60% of base salary based on achievement of performance milestones, as Mr. Sellitto and the Compensation Committee of the Board, will mutually agree for each year. The bonus shall be pro-rated for the year 2023. At the outset of employment, Mr. Sellitto was provided with a grant of options to purchase 50,000 shares of common stock vesting subject to achievement of performance and service conditions at an exercise price of $8.87, with an exercise period of 10 years. The employment of Mr. Sellitto will be at will and may be terminated at any time, with or without formal cause.

 

Board of Directors

 

Messrs. Thomas Thimot, Phillip L. Kumnick, Philip R. Broenniman, Michael A. Gorriz and Ms. Neepa Patel tendered their resignations from the Board of Directors of the Company on March 9, 2023. The Board of Directors appointed Joseph Trelin to the Company’s Compensation and Audit Committees. On March 9, 2023, the Board of Directors appointed Rhon Daguro, Ken Jisser, Michael Thompson and Thomas Szoke as additional directors of the Company and reduced the size of the Board of Directors from 8 directors to 7 directors. The Company granted Messrs. Jisser, Thompson and Szoke 12,500 options each at the exercise price of $2.64 per share.

 

On March 16, 2023, the Company appointed Joseph Trelin as the Chairman of the Board, Michael Koehneman as Chairman of the Governance Committee and appointed Michael Thompson to the Company’s Compensation and Governance Committees.

 

On June 28, 2023, the Company granted 15,625 options each at the exercise price of $5.48 per share to Messrs. Joseph Trelin, Michael Koehneman and Ms. Jacqueline White and 3,125 options each at the exercise price of $5.48 to Messrs. Jisser and Thompson, in accordance with the Company’s compensation policy for non-employee directors. Each such option vests over a period of twelve months.

 

14

 

 

Services Agreements

 

Mr. Ken Jisser joined our Board of Directors on March 9, 2023. Mr. Jisser is the founder and Chief Executive Officer of The Pipeline Group, Inc. (“TPG”), a technology-enabled services company that assists the Company with pipeline generation. On June 6, 2023, the Company entered into a services agreement with TPG. The agreement provides that TPG assist in providing outsourced sales including business development resources for outbound calling, provide support for automated dialing technology, classify customer data and other sales related services. In consideration of the services, the Company will pay TPG $47,000 per month during a one-year term. On October 25, 2023 the Agreement was amended to provide for additional services and for the Company to pay TPG $70,000 per month during the remainder of the term.

 

NOTE 8STOCKHOLDERS’ EQUITY

 

On June 26, 2023, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a one-for-eight (1-for-8) reverse split (the “Reverse Split”) of the shares of the Company’s common stock. The Reverse Split became effective on July 7, 2023 (see Note 11 “Subsequent Event”). As a result of the Reverse Split, every eight shares of the Company’s issued and outstanding common stock automatically converted into one share of common stock, without any change in the par value per share, and began trading on a post-split basis under the Company’s existing trading symbol, “AUID”, when the market opened on July 10, 2023. The Reverse Split affected all holders of common stock uniformly and did not affect any common stockholder’s percentage ownership interest in the Company, except for de minimis changes as a result of the elimination of fractional shares. A total of 62,816,330 shares of common stock were issued and outstanding immediately prior to the Reverse Split, and 7,874,962 shares of common stock were issued and outstanding immediately after the Reverse Split. No fractional shares will be outstanding following the Reverse Split. Any holder who would have received a fractional share of common stock received an additional fraction of a share of common stock to round up their holding to the next whole share. In addition, effective as of the Reverse Split, proportionate adjustments were made to all then-outstanding options and warrants with respect to the number of shares of common stock subject to such options or warrants and the exercise prices thereof, as well as to the conversion price under the remaining Convertible Notes. The impact of this change in capital structure has been retroactively applied to all periods presented herein.

 

Common Stock

 

During the nine months ended September 30, 2023, shares of common stock were issued as a result of the following transactions:

 

  On May 26, 2023, pursuant to Securities Purchase Agreements, the Company issued 1,989,676 shares of common stock for cash gross proceeds of approximately $7.3 million (or approximately $6.4 million, net of offering costs).

 

  On May 26, 2023, pursuant to a Securities Purchase Agreement, Mr. Garchik capitalized the outstanding principal balance of $900,000 under the Initial Promissory Note, into 245,634 shares of common stock, respectively.

 

  On May 26, 2023, pursuant to an exchange agreement with Holders of Convertible Notes payable, the Company issued 2,348,347 shares of common stock in exchange for Convertible Notes in the gross principal amount of approximately $8.9 million (approximately $7.9 million, net of debt issuance costs and discount). In addition, the Company recorded approximately $7.5 million of expense on conversion of convertible notes.

 

  The Company issued 111,516 shares of common stock for approximately $388,000 of interest accrued under the Convertible Notes and Credit Facility. See Note 6 “Convertible Notes Payable”.

 

15

 

 

Warrants

 

  On May 12, 2023, in connection with certain recruitment services, the Company issued 187,500 common stock warrants to Madison III, LLC with a term of 5 years and an exercise price of $3.164 per share.

 

  On May 26, 2023, in connection with their placement agent services, the Company issued 156,712 common stock warrants to Madison Global Partners, LLC, with a term of 5 years and an exercise price of $3.664 per share.

 

The following is a summary of the Company’s warrant activity for the nine months ended September 30, 2023 (unaudited):

 

       Weighted   Weighted
       Average   Average
   Number of   Exercise   Remaining
   Shares   Price   Life
            
Outstanding at December 31, 2022   153,683   $36.96   2.21 Years
Granted   344,212   $3.39  
Exercised/cancelled   (9,877)  $39.60    
    488,018   $13.22   3.94 Years

 

Stock Options

 

During the nine months ended September 30, 2023, the Company granted directors a total of 78,125 options at exercise prices ranging from $2.64 to $5.48 per share. During the nine months ended September 30, 2023, the Company granted the Chief Executive Officer 490,000 options at exercise prices ranging from $3.18 to $5.48 per share, the Chief Technology Officer 62,500 options at exercise prices ranging from $2.64 to $5.48 per share and the Chief Financial Officer 50,000 options at an exercise price of $8.87. During the nine months ended September 30, 2023 the Company also granted a total of 75,000 options to certain new employees at an exercise price of $7.36 per share.

 

During the nine months ended September 30, 2023 the Company agreed to accelerate the vesting of 45,190 options for Annie Pham under her Retention Agreement with exercise prices ranging from $6.32 to $19.28 per share. These accelerated options would not otherwise have vested prior to termination of employment according to their Market and Service conditions. Therefore, the Company recalculated the fair value of these options as of her termination date of August 15, 2023 using the Black Scholes method.

 

16

 

 

The Company determined the grant date fair value of options granted for the nine months ended September 30, 2023, using the Black Scholes and Monte Carlo Methods, as applicable, with the following assumptions:

 

Expected volatility  120-124%
Expected term  0.25 - 5 years
Risk free rate  3.52% - 4.36%
Dividend rate  0.00%

 

Activity related to stock options for the nine months ended September 30, 2023 (unaudited), is summarized as follows:

 

       Weighted   Weighted     
       Average   Average   Aggregate 
   Number of   Exercise   Contractual   Intrinsic 
   Shares   Price   Term (Yrs.)   Value 
                 
Outstanding at December 31, 2022   1,291,595   $46.48    6.5   $
-
 
Granted   755,625   $4.81    10.0   $2,218,309 
Exercised   
-
   $
-
    -   $
-
 
Forfeited/cancelled   (361,650)  $52.80    -   $- 
Outstanding as of September 30, 2023   1,685,570   $25.85    6.7   $2,334,011 
Exercisable as of September 30, 2023   1,004,499   $44.36    4.9   $876,503 

 

The following table summarizes stock option information as of September 30, 2023 (unaudited):  

 

       Weighted     
       Average     
       Contractual     
Exercise Price  Outstanding   Term (Yrs.)   Exercisable 
             
Less than or equal $32.00   1,280,216    7.3    709,283 
$32.08 - $56.00   17,917    2.7    17,917 
$56.08 - $80.00   222,792    6.1    131,820 
$80.08 - $127.76   164,645    3.2    145,479 
    1,685,570    6.7    1,004,499 

 

During the nine months ended September 30, 2023, the Company recognized approximately ($0.02) million of stock option based compensation expense. As of September 30, 2023, there was approximately $3.2 million of unrecognized compensation costs related to stock options outstanding that will be expensed through 2026.

 

Revision of Prior Period Information

 

During the review of the Company’s financial statements for the three and nine-month periods ended September 30, 2023, the Company identified errors in the recording of stock-based compensation expense relating to the three months ended March 31, 2023, related to reversing cumulative stock-based compensation recognized on stock awards with market vesting conditions due to Q1 2023 terminations. The Company recorded the following revisions in the nine-month period ended September 30, 2023. The following revisions will also be included to compare the three and six month periods ending March 31 and June 30, 2023 respectively to the 2024 results.

 

17

 

 

   Three Months Ended March 31, 2023   Six Months Ended June 30, 2023 
   As
Previously
Reported
   Adjustment   As Revised   As
Previously
Reported
   Adjustment   As Revised 
Stock-based Compensation  $837,608   $(3,438,613)  $(2,601,005)  $1,895,712   $(3,438,613)  $(1,542,901)
Operating Expenses  $4,458,022   $(3,438,613)  $1,019,409   $7,254,539   $(3,438,613)  $3,815,926 
Loss from Continuing Operations  $(5,220,239)  $3,438,613   $(1,781,626)  $(16,120,559)  $3,438,613   $(12,681,946)
Net Loss  $(5,222,494)  $3,438,613   $(1,783,881)  $(15,901,051)  $3,438,613   $(12,462,438)
APIC  $141,317,627   $(3,438,613)  $137,879,014   $165,593,921   $(3,438,613)  $162,155,308 
Accumulated Deficit  $(145,352,653)  $3,438,613   $(141,914,040)  $(156,031,210)  $3,438,613   $(152,592,597)
Total Stockholders’ Equity (Deficit)  $(3,900,576)  $
-
   $(3,900,576)  $ 9,563,289   $
-
   $ 9,563,289 
Net Loss Per Share from Continuing Operations                               
Basic and Diluted
  $(1.61)  $1.06   $(0.55)  $(3.91)  $0.83   $(3.08)

 

In accordance with the SEC’s Staff Accounting Bulletin Nos. 99 and 108 (“SAB 99” and “SAB 108”), the Company evaluated this error and concluded that although the adjustment to certain areas of the statement of operations was quantitatively material, the cumulative effects were qualitatively immaterial and would not have materially impacted a reasonable investor’s opinion of the Company. This is further supported by the fact that the impact would not have been significant in comparison to prior periods and all errors are of a non-cash nature. Therefore, as permitted by SAB 108 and treated under the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 250, Accounting Changes and Error Corrections, the Company revised previously recorded results for the three months ended March 31, 2023 and the six months ended June 30, 2023, to account for the prior period error in this current filing.

 

As a result, the statement of operations for the three and nine month periods ended September 30, 2023 reflects the revised expenses, loss from continuing operations and net loss.

 

NOTE 9 – DISCONTINUED OPERATIONS AND ASSETS HELD FOR SALE

 

The Board of Directors of authID considered it in the best interests of the Company to focus its business activities on providing biometric authentication products and services by means of our proprietary Verified platform.  Accordingly, on May 4, 2022, the Board approved a plan to exit from certain non-core activities comprising the MultiPay correspondent bank, payments services in Colombia and the Cards Plus cards manufacturing and printing business in South Africa.

 

18

 

 

Cards Plus business in South Africa

 

The financial statements of Cards Plus are classified as a discontinued operation and an asset held for sale, as all required classification criteria under appropriate accounting standards were met as of June 30, 2022.

 

On August 29, 2022, the Company completed the sale of Cards Plus for a price of $300,000 of which $150,000 was received and the remaining balance of $150,000 was recorded in other current asset, less $3,272 in costs to sell, and recognized a loss of $188,247 from the transaction. While the Company and Cards Plus continue to actively pursue payment of the remaining balance, which is subject to regulatory approval, management re-evaluated the likelihood of recovery and recorded an allowance for doubtful account in September 30, 2023 related to this receivable.

 

MultiPay business in Colombia

 

The Company exited the MultiPay business in Colombia in an orderly fashion, honoring our obligations to employees, customers and under applicable laws and regulations.  We maintain our customer support and operations team in Bogota, which performs essential functions to support the global operations of our Verified product.

 

As of June 30, 2023, all impacted employees had left the Company. MultiPay finalized the sale of the Company’s proprietary software to its major customer on June 30, 2023 for approximately $96,000 of sale consideration. The Company recorded the receivable under the sale in Other current assets, released foreign currency translation gain of approximately $155,000 and recognized a gain of $216,000 from the transaction. This receivable was collected in September 2023. 

 

The following table summarizes the assets and liabilities of the MultiPay sale and the consideration received (unaudited):

 

   Amount 
Carrying value of net assets sold:     
Property and equipment write-off  $19,528 
Net assets write-off  $19,528 
      
Sale consideration on disposition of net assets:     
Sale consideration  $95,852 
Less: Value added tax   (15,304)
Net Consideration  $80,548 
Foreign currency translation:  $155,049 
Net gain on sale of a discontinued operation  $216,069 

 

19

 

 

The operations of Cards Plus and MultiPay for the three and nine months ended September 30, 2023 and 2022 on a consolidated basis are below (unaudited):

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
Discontinued Operations                
Total Revenues, net  $
-
   $446,643   $29,354   $1,468,199 
                     
Operating Expenses:                    
Cost of Sales   
-
    145,205    
-
    665,269 
General and administrative   
-
    276,866    12,268    1,003,003 
Impairment loss   
-
    -    
-
    143,698 
Depreciation and amortization   
-
    (6,749)   8,066    33,025 
Total operating expenses   
-
    415,322    20,334    1,844,995 
                     
Income (Loss) from operations   -    31,321    9,020    (376,796)
                     
Other Income (Expense):                    
Other income   
-
    12,792    
-
    20,821 
Interest expense, net   
-
    
-
    
-
    (364)
Other income (expense), net   
-
    12,792    
-
    20,457 
                     
Loss before income taxes   
-
    44,113    9,020    (356,339)
                     
Income tax expense   (1,915)   (468)   (7,496)   (7,046)
                     
Income (loss) from discontinued operations   (1,915)   43,645    1,524    (363,385)
Loss (gain) from sale of discontinued operations   -    (188,247)   216,069    (188,247)
Total income (loss) from discontinued operations  $(1,915)  $(144,602)  $217,593   $(551,632)

 

20

 

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
Cards Plus                
Total Revenues, net  $
-
   $380,372   $
-
   $1,263,672 
                     
Operating Expenses:                    
Cost of Sales   
-
    145,205    
-
    665,269 
General and administrative   
-
    21,539    
-
    412,243 
Impairment loss   
-
    -    
-
    143,698 
Depreciation and amortization   
-
    (1,482)   
-
    24,415 
Total operating expenses   
-
    165,262    
-
    1,245,625 
                     
Income (loss) from operations   
-
    215,110    
-
    18,047 
                     
Other Income (Expense):                    
Other income   
-
    2,103    
-
    8,919 
Interest expense, net   
-
    
-
    
-
    (364)
Other income, net   
-
    2,103    
-
    8,555 
                     
Loss before income taxes   
-
    217,213    
-
    26,602 
                     
Income tax expense   
-
    
-
    
-
    (4,681)
                     
Income from discontinued operations   -    217,213    -    21,921 
Loss from sale of discontinued operations   
-
    (188,247)   
 
    (188,247)
Total Income (Loss) from discontinued operations  $-   $28,966   $-   $(166,326)

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
MultiPay                
Total Revenues, net  $
-
   $66,271   $29,354   $204,527 
                     
Operating Expenses:                    
General and administrative   
-
    255,327    12,268    590,760 
Depreciation and amortization   
-
    (5,267)   8,066    8,610 
Total operating expenses   
-
    250,060    20,334    599,370 
                     
Loss from operations   
-
    (183,789)   9,020    (394,843)
                     
Other Income:                    
Other income   
-
    10,689    
-
    11,902 
Other income   -    10,689    -    11,902 
                     
Loss before income taxes   
-
    (173,100)   9,020    (382,941)
                     
Income tax expense   (1,915)   (468)   (7,496)   (2,365)
                     
Income (loss) from discontinued operations   (1,915)   (173,568)   1,524    (385,306)
Gain from sale of discontinued operations   -    
-
    216,069    
-
 
Total Income (loss) from discontinued operations  $(1,915)  $(173,568)  $217,593   $(385,306)

 

21

 

 

As a result of meeting the discontinued operations/assets held for sale criteria for Cards Plus and the MultiPay operations, the cash flow activity related to discontinued operations is presented separately on the statement of cash flows as summarized below (unaudited):

 

   Nine Months Ended 
   September 30, 
   2023   2022 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $1,524   $(363,385)
Adjustments to reconcile net loss with cash flows from operations:          
Depreciation and amortization expense   8,067    42,364 
Impairment of intangible assets   
-
    143,701 
Changes in operating assets and liabilities:          
Accounts receivable   105,194    (14,288)
Other current assets   10,562    186,370 
Inventory   
-
    (78,806)
Accounts payable and accrued expenses   (13,759)   (16,092)
Deferred revenue   
-
    (36,663)
Adjustments relating to discontinued operations   110,064    226,586 
Cash flows from discontinued operations  $111,588   $(136,799)

 

Notes to Financial Statements – Discontinued Operations

 

Revenue Recognition

 

Cards Plus – The Company recognized revenue for the design and production of cards at the point in time when products are shipped, or services have been performed due to the short-term nature of the contracts. Additionally, the cards produced by the Company have no alternative use and the Company has an enforceable right to payment for work performed should the contract be cancelled.

 

MultiPay recognized revenue for variable fees generated for payment processing solutions that are earned on a usage fee over time based on monthly transaction volumes or on a monthly flat fee rate. Additionally, MultiPay also sells certain equipment from time to time for which revenue is recognized upon delivery to the customer.

 

22

 

 

NOTE 10 – COMMITMENTS AND CONTINGENCIES

 

Legal Matters

 

From time to time, the Company is a party to various legal or administrative proceedings arising in the ordinary course of our business. While any litigation contains an element of uncertainty, we have no reason to believe the outcome of such proceedings will have a material adverse effect on the financial condition or results of operations of the Company.

 

Leases

 

The Company rented office space in Long Beach, New York at a monthly cost of $2,500 in 2022. The agreement was month to month and could be terminated on 30 days notice. The lease agreement was terminated in July 2022. The agreement was between the Company and Bridgeworks LLC, an entity principally owned by Mr. Beck, the Company’s former CEO and Director and his family.

 

In July 2022, the Company signed a new lease agreement for one year and moved its headquarters to Denver, Colorado. The office monthly lease cost is approximately $1,500 per month. The Company did not renew the lease agreement after July 2023 and has no remaining lease agreements as of September 30, 2023.

 

Rent expense included in general and administrative on the Consolidated Statements of Operations for the nine months ended September 30, 2023 was approximately $8,000. For the nine months ended September 30, 2022, rent expense was approximately $80,000, inclusive of short-term leases of which $13,000 was for continuing operations and $67,000 for discontinued operations.

 

NOTE 11 – SUBSEQUENT EVENT

 

Management of the Company has performed a review of all events and transactions occurring after the condensed consolidated balance sheet date and determined there were no events or transactions requiring adjustment to or disclosure in the accompanying condensed consolidated financial statements.

 

23

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Overview 

 

authID Inc. is a leading provider of secure, authentication solutions delivered by our easy to integrate Verified platform. Our Verified platform binds strong passwordless authentication with biometric identity, which offers our customers a streamlined path to zero trust architecture. Verified FIDO2 passwordless authentication is certified by the FIDO Alliance to be compliant and interoperable with FIDO specifications.

 

The explosive growth in online and mobile commerce, telemedicine, remote working and digital activities of all descriptions is self-evident to everyone who lived through the Covid 19 pandemic since 2020. Identity theft, phishing attacks, spear-phishing, password vulnerabilities, account takeovers, benefits fraud - it seems like these words have entered our daily lexicon overnight. These are significant impediments to the operations and growth of any business or organization, and dealing with the risks and consequences of these criminal activities has created significant friction in both time, cost and lost opportunity. Consider all the outdated methods that organizations have implemented in order to prevent fraud. The requests to receive and enter one-time passwords, that can be easily hijacked. The vulnerable security questions you get asked – whether on-line or when reaching out to a call center – what was your first pet’s name? who was your best friend in high school? These steps all add up to friction, making it difficult for consumers to login, transact and execute daily tasks, with little added protection from fraud. Surely there is a better way to address these challenges? authID believes there is.

 

authID provides secure, facial biometric, identity verification, and strong customer authentication. We maintain a global, cloud-based Verified platform for our enterprise customers or employees to enable their users to easily verify and authenticate their identity through a mobile device or desktop (with camera) of their choosing (without requiring dedicated hardware, or authentication apps). We can help our customers establish a proven identity, creating a root of trust that ensures the highest level of assurance for our passwordless login and step-up verification products. Our system enables participants to consent to transactions using their biometric information with a digitally signed authentication response, embedding the underlying transaction data and each user’s identity attributes within every electronic transaction message processed through our platform.

 

Digital transformation across all market segments requires trusted identity. Our identity platform offers innovative solutions that are flexible, fast and easy to integrate and offer seamless user experiences. authID’s products help advance digital transformation efforts without the fear of identity fraud, while delivering frictionless user experiences. We believe that it is also essential that electronic transactions have an audit trail, proving that the identity of the individual was duly authenticated. Our platform provides biometric and multi-factor identity software, which are intended to establish, authenticate and verify identity across a wide range of use cases and electronic transactions.

 

authID’s products focus on the broad requirement for enabling frictionless commerce by allowing an entity to instantly “Know Who’s Behind the Device”, their customer, employee or their member. Organizations of all descriptions require cost-effective and secure means of growing their business while mitigating identity fraud. We aim to offer our enterprise customers products that can be integrated easily into each of their business and organizational operations, in order to facilitate their adoption and enhance the end user customer experience.

 

Our management believes that some of the advantages of our Verified Platform approach are the ability to leverage the platform to support a variety of vertical markets and the adaptability of the platform to the requirements of new markets and new products requiring cost-effective, secure, and configurable mobile solutions. Our target markets include cybersecurity, workforce, banking, fintech and other disrupters of traditional commerce, small and medium sized businesses, and system integrators working with government and Fortune 1000 enterprises. At its core, the Company’s offering, combining its proprietary and acquired biometric and artificial intelligence technologies (or AI), is intended to facilitate frictionless commerce, whether in the physical or digital world. The Company intends to increase its investment in developing, patenting and acquiring the various elements necessary to enhance the platform, which are intended to allow us to achieve our goals. One of the principal intended areas of investment is to enhance and expand our use of artificial intelligence in proprietary software, that we believe will increase our value to enterprise customers and stockholders alike.

 

24

 

 

authID is dedicated to developing advanced methods of protecting consumer privacy and deploying ethical and socially responsible AI.. We believe that a proactive commitment to ethical AI presents a strong business opportunity for authID and will enable us to bring more accurate products to market more quickly and with less risk to better serve our global user base. Our methods to achieve ethical AI include engaging the users of our products with informed consent, prioritizing the security of our user’s personal information, considering and avoiding potential bias in our algorithms, and monitoring of algorithm performance in our applications.

 

The Company also owns an entity in Colombia, MultiPay. On May 4, 2022, the Board approved a plan to exit from certain non-core activities comprising the MultiPay correspondent bank, payments services in Colombia and the Cards Plus cards manufacturing and printing business in South Africa. On August 29, 2022 the Company completed the sale of Cards Plus business. On June 30, 2023, the Company completed the exit of the MultiPay business. See Discontinued Operations.

 

The Company was incorporated in the State of Delaware on September 21, 2011 and changed our name to authID Inc. on July 18, 2022.

 

Our Common Stock is traded on the Nasdaq Capital Market under the trading symbol “AUID”. Our main address is 1580 North Logan Street, Suite 660, Unit 51767, Denver, CO 80203 and our main phone number is (516) 274-8700. We maintain a website at www.authID.ai. The information contained on, or that can be accessed through, our websites is not incorporated by reference into this prospectus and is intended for informational purposes only.

 

Going Concern

 

The Company’s unaudited condensed consolidated financial statements included in this Quarterly Report have been prepared in accordance with United States GAAP assuming the Company will continue on a going concern basis, which implies the Company will continue to meet its obligations and continue its operations for the next year following the issuance date of these financial statements.

 

As of September 30, 2023, the Company had an accumulated deficit of approximately $156.3 million. For the nine months ended September 30, 2023, the Company earned revenue of approximately $0.12 million, used $6.2 million to fund its operations, and incurred a net loss from continuing operations of approximately $16.4 million. The continuation of the Company as a going concern is dependent upon financial support from the Company’s stockholders and noteholders, the ability of the Company to obtain additional debt or equity financing to continue operations, the Company’s ability to generate sufficient cash flows from operations, successfully locating and negotiating with other business entities for potential acquisition and /or acquiring new clients to generate revenues and cash flows.

 

During the nine months ended September 30, 2023, the Company has secured additional financing of approximately $6.4 million net, which provides funding for its current operations as it continues to invest in its product, people, and technology. Although there is no guarantee, the Company projects that the investments will lead to revenue expansion thereby reducing liquidity needs. However, in order to further implement its business plan and satisfy its working capital requirements, the Company will need to raise additional capital. There is no guarantee that the Company will be able to raise additional equity or debt financing at acceptable terms, if at all.

 

There is no assurance that the Company will ever be profitable. These consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. As there can be no assurance that the Company will be able to achieve positive cash flows (become cash flow profitable) and raise sufficient capital to maintain operations, there is substantial doubt about the Company’s ability to continue as a going concern.

  

25

 

 

Adjusted EBITDA

 

This discussion includes information about Adjusted EBITDA that is not prepared in accordance with GAAP. Adjusted EBITDA is not based on any standardized methodology prescribed by GAAP and is not necessarily comparable to similar measures presented by other companies. A reconciliation of this non-GAAP measure is included below. Adjusted EBITDA is a non-GAAP financial measure that represents GAAP net income (loss) adjusted to exclude (1) interest expense and debt discount and debt issuance costs amortization expense, (2) interest income, (3) provision for income taxes, (4) depreciation and amortization, (5) stock-based compensation expense (stock options) and (6) loss on debt extinguishment, and conversion expense on exchange of Convertible Notes and certain other items management believes affect the comparability of operating results. Management believes that Adjusted EBITDA, when viewed with our results under GAAP and the accompanying reconciliations, provides useful information about our period-over-period results. Adjusted EBITDA is presented because management believes it provides additional information with respect to the performance of our fundamental business activities and is also frequently used by securities analysts, investors and other interested parties in the evaluation of comparable companies. We also rely on Adjusted EBITDA as a primary measure to review and assess the operating performance of our company and our management, and it will be a focus as we invest in and grow the business. Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation from, or as a substitute for, analysis of our results as reported under GAAP. Some of these limitations are:

 

Adjusted EBITDA does not reflect our cash expenditures or future requirements for capital expenditures or contractual commitments;

 

Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;

 

Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements;

 

Adjusted EBITDA does not include the impact of certain charges or gains resulting from matters we consider not to be indicative of our ongoing operations.

 

Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business. We compensate for these limitations by relying primarily on our GAAP results and using Adjusted EBITDA only as a supplement to our GAAP results.

 

Reconciliation of Loss from Continuing Operations to Adjusted EBITDA Continuing Operations:

 

   For the   For the 
   Three Months Ended   Nine Months Ended 
   September 30,   September 30,   September 30,   September 30, 
   2023   2022   2023   2022 
                 
Loss from continuing operations  $(3,715,703)  $(6,190,347)  $(16,397,649)  $(17,656,872)
                     
Addback:                    
                     
Interest expense, net   13,138    437,301    1,095,320    931,205 
Other expense (income)   (29,511)   42,148    (30,671)   38,908 
Conversion expense   -    -    7,476,000    - 
Loss on debt  extinguishment   -    -    380,741    - 
Severance cost   22,448    -    850,813    150,000 
Depreciation and amortization   60,416    213,049    212,450    673,882 
Taxes   -    (7,052)   3,255    1,048 
Non-cash recruiting fees   -    -    438,000    - 
Stock compensation   1,519,952    2,227,764    (22,949)   6,726,871 
Adjusted EBITDA continuing operations (Non-GAAP)  $(2,129,260)  $(3,277,137)  $(5,994,690)  $(9,134,958)

 

26

 

 

Three and Nine Months Ended September 30, 2023 and September 30, 2022 – Continuing Operations

 

Revenues, net

 

During the three and nine months ended September 30, 2023, the Company’s revenues from Verified software licenses were approximately $42,000 and $114,000 compared to approximately $30,000 and $117,000 in the three and nine months ended September 30, 2022.

 

Legacy authentication services revenues were approximately $1,000 and $4,000, respectively during the three months and nine months ended September 30, 2023 compared to approximately $0 and $145,000, respectively for the three months and nine months ended September 30, 2022. Revenue from Legacy authentication services dropped significantly as the Company phased out older product offerings in 2022.

 

General and administrative expenses

 

During the three and nine months ended September 30, 2023 compared to the three and nine months ended September 30, 2022, general and administrative expense decreased by approximately $0.9 million and $5.9 million principally due to the Company’s Labor Reduction Plan, other cost saving measures resulting in lower headcount costs and lower third party vendors costs.

 

Research and development expenses

 

During the three-month and nine-month periods ended September 30, 2023 compared to September 30, 2022, research and development expenses decreased by approximately $0.9 million and $3.0 million as the Company implemented the Labor Reduction Plan, decreased staffing and third party resources.

 

Depreciation and amortization expense

 

During the three and nine months ended September 30, 2023 compared to September 30, 2022, depreciation and amortization expense was approximately $0.15 and $0.5 million less as the Company reduced the value of certain legacy business asset values.

 

Interest expense, net

 

Interest expense, net includes interest expense, debt issuance and discount amortization expense. Interest expense decreased by approximately $0.4 million during the three-month period ended September 30, 2023 compared to September 30, 2022 principally due to the exchange of Convertible Notes for common stock in May 2023. Interest expense increased by approximately $0.2 million during the nine months ended September 30, 2023 due to the issuance of $9.2 million of Convertible Notes in late March 2022, the majority of which was exchanged for common stock in May 2023.

 

Loss on debt extinguishment

 

During the nine months ended September 30, 2023, loss on debt extinguishment increased by approximately $0.4 million due to the write-off of unamortized debt issuance costs related to the Initial Promissory Note as the note balance was capitalized and extinguished in the periods. See Note 5 to the unaudited condensed consolidated financial statements “Working Capital Facility”.

 

Conversion expense

 

During the nine months ended September 30, 2023, conversion expense was approximately $7.5 million as a result of the additional shares issued by the Company in exchange for the Convertible Notes, above the number of shares that the Holders would have received upon conversion at the original conversion price under the Convertible Notes. See Note 6 to the unaudited condensed consolidated financial statements “Convertible Notes Payable”.

 

27

 

 

Three and Nine Months Ended September 30, 2023 and September 30, 2022 – Discontinued Operations

 

On May 4, 2022, the Board approved a plan to exit from certain non-core activities comprising the MultiPay correspondent bank, payments services in Colombia and the Card Plus cards manufacturing and printing business in South Africa.

 

Cards Plus business in South Africa

 

On August 29, 2022, the Company completed the sale of Cards Plus business for a price of $300,000, less $3,272 in costs to sell, and recognized a loss of $188,247 from the transaction. Of the $300,000 gross proceeds, $150,000 was paid on closing and the remaining balance of $150,000 was recorded in other current assets as of September 30, 2023. While the Company and Cards Plus continue to actively pursue payment of the remaining balance, which is subject to regulatory approval, management re-evaluated the likelihood of recovery and recorded an allowance for doubtful account in September 30, 2023 related to this receivable.

  

MultiPay business in Colombia

 

On June 30, 2023, the Company completed the sale of MultiPay business software for a price of approximately $96,000 including VAT, less $20,000 in fixed assets write-off, and recognized approximately $216,000 net gain from the transaction. The gross proceeds have been collected as of September 30, 2023.

 

Liquidity and Capital Resources

 

The Company has approximately $3.8 million of cash on hand and approximately $3.3 million of working capital as of September 30, 2023.

 

Cash used in operating activities was approximately $6.2 million and $9.6 million in the nine months ended September 30, 2023 and 2022, respectively.

 

Cash flows from investing activities for the nine months ended September 30, 2023 was approximately $17,000 for purchases of intangible assets and net cash used in investing activities for the nine months ended September 30, 2022 was approximately $183,000 for from cash disposed from sale of a continued operation, net of proceeds received from sale of discontinued operations.

 

Cash provided by financing activities in the nine months ended September 30, 2023 consisted of approximately $6.3 million in proceeds from the sale of common stock, net of offering costs, and $0.5 million initial drawdown net of debt issuance costs under the Company’s A&R Facility Agreement.

 

Cash provided by financing activities in the nine months ended September 30, 2022 consisted of approximately $3.1 million net proceeds from sale of common stock, net of offering costs and approximately $8 million net proceeds from issuance of Convertible Notes.

 

In 2023 and 2024, the Company will need to raise additional funds to support its operations and investments as it seeks to create a sustainable organization. There is no guarantee that such financing will be available, or available on acceptable terms. Our growth-oriented business plan to offer products to our customers will require continued capital investment. Research and development activities and technology deployment will require continued investment. We have raised approximately $6.4 million in 2023 (net of offering costs), through equity and debt financing at varying terms, which provides funding for our current operations as the Company continues to invest in its product, people, and technology. In order to further implement its business plan and satisfy its working capital requirements, the Company will need to raise additional capital. There is no guarantee that the Company will be able to raise additional equity or debt financing at acceptable terms, if at all.

 

There is no guarantee that our current business plan will not change, and as a result of such change, we will need additional capital to implement such business plan. Further, assuming we achieve our expected growth plan, of which there is no guarantee, we will need additional capital to implement growth beyond our current business plan.

 

28

 

 

Covid 19

 

Covid-19 emerged globally in December 2019, and it has been declared a pandemic. Covid-19 is still impacting customers, business, results and financial condition throughout the world. The Company’s day-to-day operations have been impacted differently depending on geographic location and services that are being performed. The Company cannot predict the potential impact of any future pandemics.

  

Ukraine and the Middle East

 

The ongoing war in Ukraine and the war recently commenced in the Middle East following the terrorist attack by Hamas, may impact the Company and its operations in a number of different ways, which are yet to be fully assessed and are therefore causing uncertainty. The Company works with third party sub-contractors for outsourced services, including software engineering and development, some of whom are based in Eastern Europe, including Ukraine. The Company also works with outsourced engineers and developers and third-party providers in other parts of the world, including the United States, Eastern Europe and Pakistan. While the continuing impact of these conflicts and the response of the United States and other countries to them by means of trade and economic sanctions, or other actions is still unknown, any disruption of our ability to work with such contractors caused by these conflicts could require the Company to seek alternative sub-contractors at short notice, which may give rise to additional costs and delays in delivering software and product upgrades.

 

The uncertainty impacting and potential interruption in energy and other supply chains resulting from military hostilities in Europe and the Middle East and the response of the United States and other countries to them by means of trade and economic sanctions, or other actions, may give rise to increases in costs of goods and services generally and may impact the market for our products as prospective customers reconsider additional capital expenditure, or other investment plans until the situation becomes clearer. On the other hand, the threat of increased cyber-attacks from Russia or other countries may prompt enterprises to adopt additional security measures such as those offered by the Company.

 

For so long as the hostilities continue and perhaps even thereafter as the situations in Europe and the Middle East unfold, we may see increased volatility in financial markets which may make it more difficult for the Company to raise additional capital at the time when it needs to do so, or for financing to be available on acceptable terms. All or any of these risks separately, or in combination, could have a material adverse effect on our business, financial condition, results of operations, and cash flows.

 

Off-Balance Sheet Arrangements

 

The Company has no off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is deemed by our management to be material to investors.

 

Recent Accounting Policies

 

The recent material accounting policies that may be the most critical to understanding of the financial results and conditions are discussed in Note 1 of the unaudited financial statements.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

As a smaller reporting company, we are not required to include disclosure under this item.

 

29

 

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

As of the end of the period covered by this Quarterly Report, our Chief Executive Officer and Chief Financial Officer performed an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on the evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2023, as a result of a material weakness discussed below, the Company’s disclosure controls and procedures were not effective to ensure that the information required to be disclosed by the Company in the report that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms.

 

Material Weakness in Internal Control Over Financial Reporting

 

During the quarter ended June 30, 2023, the Company identified a material weakness in its internal control over financial reporting related to the review of accounting treatment for the Convertible Notes conversion transaction, which occurred during the period. The Convertible Note conversion transaction which gave rise to this issue (See Note 6 “Convertible Notes Payable”) was a complex and infrequent transaction, which requires particular accounting treatment. The correct accounting treatment was not immediately identified by the Company, due to the Company’s limited resources available for advanced technical analysis and advice, similar to other companies of our size. The correct accounting treatment was identified and reflected prior to filing of the quarterly report on Form 10-Q for the quarter ended June 30, 2023 and no previously published financial statements were impacted by this issue.

 

Our plan to remediate this material weakness is to undertake a review of the Company’s activities during each quarter in order to identify any potential complex accounting matters and then to engage a CPA advisory firm to review the proposed accounting treatment on any complex accounting matters that may arise in the future.

 

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting (as that term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the nine months ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

30

 

 

PART II

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, the Company is a party to various legal or administrative proceedings arising in the ordinary course of business. While any litigation contains an element of uncertainty, we have no reason to believe the outcome of such proceedings will have a material adverse effect on the financial condition or results of operations of the Company.

 

ITEM 1A. RISK FACTORS

 

Risk factors describing the major risks to our business can be found under Item 1A, “Risk Factors”, in our Annual Report on Form 10-K for the year ended December 31, 2022. Except as set forth below, which discusses a material weakness in our control over financial reporting as of September 30, 2023, and the recent outbreak of war in the Middle East following the terrorist attack by Hamas, there has been no material change in our risk factors from those previously discussed in the Annual Report on Form 10-K. We operate in a business environment that is sensitive to political, economic and regulatory uncertainty, including with respect to cybersecurity and infrastructure investment, all of which may also be compounded by any future global impact from the COVID-19 pandemic, the continuing wars in Ukraine and the Middle East and inflationary pressures, rising energy prices and increases in interest rates (see “Covid 19” and “Ukraine and the Middle East” above).

 

Our business is subject to changing regulations regarding corporate governance, disclosure controls, internal control over financial reporting and other compliance areas that will increase both our costs and the risk of noncompliance. If we fail to comply with these regulations, we could face difficulties in preparing and filing timely and accurate financial reports.

 

We are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, or the Exchange Act, the Sarbanes-Oxley Act and the Dodd-Frank Act. We are also subject to the corporate governance and other listing rules of the Nasdaq Stock Market. Maintaining compliance with these rules and regulations, particularly after we cease to be an emerging growth company, will increase our legal, accounting and financial compliance costs, will make some activities more difficult, time-consuming and costly and may also place increased strain on our personnel, systems and resources.

 

The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and at the time we cease to be an emerging growth company and a smaller reporting company, we will be required to provide attestation that we maintain effective disclosure controls and procedures by our registered public accounting firm. Any failure to develop or maintain effective controls, or any difficulties encountered in their implementation or improvement, could harm our operating results or cause us to fail to meet our reporting obligations. Any failure to implement and maintain effective internal control also could adversely affect the results of periodic management evaluations regarding the effectiveness of our internal control over financial reporting that are required to include in our periodic reports filed with the SEC, under Section 404(a) of the Sarbanes-Oxley Act or the annual auditor attestation reports regarding effectiveness of our internal controls over financial reporting that we will be required to include in our periodic reports filed with the SEC upon our ceasing to be an emerging growth company and a smaller reporting company, unless, under the JOBS Act, we meet certain criteria that would require such reports to be included prior to then, under Section 404(b) of the Sarbanes-Oxley Act. Ineffective disclosure controls and procedures and internal control over financial reporting could also cause investors to lose confidence in our reported financial and other information, which would likely have a negative effect on the trading price of shares of our Common Stock.

 

31

 

 

In order to maintain the effectiveness of our disclosure controls and procedures and internal control over financial reporting going forward, we will need to expend significant resources and provide significant management oversight. There is a substantial effort involved in continuing to implement appropriate processes, document our system of internal control over relevant processes, assess their design, remediate any deficiencies identified and test their operation. As a result, management’s attention may be diverted from other business concerns, which could harm our business, operating results and financial condition. These efforts will also involve substantial accounting-related costs. We may experience difficulty in meeting these reporting requirements in a timely manner.

 

As disclosed in Item 4 of this Quarterly Report, we had a material weakness in our control over financial reporting as of September 30, 2023.  Management has taken action to implement a plan to remediate the various elements of this material weakness, with immediate effect in relation to the financial statements for the quarter and nine months ending September 30, 2023. The remediation plan is to undertake a review of the Company’s activities during each quarter in order to identify any potential complex accounting matters and then to engage a CPA advisory firm to review the proposed accounting treatment on any complex accounting matters that may arise in the future. The Company engaged a CPA advisory firm to advise on certain complex accounting matters with respect to the financial statements for the three and nine month periods ending and as of September 30, 2023.

 

If we are unable to appropriately implement and maintain this remediation plan and maintain any other necessary controls currently in place or that we implement in the future and pending such implementation, or if any difficulties are encountered in their implementation or improvement, (1) our management might not be able to certify, and our independent registered public accounting firm might not be able to report on, the adequacy of our internal control over financial reporting, which would cause us to fail to meet our reporting obligations, (2) misstatements in our financial statements may occur that may not be prevented or detected on a timely basis and (3) we may be deemed to have significant deficiencies or material weaknesses, any of which could adversely affect our business, financial condition and results of operations.

 

Implementing any appropriate changes to our internal controls may require specific compliance training of our directors, officers and employees, entail substantial costs in order to modify our existing accounting systems, and take a significant period of time to complete. Such changes may not, however, be effective in maintaining the adequacy of our internal controls, and any failure to maintain that adequacy, or consequent inability to produce accurate financial statements on a timely basis, could increase our operating costs and could materially impair our ability to operate our business. In the event that we are not able to demonstrate compliance with Section 404 of the Sarbanes-Oxley Act in a timely manner, our internal controls are perceived as inadequate or that we are unable to produce timely or accurate financial statements, our stock price could decline and we could be subject to sanctions or investigations by the SEC or other regulatory authorities, which would require additional financial and management resources. 

 

32

 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Director & Executive Officer Stock Option Grants

 

On August 15 , 2023 the Company made a grant of options to Mr. Sellitto to acquire 50,000 shares of common stock at an exercise price of $8.87 per share, exercisable for a period of ten years, vesting subject to achievement of performance and service conditions.

 

Other Stock Option Grants

 

During the nine months ended September 30, 2023 the Company also granted a total of 75,000 options to certain new employees at an exercise price of $7.36 per share.

 

All the offers and sales of securities listed above were made to accredited investors. The issuance of the above securities is exempt from the registration requirements under Rule 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506 as promulgated under Regulation D.

  

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable to our operations.

 

ITEM 5. OTHER INFORMATION

 

Nasdaq Notices

 

On January 25, 2023 the Company received a notice letter from the Listing Qualifications staff of the NASDAQ Stock Market LLC (“Nasdaq”) that it was not in compliance with the Nasdaq Listing Rule 5550(a)(2) that the Company maintain a bid price for the Company’s common stock above $1.00 per share (the “Bid Price Requirement”). On April 4, 2023, the Company received a notice letter from the Listing Qualifications staff of Nasdaq indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(b)(1) (“Rule 5550(b)(1)”) as the Company’s stockholders’ equity of $283,536, as reported on the Company’s Annual Report on Form 10-K for the period ended December 31, 2022, was below $2.5 million, which is the minimum stockholders’ equity required for compliance with Rule 5550(b)(1). Further, as of April 3, 2023, the Company did not meet the alternative compliance standards relating to the market value of listed securities, or net income from continuing operations..

  

As a result of the closing of the Offering and the Note Exchange in May 2023, the Company’s total stockholder equity is approximately $9.6 million, as reported on the Company’s form 10-Q for the period ended June 30, 2023. On May 30, 2023, the Company received notice from Nasdaq, that Nasdaq Staff has determined, that the Company complies with Rule 5550(b)(1), subject to its review of the quarterly report on Form 10-Q for the period ended June 30, 2023.

 

As a result of the Reverse Split, the Company received notice on July 24, 2023 from Nasdaq that the Company is now in compliance with the Bid Price Requirement and the matter raised by their letter of January 25, 2023 is now closed.

 

Resignation of Annie Pham and Engagement of Edward Sellitto

 

Annie Pham resigned as Chief Financial Officer effective August 15, 2023. On July 31, 2023, the Company and Edward Sellitto entered an Offer Letter pursuant to which Mr. Sellitto agreed to serve as Chief Financial Officer of the Company commencing August 15, 2023 in consideration of an annual salary of $250,000. On August 15 , 2023 the Company made a grant of options to Mr. Sellitto to acquire 50,000 shares of common stock at an exercise price of $8.87 per share, exercisable for a period of ten years, vesting subject to achievement of performance and service conditions. Annie Pham continued to assist the Company for a short period during the transition on a consulting basis.

 

33

 

 

ITEM 6. EXHIBITS

 

Exhibit
Number
  Description
3.1 (1)   Amended & Restated Certificate of Incorporation
3.2 (14)   Amended & Restated Bylaws as of July 18, 2022
3.3(2)   Certificate of Amendment dated June 1, 2021
3.4 (14)   Certificate of Amendment to Amended and Restated Certificate of Incorporation as of July 18, 2022
3.5 (15)   Certificate of Amendment to Amended and Restated Certificate of Incorporation as of September 21, 2022
3.6 (23)   Certificate of Amendment to the Amended and Restated Certificate of Incorporation dated June 26, 2023
4.1 (2)   Form of Stock Option
4.2 (3)   Form of 8.0% Convertible Note
4.3 (4)   Form of 15.0% Convertible Note
4.4 (4)   Amended and Restated Promissory Note issued to The Theodore Stern Revocable Trust
4.5 (5)   Paycheck Protection Program Term Note dated May 6, 2020
4.6 (6)   Paycheck Protection Program Term Note dated February 1, 2021
4.7 (18)   Description of the Registrant’s Securities
10.1 (2)   Form of Director Agreement
10.2 (2)   Form of Indemnification Agreement
10.5 (7)   2017 Incentive Stock Plan
10.7 (2)   Executive Retention Agreement entered between the Company and Thomas L. Thimot dated June 14, 2021
10.8 (2)   Executive Retention Agreement entered between the Company and Cecil N. Smith III dated June 14, 2021
10.9 (2)   Letter Agreement between the Company and Thomas L. Thimot dated June 14, 2021
10.10 (2)   Letter Agreement between the Company and Cecil N. Smith III dated June 14, 2021
10.11 (8)   Letter Agreement between the Company and Phillip L. Kumnick dated as November 5, 2021
10.12 (8)   Letter Agreement between the Company and Philip R. Broenniman dated as November 5, 2021
10.13 (9)   AuthID Inc. 2021 Equity Incentive Plan
10.14 (11)   Letter Agreement between AuthID Inc. and Thomas Szoke dated November 19, 2021
10.15 (10)   Form of Securities Purchase Agreement entered into between the Company and the Note Investors dated March 21, 2022.
10.16 (10)   Form of Senior Secured Convertible Note issued by the Company to the Note Investors dated March 21, 2022.
10.17 (10)   Security and Pledge Agreement entered into between the Company and Stephen J. Garchik as Collateral Agent dated March 21, 2022.
10.19 (10)   Form of Registration Rights Agreement entered into between the Company and the Note Investors dated March 21, 2022.
10.20 (10)   Facility Agreement entered into between the Company and Stephen J. Garchik dated March 21, 2022.
10.21 (10)   Form of Subscription Agreement entered into between the Company and the PIPE Investors dated March 21, 2022.
10.22 (12)   Letter Agreement between Joseph Trelin and AuthID Inc. dated April 18, 2022
10.23 (13)   Letter Agreement between Annie Pham and AuthID Inc. dated April 25, 2022
10.24 (16)   Amended and Restated Facility Agreement between the Company and Stephen J. Garchik dated March 8, 2023.
10.25 (16)   Promissory Note between the Company and Stephen J. Garchik dated March 9, 2023.
10.26 (16)   Guaranty Agreement by FIN Holdings Inc., Innovation in Motion, Inc. and ID Solutions, Inc. in favor of Stephen J. Garchik dated March 9, 2023.
10.27 (16)   Release Agreement between the Company and Stephen J. Garchik dated March 9, 2023.
10.28 (17)   Letter Agreement between Rhoniel Daguro and AuthID Inc. dated March 23, 2023
10.29 (17)   Executive Retention Agreement between Rhoniel Daguro and AuthID Inc. dated March 23, 2023
10.30 (17)   Confidential Separation Agreement and General Release between Thomas Thimot and authID Inc. Dated March 23, 2023
10.31 (19)   Letter Agreement between Thomas Szoke and AuthID Inc. dated April 12, 2023
10.32 (19)   Executive Retention Agreement between Thomas Szoke and AuthID Inc. dated April 12, 2023
10.33 (21)   Executive Retention Agreement between Annie Pham and AuthID Inc. dated May 11, 2023
10.34 (22)**   Form of Securities Purchase Agreement dated as of May 23, 2023 between the Company and accredited investors
10.35 (22)   Engagement Agreement dated as of April 20, 2023 between the Company and Madison Global Partners LLC
10.36 (22)   Stock Purchase Warrant dated May 26, 2023 issued to Madison Global Partners LLC
10.37 (22)**   Form of Exchange Agreement dated as of May 23, 2023 between the Company and certain Holders
10.38 (24)   Letter Agreement between Edward Sellitto and authID Inc. dated July 31, 2023
10.39 (25)   Agreement dated October 25, 2023 between The Pipeline Group, Inc. and authID Inc.
14.1*   Code of Ethics
21.1 (20)   List of Subsidiaries
31.1*   Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act
31.2*   Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act
32.1*   Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
99.1*   Policy for the Recovery of Erroneously Awarded Compensation adopted October 6, 2023
101.INS   Inline XBRL Instance Document *
101.SCH   Inline XBRL Taxonomy Extension Schema Document *
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document *
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document *
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document *
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document *
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

* Filed herewith

 

34

 

 

** Certain schedules and exhibits to this agreement have been omitted pursuant to Instruction 4 to Item 1.01 of Form 8-K. A copy of any omitted schedule or exhibit will be furnished to the SEC upon request.

 

(1) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on March 23, 2021.
(2) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on June 15, 2021.
(3) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on December 16, 2019.
(4) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on February 18, 2020.
(5) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on May 13, 2020.
(6) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities Exchange Commission on May 6, 2021.
(7) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities Exchange Commission on May 4, 2018.
(8) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities Exchange Commission on November 8, 2021.
(9) Incorporated by reference to the Form S-8 Registration Statement filed with the Securities Exchange Commission on February 1, 2022.
(10) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on March 21, 2022.
(11) Incorporated by reference to the Form 10-K Annual Report filed with the Securities Exchange Commission on March 22, 2022.
(12) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on April 18, 2022.
(13) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on April 27, 2022.
(14) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on July 19, 2022.
(15) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on September 21, 2022.
(16) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on March 10, 2023.
(17) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on March 28, 2023.
(18) Incorporated by reference to the Form 10-K Annual Report filed with the Securities Exchange Commission on March 30, 2023.
(19) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on April 18, 2023.
(20) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities Exchange Commission on May 11, 2023.
(21) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on May 16, 2023.
(22) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on May 26, 2023.
(23) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on June 27, 2023.
(24) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on August 3, 2023.
(25) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 26, 2023.

 

35

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  authID Inc.

 

  By: /s/ Rhoniel Daguro
    Rhoniel A. Daguro
    Chief Executive Officer
    (Principal Executive Officer)
     
  By: /s/ Ed Sellitto
    Ed Sellitto
    Chief Financial Officer,
    (Principal Financial and Accounting Officer)
Dated: November 8, 2023    

 

 

36

 

 

0.53 2.00 3.13 5.80 0.00 0.04 0.05 0.18 3044151 3102745 5376821 7874962 0.55 0.83 1.06 1.61 3.08 3.91 false --12-31 Q3 0001534154 0001534154 2023-01-01 2023-09-30 0001534154 2023-11-06 0001534154 2023-09-30 0001534154 2022-12-31 0001534154 auid:VerifiedSoftwareLicenseMember 2023-07-01 2023-09-30 0001534154 auid:VerifiedSoftwareLicenseMember 2022-07-01 2022-09-30 0001534154 auid:VerifiedSoftwareLicenseMember 2023-01-01 2023-09-30 0001534154 auid:VerifiedSoftwareLicenseMember 2022-01-01 2022-09-30 0001534154 auid:LegacyAuthenticationServicesMember 2023-07-01 2023-09-30 0001534154 auid:LegacyAuthenticationServicesMember 2022-07-01 2022-09-30 0001534154 auid:LegacyAuthenticationServicesMember 2023-01-01 2023-09-30 0001534154 auid:LegacyAuthenticationServicesMember 2022-01-01 2022-09-30 0001534154 2023-07-01 2023-09-30 0001534154 2022-07-01 2022-09-30 0001534154 2022-01-01 2022-09-30 0001534154 us-gaap:CommonStockMember 2022-12-31 0001534154 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001534154 us-gaap:RetainedEarningsMember 2022-12-31 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001534154 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001534154 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001534154 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0001534154 us-gaap:CommonStockMember 2023-09-30 0001534154 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001534154 us-gaap:RetainedEarningsMember 2023-09-30 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001534154 us-gaap:CommonStockMember 2023-06-30 0001534154 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001534154 us-gaap:RetainedEarningsMember 2023-06-30 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001534154 2023-06-30 0001534154 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001534154 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001534154 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001534154 us-gaap:CommonStockMember 2021-12-31 0001534154 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001534154 us-gaap:RetainedEarningsMember 2021-12-31 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001534154 2021-12-31 0001534154 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001534154 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001534154 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0001534154 us-gaap:CommonStockMember 2022-09-30 0001534154 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001534154 us-gaap:RetainedEarningsMember 2022-09-30 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001534154 2022-09-30 0001534154 us-gaap:CommonStockMember 2022-06-30 0001534154 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001534154 us-gaap:RetainedEarningsMember 2022-06-30 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001534154 2022-06-30 0001534154 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001534154 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001534154 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001534154 srt:ScenarioForecastMember 2024-09-30 0001534154 us-gaap:ConvertibleDebtSecuritiesMember 2023-07-01 2023-09-30 0001534154 us-gaap:ConvertibleDebtSecuritiesMember 2023-01-01 2023-09-30 0001534154 us-gaap:ConvertibleDebtSecuritiesMember 2022-07-01 2022-09-30 0001534154 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-09-30 0001534154 us-gaap:WarrantMember 2023-07-01 2023-09-30 0001534154 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001534154 us-gaap:WarrantMember 2022-07-01 2022-09-30 0001534154 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001534154 us-gaap:StockOptionMember 2023-07-01 2023-09-30 0001534154 us-gaap:StockOptionMember 2023-01-01 2023-09-30 0001534154 us-gaap:StockOptionMember 2022-07-01 2022-09-30 0001534154 us-gaap:StockOptionMember 2022-01-01 2022-09-30 0001534154 auid:AcquiredAndDevelopedSoftwareMember 2023-09-30 0001534154 us-gaap:PatentsMember 2023-09-30 0001534154 auid:AcquiredAndDevelopedSoftwareMember 2022-12-31 0001534154 us-gaap:PatentsMember 2022-12-31 0001534154 auid:AcquiredAndDevelopedSoftwareMember 2023-01-01 2023-09-30 0001534154 us-gaap:PatentsMember 2023-01-01 2023-09-30 0001534154 auid:LaborReductionPlanMember 2023-01-01 2023-09-30 0001534154 auid:LaborReductionPlanMember 2023-09-30 0001534154 auid:OriginalFacilityAgreementMember 2022-03-21 0001534154 auid:OriginalFacilityAgreementMember 2022-03-21 2022-03-21 0001534154 auid:ARFacilityAgreementMember 2023-03-08 2023-03-08 0001534154 auid:GarchikMember 2023-03-09 2023-03-09 0001534154 auid:OriginalFacilityAgreementMember 2023-03-31 0001534154 auid:ARFacilityAgreementMember 2023-03-31 0001534154 auid:ARFacilityAgreementMember 2023-05-25 2023-05-25 0001534154 auid:ARFacilityAgreementMember 2023-01-01 2023-09-30 0001534154 auid:ConvertibleNotesMember 2022-03-21 2022-03-21 0001534154 auid:ConvertibleNotesMember 2022-03-21 0001534154 2022-03-21 2022-03-21 0001534154 2022-03-21 0001534154 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-09-30 0001534154 us-gaap:ConvertibleNotesPayableMember 2022-09-30 0001534154 us-gaap:CommonStockMember 2022-09-30 0001534154 us-gaap:CommonStockMember 2023-09-30 0001534154 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001534154 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001534154 us-gaap:CommonStockMember 2023-05-23 0001534154 auid:ConvertibleNotesMember 2023-05-23 2023-05-23 0001534154 auid:ConvertibleNotesMember 2023-05-23 0001534154 srt:OfficerMember auid:ConvertibleNotesMember 2023-05-23 0001534154 auid:ConvertibleNotesMember 2023-06-07 2023-06-07 0001534154 auid:ConvertibleNotesMember 2023-06-07 0001534154 2023-05-23 2023-05-23 0001534154 auid:ConvertibleNotesMember 2023-09-30 0001534154 2023-05-23 0001534154 auid:MrStephenJGarchikMember 2023-05-23 0001534154 srt:MaximumMember auid:MrStephenJGarchikMember 2023-05-23 2023-05-23 0001534154 srt:MinimumMember auid:MrStephenJGarchikMember 2023-05-23 2023-05-23 0001534154 auid:MrGarchikMember 2023-05-23 2023-05-23 0001534154 2023-03-01 2023-03-06 0001534154 auid:MrGarchikMember auid:ARFacilityAgreementMember 2023-05-09 2023-05-09 0001534154 srt:MaximumMember 2023-05-25 2023-05-25 0001534154 srt:MinimumMember 2023-05-25 2023-05-25 0001534154 auid:MrDaguroMember auid:InitialAnnualSalaryMember 2023-03-23 2023-03-23 0001534154 srt:MaximumMember auid:MrDaguroMember us-gaap:DeferredBonusMember 2023-03-23 2023-03-23 0001534154 srt:ScenarioForecastMember auid:MrDaguroMember us-gaap:DeferredBonusMember 2024-03-01 2024-03-31 0001534154 srt:ScenarioForecastMember auid:MrDaguroMember auid:AchievingIncrementsMember 2024-03-01 2024-03-31 0001534154 srt:ScenarioForecastMember srt:ChiefExecutiveOfficerMember 2024-03-01 2024-03-31 0001534154 auid:MrDaguroMember 2023-04-10 2023-04-10 0001534154 auid:MrDaguroMember us-gaap:WarrantMember 2023-04-10 2023-04-10 0001534154 auid:MrDaguroMember 2023-06-28 2023-06-28 0001534154 auid:MrDaguroMember us-gaap:WarrantMember 2023-06-28 2023-06-28 0001534154 srt:ChiefFinancialOfficerMember 2022-04-25 2022-04-25 0001534154 2022-04-25 2022-04-25 0001534154 auid:MsPhamMember 2022-04-25 2022-04-25 0001534154 auid:MsPhamMember 2022-04-25 0001534154 auid:MsPhamMember us-gaap:DeferredBonusMember 2023-05-11 2023-05-11 0001534154 auid:MrSzokeMember auid:InitialAnnualSalaryMember 2023-04-12 2023-04-12 0001534154 auid:MrSzokeMember us-gaap:DeferredBonusMember 2023-04-12 2023-04-12 0001534154 srt:MaximumMember auid:MrSzokeMember us-gaap:DeferredBonusMember 2023-04-12 2023-04-12 0001534154 srt:ScenarioForecastMember auid:MrSzokeMember us-gaap:DeferredBonusMember 2024-03-01 2024-03-31 0001534154 srt:ScenarioForecastMember auid:MrSzokeMember auid:AchievingIncrementsMember 2024-03-01 2024-03-31 0001534154 srt:ScenarioForecastMember 2024-03-01 2024-03-31 0001534154 auid:MrSzokeMember 2023-03-14 2023-03-14 0001534154 auid:MrSzokeMember 2023-06-28 2023-06-28 0001534154 auid:MrSzokeMember 2023-06-28 0001534154 auid:MrSzokeMember 2023-01-01 2023-09-30 0001534154 auid:MrSellittoMember auid:InitialAnnualSalaryMember 2023-08-15 2023-08-15 0001534154 auid:MrSellittoMember 2023-01-01 2023-09-30 0001534154 srt:BoardOfDirectorsChairmanMember 2023-03-09 2023-03-09 0001534154 2023-03-09 0001534154 auid:MessrsJosephTrelinMichaelKoehnemanMember 2023-06-28 2023-06-28 0001534154 auid:MessrsJosephTrelinMichaelKoehnemanMember 2023-06-28 0001534154 auid:MsJacquelineWhiteMember 2023-06-28 2023-06-28 0001534154 auid:MsJacquelineWhiteMember 2023-06-28 0001534154 auid:TPGMember 2023-01-01 2023-09-30 0001534154 auid:TPGMember 2023-10-25 2023-10-25 0001534154 2023-06-26 2023-06-26 0001534154 2023-05-26 2023-05-26 0001534154 us-gaap:CommonStockMember 2023-05-26 2023-05-26 0001534154 us-gaap:CommonStockMember 2023-05-26 0001534154 auid:MrGarchikMember 2023-05-26 2023-05-26 0001534154 auid:ConvertibleNotesMember 2023-05-26 2023-05-26 0001534154 auid:ConvertibleNotesMember 2023-05-26 0001534154 auid:ConvertibleNotesMember 2023-01-01 2023-09-30 0001534154 auid:MadisonIIILLCMember 2023-05-12 0001534154 auid:MadisonGlobalPartnersLLCMember 2023-05-26 0001534154 srt:BoardOfDirectorsChairmanMember 2023-09-30 0001534154 srt:BoardOfDirectorsChairmanMember 2023-01-01 2023-09-30 0001534154 srt:ChiefExecutiveOfficerMember 2023-09-30 0001534154 srt:ChiefExecutiveOfficerMember 2023-01-01 2023-09-30 0001534154 auid:ChiefTechnologyOfficerMember 2023-09-30 0001534154 auid:ChiefTechnologyOfficerMember 2023-01-01 2023-09-30 0001534154 srt:ChiefFinancialOfficerMember 2023-09-30 0001534154 srt:ChiefFinancialOfficerMember 2023-01-01 2023-09-30 0001534154 us-gaap:WarrantMember 2022-12-31 0001534154 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001534154 us-gaap:WarrantMember 2023-09-30 0001534154 srt:MinimumMember 2023-01-01 2023-09-30 0001534154 srt:MaximumMember 2023-01-01 2023-09-30 0001534154 auid:LessThanOrEqual3200Member 2023-09-30 0001534154 auid:LessThanOrEqual3200Member 2023-01-01 2023-09-30 0001534154 auid:LessThanOrEqual32085600Member 2023-09-30 0001534154 auid:LessThanOrEqual32085600Member 2023-01-01 2023-09-30 0001534154 auid:LessThanOrEqual56088000Member 2023-09-30 0001534154 auid:LessThanOrEqual56088000Member 2023-01-01 2023-09-30 0001534154 auid:LessThanOrEqual800812776Member 2023-09-30 0001534154 auid:LessThanOrEqual800812776Member 2023-01-01 2023-09-30 0001534154 srt:ScenarioPreviouslyReportedMember 2023-01-01 2023-03-31 0001534154 srt:RestatementAdjustmentMember 2023-01-01 2023-03-31 0001534154 auid:AsRevisedMember 2023-01-01 2023-03-31 0001534154 srt:ScenarioPreviouslyReportedMember 2023-01-01 2023-06-30 0001534154 srt:RestatementAdjustmentMember 2023-01-01 2023-06-30 0001534154 auid:AsRevisedMember 2023-01-01 2023-06-30 0001534154 srt:ScenarioPreviouslyReportedMember 2023-03-31 0001534154 srt:RestatementAdjustmentMember 2023-03-31 0001534154 auid:AsRevisedMember 2023-03-31 0001534154 srt:ScenarioPreviouslyReportedMember 2023-06-30 0001534154 srt:RestatementAdjustmentMember 2023-06-30 0001534154 auid:AsRevisedMember 2023-06-30 0001534154 auid:CardsPlusBusinessInSouthAfricaMember 2022-08-29 2022-08-29 0001534154 auid:CardsPlusBusinessInSouthAfricaMember 2022-08-29 0001534154 auid:MultiPayBusinessInColombiaMember 2023-01-01 2023-09-30 0001534154 auid:MultiPayMember 2023-09-30 0001534154 auid:MultiPayMember 2023-01-01 2023-09-30 0001534154 us-gaap:SegmentDiscontinuedOperationsMember 2023-07-01 2023-09-30 0001534154 us-gaap:SegmentDiscontinuedOperationsMember 2022-07-01 2022-09-30 0001534154 us-gaap:SegmentDiscontinuedOperationsMember 2023-01-01 2023-09-30 0001534154 us-gaap:SegmentDiscontinuedOperationsMember 2022-01-01 2022-09-30 0001534154 auid:CardsPlusMember 2023-07-01 2023-09-30 0001534154 auid:CardsPlusMember 2022-07-01 2022-09-30 0001534154 auid:CardsPlusMember 2023-01-01 2023-09-30 0001534154 auid:CardsPlusMember 2022-01-01 2022-09-30 0001534154 auid:MultiPayMember 2023-07-01 2023-09-30 0001534154 auid:MultiPayMember 2022-07-01 2022-09-30 0001534154 auid:MultiPayMember 2023-01-01 2023-09-30 0001534154 auid:MultiPayMember 2022-01-01 2022-09-30 0001534154 2022-01-01 2022-12-31 0001534154 2022-07-01 2022-07-31 0001534154 auid:ContinuingOperationsMember 2022-01-01 2022-09-30 0001534154 auid:DiscontinuedOperationsMember 2022-01-01 2022-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Exhibit 14.1

 

AUTHID INC.

 

CODE OF ETHICS

 

Adopted October 6, 2023

 

GENERAL STATEMENT OF POLICY:

 

Honesty and candor in our activities, including observance of the spirit, as well as the letter of the law;

 

Avoidance of conflicts between personal interests and the interests of the Company, or even the appearance of such conflicts;

 

Avoidance of Company payments to candidates running for government posts or other government officials;

 

Compliance with generally accepted accounting principles and controls;

 

Maintenance of our reputation and avoidance of activities which might reflect adversely on the Company; and

 

Integrity in dealing with the Company's assets.

 

References to “authID Inc.”, “authID” or the “Company” are intended to refer only to authID Inc. and its subsidiaries. The term "associate" shall include all directors, officers and employees and any spouse, children, any dependents, or any person or entity acting as the agent or fiduciary for any of the foregoing, through which an associate may receive direct or indirect personal benefit.

 

A.HONESTY, CANDOR AND OBSERVANCE OF LAWS

 

a.VIOLATIONS OF THE CODE OF ETHICS

 

Violations of the Code of Ethics or any of the Company's rules of conduct in effect will constitute grounds for disciplinary action, up to and including termination. Associates are expected to act fairly and honestly in all transactions with the Company and with others and to maintain the high ethical standards of the Company in accordance with this Code of Ethics.

 

b.DISCOVERY OF VIOLATIONS OF THE CODE OF ETHICS OR
ILLEGAL ACTIVITIES

 

Discovery of events of a questionable, fraudulent or illegal nature or which appear to be in violation of the Code of Ethics must be promptly reported. Failure to report such events also constitutes a violation of the Code of Ethics.

 

Associates are encouraged to report concerns of internal fraud — whether it is a suspicion of theft, accounting irregularities or violations of the law — through a choice of confidential reporting processes outlined in the Company’s Whistleblower Policy.

 

Retaliation against any associate who files a claim of internal fraud will not be tolerated. Any act of retaliation will be subject to corrective action up to and including immediate termination.

 

1

 

 

c.COMPLIANCE WITH LAWS AND REGULATIONS

 

The Company strives to comply with all the laws and regulations that are applicable to its business. As a good citizen, the Company emphasizes good faith efforts to follow the spirit and intent of the law.

 

d.CANDOR AMONG ASSOCIATES AND IN DEALING WITH AUDITORS
AND COUNSEL

 

Senior management of the Company must be informed at all times of matters that might adversely affect the reputation of the Company, regardless of the source of such information. Concealment may be considered a signal that the Company's policies and rules can be ignored, and such conduct cannot be tolerated. Moreover, complete candor is essential in dealing with the Company's independent auditors and attorneys.

 

B.CONFLICTS OF INTEREST

 

a.CONFLICTS OF INTEREST, GENERALLY

 

i.The primary principle underlying the Company's conflicts of interest policies is that associates, and officers in particular, must never permit their personal interests to conflict or appear to conflict with the interests of the Company or its customers.

 

ii.No associate of authID, nor any member of their family, should accept any form of compensation from, be employed by or act as a consultant to, or have any ownership in, a vendor of authID, or any competitor of authID, without the express approval of authID's Chief Executive Officer. Generally speaking, associates and family members (including spouses, children, parents and siblings) should avoid any financial interest in a non-publicly owned vendor or competitor. If such interest does exist, subject to CEO approval, it should be limited to one-tenth of one percent of the entity's (vendor or competitor) outstanding securities and a maximum of ten percent of the associate or family member's total assets.

 

iii.No associate may act on behalf of the Company in any transaction involving persons or organizations with whom he/she or his/her family has any significant connection or financial interest.

 

iv.Officers and Directors are subject to higher standards of review for interested-party transactions. All such transactions must be openly disclosed to a disinterested majority of the Board of Directors and subject to a rigorous independent review.

 

v.Any associate in a conflict situation should discuss the matter with his or her immediate supervisor or should contact their Executive Staff representative. Usually, associates will be required to remove themselves from a conflict situation.

 

b.RECEIPT OR PAYMENT OF BRIBES, COMMISSIONS, HONORARIUMS, LOANS, GIFTS, GRATUITIES AND ENTERTAINMENT

 

i.The Company does not permit or condone bribes, kickbacks, improper commissions, honorariums, loans, gifts, gratuities or any other illegal, secret, or improper payments, transfers or receipts.

 

2

 

 

ii.No associate may accept a gift other than of nominal value directly or indirectly, in any form, from a supplier or prospective supplier.

 

iii.As a general rule, no associate may accept a gift from any customer or prospective customer of the Company. Under no circumstances should an associate request or otherwise solicit from any customer, supplier or prospective customer or supplier, any gifts or similar gratuities, regardless of monetary worth.

 

c.CORPORATE HOSPITALITY TO THE PUBLIC OFFICIALS

 

i.Acts of hospitality toward public officials should never be on such a scale or of such a nature as might tend to compromise or give the impression of compromising the integrity or the reputation of either the public official or the Company.

 

ii.In no event shall authID's name be used to enhance an associate's own political opportunities.

 

d.DEALING WITH PROSPECTIVE SUPPLIERS

 

i.Associates must award orders, contracts and commitment to suppliers of goods or services without favoritism. Company business of this nature must be conducted strictly on the basis of merit.

 

e.FAIR COMPETITION

 

i.Under no circumstances should associates enter into arrangements with the Company's competitors affecting pricing or marketing arrangements. Such arrangements are illegal under federal and state antitrust laws.

 

f.CONDUCT WITH COMPETITORS

 

i.In all contacts with competitors, whether at trade/business association meetings or in other venues, do not discuss pricing policy, contract terms, costs, inventories, marketing and product plans, market surveys and studies, production plans and capabilities; and, of course, any other proprietary or confidential information.

 

3

 

 

Discussion of these subjects or collaboration on them with competitors can be illegal. If a competitor raises any of them, even lightly or with apparent innocence, you should object, stop the conversation immediately, and tell the competitor that under no circumstances will you discuss these matters.

 

In summary, disassociate yourself and authID from participation in any possibly illegal activity with competitors; confine your communication to what is clearly legal and proper. If necessary, you should leave the meeting. Finally, report immediately to the Chief Financial Officer or General Counsel any incident involving a prohibited subject.

 

Accidental, casual or social contact with competitors can be suspect and considered circumstantial evidence of a conspiracy.

 

g.PERSONAL FEES AND COMMISSIONS

 

i.No associate may accept personal fees or commissions from third parties in connection with any transactions on behalf of the Company. The acceptance of payments from suppliers requires the prior written approval of the Chief Financial Officer.

 

h.WORK RELATIONSHIPS

 

i.No associate shall give or receive any special consideration to the conditions of employment of another associate due to family or personal relationships.

 

ii.No employment decisions, whether they be decisions to hire, employ, promote, transfer, change compensation, or bar or discharge from employment, shall be based in whole or in part upon considerations of age, race, creed, color, national origin, sex, pregnancy, disability, sexual orientation, veteran or marital status or any other category protected under federal, state or local law, regulation or ordinance of any individual, unless based upon a bona fide occupational qualification or other exception.

 

C.CONFIDENTIALITY

 

a.CONFIDENTIAL INFORMATION CONCERNING THE COMPANY

 

Except as set forth under the heading “Reservation of Right”, officers and associates must not divulge any non-public information regarding the Company to any outsider except for a legitimate business purpose and with the express understanding that the information is confidential and is to be used solely for the limited business purpose for which it was given and received. This information may include, but is not limited to: salary and personnel information, customer lists and data; including names, addresses, phone numbers, banking, credit card and other personal data, budgets and forecasts, and marketing and sales plans. Disclosure of such proprietary information to non-authID personnel (vendors, customers, competitors, etc.) should only occur with the express approval of the CEO, CFO or General Counsel.

 

4

 

 

b.CONFIDENTIAL INFORMATION CONCERNING SUPPLIERS

 

Confidential or sensitive information, such as pricing, submitted to and maintained by the Company in connection with the purchase of equipment, supplies and services, must be maintained in strictest confidence, in order to avoid giving or removing any competitive advantage with respect to any of several suppliers. Such information should remain confidential, except as set forth under the heading “Reservation of Rights”.

 

D.SECURITIES, INVESTMENT AND TRADING

 

a.PERSONAL INVESTMENTS

 

Associates are free to invest in stock, bonds and other securities at their discretion, but must always comply with applicable laws and regulations.

 

b.INSIDER TRADING

 

Associates must never make changes in their personal investment portfolios on the basis of confidential information relating to the Company or obtained through the Company's business. In addition, associates are expected to follow the Company's Insider Stock Trading Policy and any other internal policies and procedures in effect from time to time.

 

c.VIOLATIONS OF LAW

 

Significant federal laws govern the disclosure of material, non-public information or trading in the Company's Common Stock on the basis of any such information. Those who disclose confidential information to an outsider who either trades on the information or passes the information along will be subject to the same sanctions as if they had traded the Company's Common Stock themselves.

 

d.RESPONSE TO INQUIRIES FROM OUTSIDERS

 

Requests for information on authID's financial performance or other topics from the media or any other source should be directed to the Chief Financial Officer or General Counsel. authID associates should not answer such inquiries themselves. This does not preclude communications as set forth under the heading “Reservation of Rights”.

 

5

 

 

E.DEALING WITH THE ASSETS OF THE CORPORATION

 

a.PROPRIETARY INFORMATION, PRODUCTS, SERVICES AND OTHER PROPERTY

 

i.All associates shall protect the Company's ownership of property, including information, products and services.

 

ii.The misuse or removal from Company office, warehouse or store facilities of the Company's merchandise, promotional product, furnishings, equipment, reports, computer software, data processing systems and supplies is prohibited, unless specifically authorized.

 

iii.Any contribution an associate makes to development and implementation of ideas or products while employed by the Company are the Company's property and remain its property even if the associate leaves the Company's employ.

 

b.BRIBES AND PREFERENTIAL TREATMENT

 

Bribes and kickbacks are illegal. No bribes, kickbacks, or other similar remuneration or consideration shall be given to any person or organization in order to attract business, obtain real estate or otherwise act in a manner even though it may appear to enhance the Company's best interests.

 

c.PAYMENTS OR GIFTS TO U.S. OR FOREIGN GOVERNMENT OFFICIALS

 

Payments or gifts to U.S. or foreign government officials are strictly prohibited.

 

d.POLITICAL CONTRIBUTIONS

 

Federal law (and many states) prohibits corporations from making contributions directly or in kind to candidates for elected office or to political parties.

 

e.FOREIGN BUSINESS

 

authID and its associates are required to honor all applicable foreign and United States law, including international agreements to which the U.S. has assented.

 

f.ENVIRONMENTAL, HEALTH AND SAFETY STANDARDS

 

authID and its associates are required to comply with all applicable environmental, health and safety laws and regulations.

 

g.COMMUNITY RELATIONS

 

authID and its associates are required to conduct themselves as responsible and useful corporate citizens in all of the communities in which we operate.

 

6

 

 

h.PROPER ACCOUNTING

 

i.The Company has established internal accounting controls and record-keeping policies in order to meet both the legal and the business requirements of the Company. The Company has designed the accounting policies to comply with the Foreign Corrupt Practices Act, as well as all other current and future relevant legislation and regulations. Associates are expected to maintain and adhere to these controls and policies.

 

ii.The accounting records of the Company must be complete, accurate and in reasonable detail. Such records include books of original entry and other financial information used for internal management decision-making and external reporting. The underlying transactions must be properly authorized and recorded on a timely basis in order to permit preparation of financial statements in accordance with generally accepted accounting principles and maintain accountability of assets. No fund or asset which is not fully and properly recorded on the Company's books is permitted.

 

iii.All officers and associates of the Company who are authorized to incur business expenses are responsible for the accurate and timely reporting of such expenses. All expenditures must be in accordance with existing policies.

 

iv.It is unlawful to falsify any book, record or account which reflects transactions of the Company's assets.

 

v.No secret or unrecorded funds or assets shall be established or continued.

 

F.RESERVATION OF RIGHTS

 

Nothing in this Code of Ethics or any policies of the Company prohibits any Associate from reporting possible violations of law or regulation to any governmental agency or entity or making other disclosures that are protected under the whistleblower provisions of federal law or regulation or from participating in any investigation or proceeding that may be conducted by any government agency. You do not need the prior consent of the Company to make any such reports and you are not required to disclose to or notify the Company if any such reports are made.

 

G.EQUAL EMPLOYMENT OPPORTUNITY

 

authID is an equal opportunity employer. This policy prohibits discrimination on any basis considered unlawful under federal, state and/or local laws including but not limited to age, race, religion, color, national origin, citizenship, physical or mental disability, sex, marital status, veteran's status, sexual orientation, pregnancy or any other category protected under federal, state or local law, regulation or ordinance. authID is dedicated to ensuring the fulfillment of this policy with respect to hiring, placement, promotion, transfer, demotion, lay-off, termination, recruitment, advertising, rates of pay or other forms of compensation, selection for training and general treatment during employment. This includes making reasonable accommodations for applicants and employees with disabilities unless the accommodation would impose an undue hardship on the operation of our business.

 

In addition, it is authID's policy to prohibit harassment of any associate by a manager, supervisor, co-worker, client, customer or visitor on the basis of the above-mentioned classifications, including gender. The purpose of this policy is to ensure that at authID all associates are free from harassment on the basis of all the above-mentioned classifications including but not limited to gender.

 

 

7

 

 

Exhibit 31.1

 

 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

 

I, Rhoniel Daguro, Chief Executive Officer certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of authID Inc;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant) and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial data information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: November 8, 2023

/s/ Rhoniel Daguro

  Rhoniel Daguro
 

Chief Executive Officer

(Principal Executive Officer)

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER
PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

 

I, Edward Sellitto Chief Financial Officer, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of authID Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant) and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial data information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: November 8, 2023

/s/ Ed Sellitto

  Ed Sellitto
 

Chief Financial Officer

(Principal Financial and Accounting Officer)

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of authID Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023 as filed with the Securities and Exchange Commission (the “Report”), I, Rhoniel Daguro, Chief Executive Officer of the Company, and, Edward Sellitto, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

November 8, 2023

/s/ Rhoniel Daguro

 

Rhoniel Daguro

Chief Executive Officer

  (Principal Executive Officer)

 

November 8, 2023

/s/ Ed Sellitto

  Ed Sellitto, Chief Financial Officer
  (Principal Financial and Accounting Officer)

 

 

 

Exhibit 99.1 

 

AUTHID INC.

POLICY FOR THE

RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION

 

A.OVERVIEW

 

In accordance with the applicable rules of The Nasdaq Stock Market (the “Nasdaq Rules”), Section 10D and Rule 10D-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (“Rule 10D-1”), the Board of Directors (the “Board”) of authID Inc. (the “Company”) has adopted this Policy (the “Policy”) to provide for the recovery of erroneously awarded Incentive-based Compensation from Covered Persons. All capitalized terms used and not otherwise defined herein shall have the meanings set forth in Section H, below.

 

B.RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION

 

(1) In the event of an Accounting Restatement, the Company will reasonably promptly recover the Erroneously Awarded Compensation Received in accordance with Nasdaq Rules and Rule 10D-1 as follows:

 

(i)After an Accounting Restatement, the Compensation Committee (if composed entirely of independent directors, or in the absence of such a committee, a majority of independent directors serving on the Board) (the “Committee”) shall determine the amount of any Erroneously Awarded Compensation Received by each Covered Person and shall promptly notify each Covered Person with a written notice containing the amount of any Erroneously Awarded Compensation and a demand for repayment or return of such compensation, as applicable.

 

(ii)For Incentive-based Compensation based on (or derived from) the Company’s stock price or total shareholder return, where the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in the applicable Accounting Restatement:

 

(a)The amount to be repaid or returned shall be determined by the Committee based on a reasonable estimate of the effect of the Accounting Restatement on the Company’s stock price or total shareholder return upon which the Incentive-based Compensation was Received; and
   
(b)The Company shall maintain documentation of the determination of such reasonable estimate and provide the relevant documentation as required to the Nasdaq.

 

(iii)The Committee shall have discretion to determine the appropriate means of recovering Erroneously Awarded Compensation based on the particular facts and circumstances. Notwithstanding the foregoing, except as set forth in Section B(2) below, in no event may the Company accept an amount that is less than the amount of Erroneously Awarded Compensation in satisfaction of a Covered Person’s obligations hereunder. The method for recovering Erroneously Awarded Compensation hereunder may include, without limitation, any one or more of the following:

 

(a)requiring reimbursement of cash Incentive-Based Compensation previously paid;
   
(b)seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards;

 

 

 

 

(c)cancelling or rescinding some or all outstanding vested or unvested equity-based awards;
   
(d)adjusting or withholding from unpaid compensation or other set-off;
   
(e)cancelling or offsetting against planned future grants of equity-based awards; and/or
   
(f)any other method permitted by applicable law or contract.

 

Notwithstanding the foregoing, a Covered Person will be deemed to have satisfied such person’s obligation to return Erroneously Awarded Compensation to the Company if such Erroneously Awarded Compensation is returned in the exact same form in which it was received; provided that equity withheld to satisfy tax obligations will be deemed to have been received in cash in an amount equal to the tax withholding payment made.

 

(iv)To the extent that the Covered Person has already reimbursed the Company for any Erroneously Awarded Compensation Received under any duplicative recovery obligations established by the Company or applicable law, it shall be appropriate for any such reimbursed amount to be credited to the amount of Erroneously Awarded Compensation that is subject to recovery under this Policy.

 

(v)To the extent that a Covered Person fails to repay all Erroneously Awarded Compensation to the Company when due, the Company shall take all actions reasonable and appropriate to recover such Erroneously Awarded Compensation from the applicable Covered Person. The applicable Covered Person shall be required to reimburse the Company for any and all expenses reasonably incurred (including legal fees) by the Company in recovering such Erroneously Awarded Compensation in accordance with the immediately preceding sentence.

 

(2) Notwithstanding anything herein to the contrary, the Company shall not be required to take the actions contemplated by Section B(1) above if the Committee (which, as specified above, is composed entirely of independent directors or in the absence of such a committee, a majority of the independent directors serving on the Board) determines that recovery would be impracticable and any of the following two conditions are met:

 

(i)The Committee has determined that the direct expenses paid to a third party to assist in enforcing the Policy would exceed the amount to be recovered. Before making this determination, the Company must make a reasonable attempt to recover the Erroneously Awarded Compensation, documented such attempt(s) and provided such documentation to Nasdaq; or

 

(ii)Recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of Section 401(a)(13) or Section 411(a) of the Internal Revenue Code of 1986, as amended, and regulations thereunder.

 

C.DISCLOSURE REQUIREMENTS

 

The Company shall file all disclosures with respect to this Policy required by applicable U.S. Securities and Exchange Commission (“SEC”) filings and rules.

 

D.PROHIBITION OF INDEMNIFICATION

 

The Company shall not be permitted to insure or indemnify any Covered Person against (i) the loss of any Erroneously Awarded Compensation that is repaid, returned or recovered pursuant to the terms of this Policy, or (ii) any claims relating to the Company’s enforcement of its rights under this Policy. Further, the Company shall not enter into any agreement that exempts any Incentive-based Compensation that is granted, paid or awarded to a Covered Person from the application of this Policy or that waives the Company’s right to recovery of any Erroneously Awarded Compensation, and this Policy shall supersede any such agreement (whether entered into before, on or after the Effective Date of this Policy).

 

2

 

 

E.ADMINISTRATION AND INTERPRETATION

 

This Policy shall be administered by the Committee, and any determinations made by the Committee shall be final and binding on all affected individuals.

 

The Committee is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy and for the Company’s compliance with Nasdaq Rules, Section 10D, Rule 10D-1 and any other applicable law, regulation, rule or interpretation of the SEC or Nasdaq promulgated or issued in connection therewith.

 

F.AMENDMENT; TERMINATION

 

The Committee may amend this Policy from time to time in its discretion and shall amend this Policy as it deems necessary. Notwithstanding anything in this Section F to the contrary, no amendment or termination of this Policy shall be effective if such amendment or termination would (after taking into account any actions taken by the Company contemporaneously with such amendment or termination) cause the Company to violate any federal securities laws, SEC rule or Nasdaq rule.

 

G.OTHER RECOVERY RIGHTS

 

This Policy shall be binding and enforceable against all Covered Persons and, to the extent required by applicable law or guidance from the SEC or Nasdaq, their beneficiaries, heirs, executors, administrators or other legal representatives. The Committee intends that this Policy will be applied to the fullest extent required by applicable law. Any employment agreement, equity award agreement, compensatory plan or any other agreement or arrangement with a Covered Person shall be deemed to include, as a condition to the grant of any benefit thereunder, an agreement by the Covered Person to abide by the terms of this Policy. Any right of recovery under this Policy is in addition to, and not in lieu of, any other remedies or rights of recovery that may be available to the Company under applicable law, regulation or rule or pursuant to the terms of any policy of the Company or any provision in any employment agreement, equity award agreement, compensatory plan, agreement or other arrangement.

 

H.DEFINITIONS

 

For purposes of this Policy, the following capitalized terms shall have the meanings set forth below.

 

(1) “Accounting Adjustment” means a material change to a Financial Reporting Measure which is not based on the accounting principles used in preparing the Company’s financial statements, such as Booked Annual Recurring Revenue, where such change results from a determination that such Financial Measure was incorrectly calculated when originally published, based on the facts that were known to management at the time of such original publication.

 

3

 

 

(2) Accounting Restatement” means (i) an accounting restatement due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period and (ii) an Accounting Adjustment.

 

(3) Clawback Eligible Incentive Compensation” means all Incentive-based Compensation Received by a Covered Person (i) on or after the effective date of the applicable Nasdaq rules, (ii) after beginning service as a Covered Person, (iii) who served as a Covered Person at any time during the applicable performance period relating to any Incentive-based Compensation (whether or not such Covered Person is serving at the time the Erroneously Awarded Compensation is required to be repaid to the Company), (iv) while the Company has a class of securities listed on a national securities exchange or a national securities association, and (v) during the applicable Clawback Period (as defined below).

 

(4) Clawback Period” means, with respect to any Accounting Restatement, the three completed fiscal years of the Company immediately preceding the Restatement Date (as defined below), and if the Company changes its fiscal year, any transition period of less than nine months within or immediately following those three completed fiscal years.

 

(5) Covered Person” means any Executive Officer and any employee of the Company or a subsidiary of the Company holding the title of Chief Officer, Senior Vice President or Executive Vice President, or any other person designated as a Covered Person by the Compensation Committee at the time of the award of Incentive-Based Compensation. A person’s status as a Covered Person with respect to Erroneously Awarded Compensation shall be determined as of the time of receipt of such Erroneously Awarded Compensation regardless of the person’s current role or status with the Company (e.g., if a person began service as an Executive Officer after the beginning of an Applicable Recovery Period, that person would not be considered a Covered Person with respect to Erroneously Awarded Compensation received before the person began service as an Executive Officer, but would be considered a Covered Person with respect to Erroneously Awarded Compensation received after the person began service as an Executive Officer where such person served as an Executive Officer at any time during the performance period for such Erroneously Awarded Compensation).

 

(6) Erroneously Awarded Compensation” means, with respect to each Covered Person in connection with an Accounting Restatement, the amount of Clawback Eligible Incentive Compensation that exceeds the amount of Incentive-based Compensation that otherwise would have been received had it been determined based on the restated amounts, computed without regard to any taxes paid.

 

(7) Executive Officer” means each individual who is currently or was previously designated as an “officer” of the Company as defined in Rule 16a-1(f) under the Exchange Act. For the avoidance of doubt, the identification of an executive officer for purposes of this Policy shall include each executive officer who is or was identified pursuant to Item 401(b) of Regulation S-K or Item 6.A of Form 20-F, as applicable, as well as the principal financial officer and principal accounting officer (or, if there is no principal accounting officer, the controller).

 

(8) Financial Reporting Measures” means measures that are determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and all other measures that are derived wholly or in part from such measures. Stock price and total shareholder return (and any measures that are derived wholly or in part from stock price or total shareholder return) as well as Booked Annual Recurring Revenue and any other measure designated by the Compensation Committee as a Financial Reporting Measure, shall for purposes of this Policy, be considered Financial Reporting Measures. For the avoidance of doubt, a Financial Reporting Measure need not be presented in the Company’s financial statements or included in a filing with the SEC.

 

4

 

 

(9) Incentive-based Compensation” means any compensation that is granted, earned or vested based wholly or in part upon the attainment of a Financial Reporting Measure.

 

(10) Nasdaq” means The Nasdaq Stock Market.

 

(11) Received” means, with respect to any Incentive-based Compensation, actual or deemed receipt, and Incentive-based Compensation shall be deemed received in the Company’s fiscal period during which the Financial Reporting Measure specified in the Incentive-based Compensation award is attained, even if the payment or grant of the Incentive-based Compensation to the Covered Person occurs after the end of that period.

 

(12) Restatement Date” means the earlier to occur of (i) the date the Board, a committee of the Board or the officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement, or (ii) the date a court, regulator or other legally authorized body directs the Company to prepare an Accounting Restatement.

 

Effective as of October 6, 2023.

 

5

 

 

Exhibit A

 

AUTHID INC.

ATTESTATION AND ACKNOWLEDGEMENT OF POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION

 

By my signature below, I acknowledge and agree that:

 

I have received and read the attached Policy for the Recovery of Erroneously Awarded Compensation (this “Policy”).

 

I hereby agree to abide by all of the terms of this Policy both during and after my employment with authID Inc. (the “Company”), including, without limitation, by promptly repaying or returning any Erroneously Awarded Compensation to the Company as determined in accordance with this Policy.

 

  Signature:  
     
  Printed Name:   
     
  Date:  

 

6

 

v3.23.3
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2023
Nov. 06, 2023
Document Information Line Items    
Entity Registrant Name authID Inc.  
Trading Symbol AUID  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   7,874,962
Amendment Flag false  
Entity Central Index Key 0001534154  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Sep. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company false  
Entity Ex Transition Period true  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-40747  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 46-2069547  
Entity Address, Address Line One 1580 North Logan Street  
Entity Address, Address Line Two Suite 660, Unit 51767  
Entity Address, City or Town Denver  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80203  
City Area Code 516  
Local Phone Number 274-8700  
Title of 12(b) Security Common Stock par value $0.0001 per share  
Security Exchange Name NASDAQ  
Entity Interactive Data Current Yes  
v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current Assets:    
Cash $ 3,811,014 $ 3,237,106
Accounts receivable, net 48,832 261,809
Other current assets, net 474,178 729,342
Deferred contract costs 66,300
Current assets held for sale 118,459
Total current assets 4,400,324 4,346,716
Other Assets 250,383
Intangible Assets, net 370,409 566,259
Goodwill 4,183,232 4,183,232
Non-current assets held for sale 27,595
Total assets 8,953,965 9,374,185
Current Liabilities:    
Accounts payable and accrued expenses 989,538 1,154,072
Deferred revenue 103,052 81,318
Current liabilities held for sale 13,759
Total current liabilities 1,092,590 1,249,149
Non-current Liabilities:    
Convertible debt 220,309 7,841,500
Accrued severance liability 325,000
Total liabilities 1,637,899 9,090,649
Commitments and Contingencies (Note 10)
Stockholders’ Equity:    
Common stock, $0.0001 par value, 250,000,000 shares authorized; 7,874,962 and 3,179,789 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 786 318
Additional paid in capital 163,613,111 140,257,448
Accumulated deficit (156,310,215) (140,130,159)
Accumulated comprehensive income 12,384 155,929
Total stockholders’ equity 7,316,066 283,536
Total liabilities and stockholders’ equity $ 8,953,965 $ 9,374,185
v3.23.3
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 250,000,000 250,000,000
Common stock, shares issued 7,874,962 3,179,789
Common stock, shares outstanding 7,874,962 3,179,789
v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues:        
Total revenues, net $ 43,389 $ 30,023 $ 118,387 $ 261,484
Operating Expenses:        
General and administrative 2,965,344 3,914,432 5,712,303 11,583,798
Research and development 749,705 1,620,492 1,666,638 4,689,515
Depreciation and amortization 60,416 213,049 212,450 673,882
Total operating expenses 3,775,465 5,747,973 7,591,391 16,947,195
Loss from continuing operations (3,732,076) (5,717,950) (7,473,004) (16,685,711)
Other Income (Expense):        
Other income (expense) 29,511 (42,148) 30,671 (38,908)
Interest expense, net (13,138) (437,301) (1,095,320) (931,205)
Conversion expense (7,476,000)
Loss on debt extinguishment (380,741)
Other income (expense), net 16,373 (479,449) (8,921,390) (970,113)
Loss from continuing operations before income taxes (3,715,703) (6,197,399) (16,394,394) (17,655,824)
Income tax benefit (expense) 7,052 (3,255) (1,048)
Loss from continuing operations (3,715,703) (6,190,347) (16,397,649) (17,656,872)
Gain (loss) from discontinued operations (1,915) 43,645 1,524 (363,385)
Gain (loss) on sale of discontinued operations (188,247) 216,069 (188,247)
Total gain (loss) from discontinued operations (1,915) (144,602) 217,593 (551,632)
Net loss $ (3,717,618) $ (6,334,949) $ (16,180,056) $ (18,208,504)
Net Loss Per Share - Basic and Diluted        
Continuing operations (in Dollars per share) $ (0.47) $ (2) $ (3.05) $ (5.8)
Discontinued operations (in Dollars per share) $ 0 $ (0.05) $ 0.04 $ (0.18)
Weighted Average Shares Outstanding - Basic (in Shares) 7,874,962 3,102,745 5,376,821 3,044,151
Verified software license [Member]        
Revenues:        
Total revenues, net $ 42,369 $ 30,023 $ 114,269 $ 116,925
Legacy authentication services [Member]        
Revenues:        
Total revenues, net $ 1,020 $ 4,118 $ 144,559
v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Continuing operations, Diluted $ (0.53) $ (2.00) $ (3.13) $ (5.80)
Discontinued operations, Diluted $ 0.00 $ (0.05) $ 0.04 $ (0.18)
Weighted Average Shares Outstanding – Diluted (in Shares) 7,874,962 3,102,745 5,376,821 3,044,151
v3.23.3
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Statement of Comprehensive Income [Abstract]        
Net Loss $ (3,717,618) $ (6,334,949) $ (16,180,056) $ (18,208,504)
Foreign currency translation (loss) gain 12,592 (37,383) (143,545) (72,431)
Comprehensive loss $ (3,705,026) $ (6,372,332) $ (16,323,601) $ (18,280,935)
v3.23.3
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total
Balances at Dec. 31, 2021 $ 293 $ 126,583,738 $ (115,899,939) $ 211,486 $ 10,895,578
Balances (in Shares) at Dec. 31, 2021 2,926,655        
Stock-based compensation 6,726,871 6,726,871
Shares issued in lieu of interest $ 2 473,810 473,812
Shares issued in lieu of interest (in Shares) 23,964        
Warrants for services with the issuance of convertible debt 449,474 449,474
Cashless stock option exercise $ 2 (2)
Cashless stock option exercise (in Shares) 23,139        
Cashless warrant exercise
Cashless warrant exercise (in Shares) 172        
Warrant exercise for cash $ 1 66,002 66,003
Warrant exercise for cash (in Shares) 4,584        
Convertible note converted into common stock $ 1 49,999 50,000
Convertible note converted into common stock (in Shares) 1,689        
Sale of common stock for cash, net of offering costs $ 13 3,146,927 3,146,940
Sale of common stock for cash, net of offering costs (in Shares) 132,940        
Common stock issued with convertible debt $ 1 91,756 91,757
Common stock issued with convertible debt (in Shares) 3,562        
Common stock issued for working capital facility $ 1 302,999 303,000
Common stock issued for working capital facility (in Shares) 12,500        
Net loss (18,208,504) (18,208,504)
Foreign currency translation (72,431) (72,431)
Balances at Sep. 30, 2022 $ 314 137,891,574 (134,108,443) 139,055 3,922,500
Balances (in Shares) at Sep. 30, 2022 3,129,205        
Balances at Jun. 30, 2022 $ 311 135,325,005 (127,773,494) 176,438 7,728,260
Balances (in Shares) at Jun. 30, 2022 3,113,580        
Stock-based compensation 2,227,764 2,227,764
Shares issued in lieu of interest $ 1 222,804 222,805
Shares issued in lieu of interest (in Shares) 9,352        
Warrant exercise for cash $ 1 66,002 66,003
Warrant exercise for cash (in Shares) 4,584        
Convertible note converted into common stock $ 1 49,999 50,000
Convertible note converted into common stock (in Shares) 1,689        
Net loss (6,334,949) (6,334,949)
Foreign currency translation (37,383) (37,383)
Balances at Sep. 30, 2022 $ 314 137,891,574 (134,108,443) 139,055 3,922,500
Balances (in Shares) at Sep. 30, 2022 3,129,205        
Balances at Dec. 31, 2022 $ 318 140,257,448 (140,130,159) 155,929 $ 283,536
Balances (in Shares) at Dec. 31, 2022 3,179,789       3,179,789
Balances at Dec. 31, 2022 $ 318 140,257,448 (140,130,159) 155,929 $ 283,536
Balances (in Shares) at Dec. 31, 2022 3,179,789       3,179,789
Balances at Jun. 30, 2023 $ 786 162,155,308 (152,592,597) (208) $ 9,563,289
Balances (in Shares) at Jun. 30, 2023 7,874,962        
Balances at Dec. 31, 2022 $ 318 140,257,448 (140,130,159) 155,929 $ 283,536
Balances (in Shares) at Dec. 31, 2022 3,179,789       3,179,789
Stock-based compensation (22,949) $ (22,949)
Shares issued in lieu of interest $ 11 387,567 $ 387,578
Shares issued in lieu of interest (in Shares) 111,516        
Cashless stock option exercise (in Shares)        
Warrants for services with securities purchase agreement 438,000 $ 438,000
Conversion of convertible debt into common stock $ 235 15,331,776 15,332,011
Conversion of convertible debt into common stock (in Shares) 2,348,347        
Conversion of credit facility borrowings into common stock $ 24 899,976 900,000
Conversion of credit facility borrowings into common stock (in Shares) 245,634        
Sale of common stock for cash, net of offering costs $ 198 6,321,293 6,321,491
Sale of common stock for cash, net of offering costs (in Shares) 1,989,676        
Net loss (16,180,056) (16,180,056)
Foreign currency translation (143,545) (143,545)
Balances at Sep. 30, 2023 $ 786 163,613,111 (156,310,215) 12,384 $ 7,316,066
Balances (in Shares) at Sep. 30, 2023 7,874,962       7,874,962
Balances at Jun. 30, 2023 $ 786 162,155,308 (152,592,597) (208) $ 9,563,289
Balances (in Shares) at Jun. 30, 2023 7,874,962        
Stock-based compensation 1,519,952 1,519,952
Incremental offering costs (62,149) (62,149)
Net loss (3,717,618) (3,717,618)
Foreign currency translation 12,592 12,592
Balances at Sep. 30, 2023 $ 786 $ 163,613,111 $ (156,310,215) $ 12,384 $ 7,316,066
Balances (in Shares) at Sep. 30, 2023 7,874,962       7,874,962
v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (16,180,056) $ (18,208,504)
Adjustments to reconcile net loss with cash flows from operations:    
Depreciation and amortization expense 212,450 674,836
Provision for doubtful collection of other receivable 150,000
Stock-based compensation (22,949) 6,726,871
Warrants for services with securities purchase agreement 438,000
Shares issued in lieu of interest 387,578 473,812
Amortization of debt discounts and issuance costs 693,420 403,244
(Gain) loss from sale of discontinued operation (216,069) 188,247
Conversion expense 7,476,000
Loss on debt extinguishment 380,741
Changes in operating assets and liabilities:    
Accounts receivable 212,977 (9,234)
Deferred contract costs (66,300)
Other assets 66,676 (161,884)
Accounts payable and accrued expenses (178,428) 235,050
Deferred revenue 21,734 (102,074)
Other accrued liabilities 290,000
Adjustments relating to discontinued operations 110,064 226,586
Net cash flows from operating activities (6,224,162) (9,553,050)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from sale of discontinued operations, net of selling costs 91,751 146,728
Cash disposed of from the sale of a discontinued operation (299,505)
Purchase of property and equipment - discontinued operations (16,159)
Purchase of property and equipment (7,981)
Purchase of intangible assets (16,601) (6,311)
Net cash flows from investing activities 75,150 (183,228)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from sale of common stock, net of offering costs 6,321,492 3,146,940
Credit facility drawdown, net of issuance costs 543,760
Proceeds from issuance of convertible note payable, net of issuance costs 7,992,841
Proceeds from exercise of warrants 66,003
Cash paid for working capital facility (300,000)
Payments on notes payable - discontinued operations (1,579)
Principal payments on capital lease obligation - discontinued operations (10,582)
Net cash flows from financing activities 6,865,252 10,893,623
Effect of Foreign Currencies (145,035) (78,019)
Net Change in Cash 571,205 1,079,326
Cash, Beginning of the Period 3,237,106 5,767,276
Cash, Beginning of the Period - Discontinued Operations 2,703 270,707
Cash, End of the Period - Discontinued Operations (11,342)
Cash, End of the Period 3,811,014 7,105,967
Supplemental Disclosure of Cash Flow Information:    
Cash paid for interest - discontinued operations 364 8,779
Cash paid for income taxes 3,255 2,193
Cash paid for income taxes - discontinued operations 1,254 4,493
Schedule of Non-cash Investing and Financing Activities:    
Conversion of convertible note payable and accrued interest to common stock 7,856,011 6,232,340
Conversion of credit facility borrowings into common stock 900,000
Warrants for consulting services with the sale of common stock 438,000
Cashless option and warrant exercises 67
Settlement of accounts payable with issuance of common stock 349,376
Reclass from other assets to intangible assets $ 8,270
v3.23.3
Basis of Presentation
9 Months Ended
Sep. 30, 2023
Basis of Presentation [Abstract]  
BASIS OF PRESENTATION

NOTE 1 – BASIS OF PRESENTATION

 

In the opinion of Management, the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which we considered as necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The results of operations for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for future periods or the full year.

 

The condensed consolidated financial statements include the accounts of authID Inc. and its wholly-owned subsidiaries MultiPay S.A.S., ID Solutions, Inc., FIN Holdings Inc., Ipsidy Enterprises Limited and authID Gaming Inc. (collectively the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation.

 

Going Concern

 

As of September 30, 2023, the Company had an accumulated deficit of approximately $156.3 million. For the three and nine months ended September 30, 2023, the Company earned revenue from continuing operations of approximately $0.04 million and $0.12 million, used approximately $2.1 million and $6.2 million to fund its operations, and incurred a net loss of approximately $3.7 million and $16.2 million, respectively.

 

The continuation of the Company as a going concern is dependent upon financial support from the Company’s stockholders and noteholders, the ability of the Company to obtain additional debt or equity financing to continue operations, the Company’s ability to generate sufficient cash flows from operations, successfully locating and negotiating with other business entities for potential acquisition, and acquiring new clients to generate revenues and cash flows.

 

During the nine months ended September 30, 2023, the Company has secured additional financing of approximately $6.4 million net, which provides funding for its current operations as it continues to invest in its product, people, and technology. Although there is no guarantee, the Company projects that the investments will lead to revenue expansion thereby reducing liquidity needs. However, in order to further implement its business plan and satisfy its working capital requirements, the Company will need to raise additional capital. There is no guarantee that the Company will be able to raise additional equity or debt financing at acceptable terms, if at all.

 

There is no assurance that the Company will ever be profitable. These unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. As there can be no assurance that the Company will be able to achieve positive cash flows (become cash flow positive) and raise sufficient capital to maintain operations, there is substantial doubt about the Company’s ability to continue as a going concern.

 

Reclassification

 

Certain prior year expenses have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the previously reported loss from continuing operations and management does not believe that this reclassification is material to the consolidated financial statements taken as a whole. Specifically, we reclassified certain expenses from general and administrative expenses to research and development expenses.

 

Net Loss per Common Share

 

The Company computes net loss per share in accordance with FASB ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the statement of operations. Basic EPS is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible notes and stock warrants, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and conversion of convertible notes. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive. The following potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and nine months ended September 30, 2023 and 2022 because their effect was antidilutive:

 

Security  2023   2022 
         
Convertible notes payable   8,278    325,188 
Warrants   488,018    163,045 
Stock options   1,685,570    1,212,202 
    2,181,866    1,700,435 

 

Revenue Recognition

 

Verified Software License – The Company recognizes revenue based on the identified performance obligations over the performance period for fixed consideration and / or variable fees generated that are earned on a usage fee based over time based on user monthly user or transaction volumes or on a monthly flat fee rate. We allocate the selling price in a contract which has multiple performance obligations based on the contract selling price that we believe represents a fair market price for the service rendered based on estimated standalone selling price.

 

The Company had contract liabilities of approximately $103,000 and $81,000 as of September 30, 2023 and December 31, 2022 respectively for certain revenue that will be earned in future periods. All deferred revenue contract liabilities as of September 30, 2023 are expected to be earned over the next twelve months.

 

Remaining Performance Obligations

 

As of September 30, 2023, the Company’s Remaining Performance Obligation (RPO) was $1.87 million, of which $0.10 million is held as deferred revenue and $1.77 million is related to other non-cancelable contracted amounts. The Company expects approximately 34% of the RPO to be recognized as revenue in the twelve months ending September 30, 2024 based on contractual commitments and expected usage patterns. However, the amount and timing of revenue recognition are generally dependent upon customers’ future consumption, which is inherently variable at customers’ discretion. Furthermore, the Company does not have historical information to estimate the recognition of revenue due to its current operations and has approximated such amount based on discussions with the contracted parties.

 

Deferred Contract Costs – We defer the portion of sales commission that is considered a cost of obtaining a new contract with a customer and amortize these deferred costs over the period of benefit. We expense the remaining sales commissions as incurred. The following table summarizes deferred contract cost activity for the nine months ended September 30, 2023:

 

   Deferred 
   Contract Costs 
     
Carrying Value at December 31, 2022  $
-
 
Additions   66,300 
Amortization   
-
 
Carrying Value at September 30, 2023  $66,300 

 

Legacy Authentication Services – The Company historically has sold certain legacy software licenses to customers and revenue is recognized when delivery occurs, and all other revenue recognition criteria have been met. During both quarters ended September 30, 2023 and 2022, the Company provided annual software maintenance support services relating to previously licensed software on a stand-ready basis. These fees were billed in advance and recognized ratably over the requisite service period as revenue.

 

Revenue Accounting Pronouncement – In June 2016, the Financial Accounting Standards Board issued Accounting Standards Update No. 2016-13, “Financial Instruments – Credit Losses (Topic),” which replaces the current incurred loss impairment methodology for most financial assets with the current expected credit lost, or CECL, methodology. The series of new guidance amends the impairment model by requiring entities to use a forward-looking approach based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. The Company adopted the new standard effective January 1, 2023, which did not have a material impact to the consolidated financial statements.

v3.23.3
Other Current Assets and Other Assets
9 Months Ended
Sep. 30, 2023
Other Current Assets and Other Assets [Abstract]  
OTHER CURRENT ASSETS AND OTHER ASSETS

NOTE 2 – OTHER CURRENT ASSETS AND OTHER ASSETS

 

Other current assets consisted of the following at September 30, 2023 (unaudited) and December 31, 2022:

 

   September 30,   December 31, 
   2023   2022 
         
Prepaid insurance  $295,188   $244,215 
Prepaid third party services   155,052    135,405 
Unamortized credit facility fees   
-
    199,156 
Other   23,938    150,566 
   $474,178   $729,342 

 

Other assets consisted of the following at September 30, 2023 (unaudited) and December 31, 2022:

 

   September 30,   December 31, 
   2023   2022 
         
Unamortized working capital facility fees  $
           -
   $248,945 
Other   
-
    1,438 
   $
-
   $250,383 
v3.23.3
Intangible Assets, Net (Other than Goodwill)
9 Months Ended
Sep. 30, 2023
Intangible Assets, Net (Other than Goodwill) [Abstract]  
INTANGIBLE ASSETS, NET (OTHER THAN GOODWILL)

NOTE 3 – INTANGIBLE ASSETS, NET (OTHER THAN GOODWILL)

 

The Company’s intangible assets primarily consist of acquired and developed software that is being amortized over their estimated useful lives as indicated below. The following is a summary of activity related to intangible assets for the nine months ended September 30, 2023 (unaudited):

 

   Acquired and         
   Developed         
   Software   Patents   Total 
             
Useful Lives   5 Years    10 Years      
                
Carrying Value at December 31, 2022  $435,595   $130,664   $566,259 
Acquisition of intangible assets   16,601    
-
    16,601 
Amortization   (200,100)   (12,351)   (212,451)
Carrying Value at September 30, 2023  $252,096   $118,313   $370,409 

  

The following is a summary of intangible assets as of September 30, 2023 (unaudited):

 

   Acquired and         
   Developed         
   Software   Patents   Total 
Cost  $4,492,872    164,614   $4,657,486 
Accumulated amortization   (4,240,776)   (46,301)   (4,287,077)
Carrying Value at September 30, 2023  $252,096   $118,313   $370,409 

 

Amortization expense totaled approximately $212,450 and $642,000 for the nine months ended September 30, 2023, and 2022, respectively.

 

Future expected amortization of intangible assets is as follows:

 

2023 (Remainder of the Year)  $51,458 
2024   171,414 
2025   67,111 
2026   19,776 
2027   9,776 
Thereafter   50,874 
   $370,409 

 

There is no impairment indicator identified for impairment of the Company’s intangible assets and goodwill as of September 30, 2023.

v3.23.3
Accounts Payable and Accrued Expenses
9 Months Ended
Sep. 30, 2023
Accounts Payable and Accrued Expenses [Abstract]  
ACCOUNTS PAYABLE AND ACCRUED EXPENSES

NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consisted of the following as of September 30, 2023 (unaudited) and December 31, 2022:

 

   September 30,   December 31, 
   2023   2022 
         
Trade payables  $426,723   $623,130 
Accrued payroll and related obligations   113,494    145,837 
Other accrued expenses   449,321    385,105 
   $989,538   $1,154,072 

 

On February 14, 2023, the Company’s Board of Directors resolved to implement a revised budget for 2023 in order to reduce expenses and cash requirements and as part of such revised budget decided to re-balance staffing levels to better align with the evolving needs of the Company (the “Labor Reduction Plan”). Under the Labor Reduction Plan, 12 employees and 6 contractors have left the Company. The Company has also given termination notice to certain vendors and contractors that provide services to the Company. For the nine months ended September 30, 2023, the Company incurred approximately $0.8 million of severance expenses, of which $0.4 million was paid and $0.1 million was included in the Accounts payable and accrued expenses and the remaining $0.3 million was accrued for in Other liabilities as a long term liability on the unaudited Condensed Consolidated Balance Sheets as of September 30, 2023.

v3.23.3
Working Capital Faciltiy
9 Months Ended
Sep. 30, 2023
Working Capital Faciltiy [Abstract]  
WORKING CAPITAL FACILTIY

NOTE 5 – WORKING CAPITAL FACILTIY

 

On March 21, 2022, the Company entered into a Credit Facility Agreement (the “Original Facility Agreement”) with Stephen J. Garchik (“Garchik”), who is a shareholder of the Company, pursuant to which Garchik agreed to provide to the Company a $10.0 million unsecured standby line of credit facility that could be drawn down in several tranches, subject to certain conditions described in the Original Facility Agreement. Pursuant to the Original Facility Agreement, the Company paid Garchik a Facility Commitment Fee of 12,500 shares of our common stock upon the effective date of the Original Facility Agreement.

 

On March 8, 2023, the Company entered into an Amended and Restated Facility Agreement (“A&R Facility Agreement”) with Garchik, pursuant to which the Company and Garchik amended and restated the Original Facility Agreement in its entirety, to replace the credit facility contemplated by the Original Facility Agreement with (i) an initial credit facility to the Company in an amount of $900,000 and (ii) the parties to use their reasonable best efforts after the Initial Funding to negotiate the terms of a subsequent credit facility in the aggregate amount of $2,700,000 (the “Subsequent Funding”).

 

On March 9, 2023, pursuant to the A&R Facility Agreement, the Company entered into a promissory note (the “Initial Promissory Note”) in favor of Garchik, pursuant to which Garchik loaned the amount of $900,000 (the “Principal Amount”) to the Company. In connection with the Company and Garchik entering into the Initial Promissory Note, each of the principal United States based subsidiaries of the Company agreed to, for the benefit and security of Garchik, guarantee the payment and performance all of the Company’s obligations under the Initial Promissory Note and the Guaranty. The Company and Garchik also entered into the Release Agreement, pursuant to which the Company and Garchik mutually agreed to release any and all rights to make a claim against the other and any existing claims against the other arising out of or relating to the Original Facility Agreement.

 

The Company wrote-off approximately $410,000 of the issuance costs related to the Original Credit Facility and capitalized $426,000 issuance costs related to the A&R Facility Agreement as of March 31, 2023.

 

On May 25, 2023, the Company and Garchik agreed to cancel the Initial Promissory Note, terminate the A&R Facility Agreement and Guaranty and satisfy and offset the outstanding balance of the Initial Promissory Note, plus accrued and unpaid interest in the aggregate amount of $929,250 against the purchase price of certain shares of common stock of the Company. See Note 8 “Shareholders’ Equity”. All remaining unamortized debt issuance costs of approximately $381,000 related to the Initial Promissory Note and the A&R Facility Agreement were recorded as a loss on debt extinguishment for the nine months ended September 30, 2023.

v3.23.3
Convertible Notes Payable
9 Months Ended
Sep. 30, 2023
Convertible Notes Payable [Abstract]  
CONVERTIBLE NOTES PAYABLE

NOTE 6 – CONVERTIBLE NOTES PAYABLE

 

On March 21, 2022, the Company entered into a Securities Purchase Agreement (“SPA”) with certain accredited investors, including certain directors of the Company or their affiliates (the “Note Investors”), and, pursuant to the SPA, sold to the Note Investors Senior Secured Convertible Notes (the “Convertible Notes”) with an aggregate initial principal amount of approximately $9.2 million and a conversion price of $29.60. The Convertible Notes were sold with an aggregate cash origination fee of approximately $200,000, and we issued a total of approximately 3,563 shares of our common stock to the Note Investors as an additional origination fee. The Convertible Notes accrue interest at the rate of 9.75% per annum, which is payable in cash or, for some or all of the first five interest payments, in shares of our common stock at the Company’s option, on the last day of each calendar quarter before the maturity date and on the maturity date. The maturity date of the Convertible Notes is March 31, 2025.

 

During the quarter ended September 30, 2022, a holder of a Convertible Note converted the full principal amount of $50,000 and accrued interest of $406 into 1,706 shares of our common stock.

 

During the quarter ended September 30, 2022, the Company issued 9,335 shares of common stock for approximately $223,000 of interest.

 

During the nine months ended September 30, 2023 and 2022, the Company issued 103,533 and 23,947 shares of common stock for approximately $358,000 and $474,000 of interest expense, respectively. The number of shares issued to each Note Investor was based on the VWAP of the common stock as of the relevant interest payment date, as defined in the Convertible Notes.

 

In connection with the issuance of the Convertible Notes, the Company issued 17,836 common stock warrants to a broker and its representatives with an estimated grant date fair value of approximately $449,000 which was recorded as a reduction in the carrying value of the Convertible Notes.

 

On May 23, 2023, the Company entered into an exchange agreement with certain holders (“Holders”) of the Convertible Notes of the Company, pursuant to which the Company agreed to issue 2,346,105 shares of common stock to the Holders in exchange for approximately $8.9 million (or approximately $7.9 million, net of debt issuance costs and discount) of the principal amount of Holders’ Convertible Notes at a price of $3.78 per share (or $4.12 if the Holder is a director, officer or insider of the Company). On June 7, 2023, the Company entered into a further Securities Purchase Agreement and Exchange Agreement with an accredited investor pursuant to which the Company agreed to issue 2,242 Exchange Shares in exchange for $13,000 of the principal amount of the Holder’s Convertible Note at a price of $5.80 per share. The Company also recognized an expense on conversion of convertible notes of approximately $7.5 million, representing the market value of the additional shares issued by the Company in exchange for the Convertible Notes, above the number of shares that the Holders would have received upon conversion at the original conversion price under the Convertible Notes.

 

On May 23, 2023, the Company solicited the consent of the Convertible Notes Holders to eliminate substantially all of the restrictive covenants and a related event of default in the Convertible Notes. The Company received consent from Holders representing over the necessary 66.67% of the outstanding principal amount under the Convertible Notes.

 

See Note 8 “Shareholders’ Equity”.

 

The following is a summary of the Convertible Notes payable outstanding as of September 30, 2023 (unaudited):

 

9.75% convertible notes due March 31, 2025  $245,000 
      
less:     
Unamortized debt issuance expense   (24,691)
   $220,309 

   

Future maturities of Convertible Notes payable as of September 30, 2023:

 

2025  $245,000 
   $245,000 
v3.23.3
Related Party Transactions
9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 7 – RELATED PARTY TRANSACTIONS

 

Convertible Notes Payable

  

On May 23, 2023, pursuant to an Exchange Agreement, Mr. Ken Jisser converted $100,000 of Convertible Notes payable and accrued interest of $1,463 into 24,628 shares of common stock.

 

On May 23, 2023, pursuant to an Exchange Agreement, Mr. Stephen J. Garchik, who is a shareholder of the Company, converted $1,000,000 of Convertible Notes payable and $14,625 of accrued interest into 264,831 and 3,874 shares of common stock, respectively. As a result of such exchange, the issuance of shares in satisfaction of the Credit Facility referred to below and the purchase of additional shares of common stock in May 2023, (See Note 8 “Shareholders’ Equity”), Mr. Garchik is now a holder of more than 10% of the outstanding shares of the Company’s common stock.

 

See Note 6 “Convertible Notes Payable” and Note 8 “Shareholders’ Equity”.

 

Issuance of Common Stock

 

On May 23, 2023, Messrs. Rhoniel Daguro, CEO, Ken Jisser, Michael Thompson, members of the Company’s Board of Directors and Joseph Trelin, the Chairman of the Board, each purchased 12,500 shares of Company’s common stock at a price of $50,000.

 

Credit Facility

 

On March 21, 2022 the Company entered into the Original Facility Agreement with Mr. Stephen Garchik, an accredited investor, who is both a current shareholder of the Company and a Note Investor, pursuant to which Mr. Garchik agreed to provide a $10.0 million unsecured standby line of credit facility that will rank behind the Convertible Notes and may be drawn down in several tranches, subject to certain conditions described in the Original Facility Agreement. Pursuant to the Original Facility Agreement, the Company agreed to pay Mr. Garchik the Facility Commitment Fee of 12,500 shares of our common stock upon the effective date of the Original Facility Agreement. Upon request by Mr. Garchik and until the full amount due under the Original Agreement is repaid in full, the Company agreed to provide for the nomination of one designee specified in writing by Garchik for appointment to our board directors and for subsequent election to our board of directors and to recommend such nominee for election to our board of directors. On April 18, 2022, Joseph Trelin, as Garchik’s designee under the Original Facility Agreement, was appointed as a member of the Board of Directors of the Company. By virtue of such right of nomination Mr. Garchik considered himself a “director by deputization”.

 

As described in Note 5 “Working Capital Facility”, the Original Facility Agreement was amended and restated effective March 8, 2023 pursuant to which amendment the amount of the facility was reduced to $3.6 million, an initial advance of $900,000 was made and subsequent advances under the A&R Facility Agreement are subject to various conditions including the granting of a security interest over substantially all the Company’s assets. Under the A&R Facility Agreement Garchik had a one-time right for the nomination of four designees specified in writing by Garchik for appointment to our board of directors. On March 9, 2023 Rhoniel Daguro, Ken Jisser, Michael Thompson and Thomas Szoke as Garchik’s designees under the A&R Facility Agreement, were appointed as members of the Board of Directors of the Company.

 

On May 25, 2023, the Company and Mr. Garchik agreed to cancel the Initial Promissory Note, terminated the A&R Facility Agreement and Guaranty and satisfied and offset the outstanding balance of the Note in the principal amount of $900,000 and $29,250 accrued and unpaid interest with the purchase price of 245,634 and 7,983 shares of common stock, respectively. See Note 5 “Working Capital Facility” and Note 8 “Shareholders’ Equity”.

 

Executive Officers’ Agreements

 

Effective March 23, 2023, Mr. Thomas Thimot resigned as the Company’s Chief Executive Officer.

 

On March 23, 2023, the Company and Rhoniel A. Daguro, a director of the Company, entered an Offer Letter pursuant to which Mr. Daguro agreed to serve as Chief Executive Officer of the Company in consideration of an initial annual salary of $400,000. Mr. Daguro will be eligible for an annual target bonus of up to $375,000 based on performance milestones. For the period ending March 31, 2024, a bonus amount of $75,000 shall be payable upon the Company achieving increments of $1,000,000 in total contract value of all customer agreements less claw backs (“Bookings”) up to an aggregate of $5,000,000 in Bookings. For subsequent years, Mr. Daguro and the Compensation Committee of the Board will mutually agree as to the performance targets to be achieved, to earn the annual bonus. On April 10, 2023, the Company provided Mr. Daguro with an initial grant of options to purchase 306,875 shares of common stock at the exercise price of $3.176 per share for a period of ten years vesting subject to achievement of performance and service conditions. On June 28, 2023, the Company made an additional grant of options to Mr. Daguro to acquire 183,125 shares of common stock at the exercise price of $5.48 for a period of ten years vesting subject to achievement of performance and service conditions.

 

The employment of Mr. Daguro is at will and may be terminated at any time, with or without formal cause. The Company also entered an Executive Retention Agreement with Mr. Daguro, pursuant to which the Company agreed to provide specified severance and bonus amounts and to accelerate the vesting on his equity awards upon termination upon a change of control or an involuntary termination, as each term is defined in the agreement. In the event of a termination upon a change of control or an involuntary termination, Mr. Daguro is entitled to receive an amount equal to 100% of his base salary, the actual bonus earned but unpaid for the previous year and any bonus that was earned but unpaid prior to the termination date. Further, upon termination upon a change of control or an involuntary termination, the Company will reimburse Mr. Daguro for the cost of continuation of health coverage for Mr. Daguro and his eligible dependents pursuant to COBRA until the earlier of 12 months following the termination date, the date Mr. Daguro and his dependents are eligible for health coverage from a new employer or the date Mr. Daguro and his eligible dependents are no longer eligible for COBRA.

 

On April 25, 2022, Hang Pham and the Company entered an Offer Letter pursuant to which Ms. Pham agreed to serve as Chief Financial Officer with a planned employment date commencing June 20, 2022. Ms. Pham receives an annual salary of $275,000. The Company agreed to provide a bonus of 40% of the base salary based on achievement of performance milestones, calculated and payable in accordance with the corporate milestones approved by the Board for the year 2022. For subsequent fiscal years the bonus shall be subject to performance targets to be mutually agreed with the Compensation Committee of the Board. In addition, Ms. Pham received a signing bonus in the amount of $25,000, which is fully refundable to the Company if Ms. Pham leaves her employment voluntarily or is terminated for cause prior to the first anniversary of the commencement of employment. Upon commencing employment, Ms. Pham was granted an option to acquire 43,750 shares of common stock at an exercise price of $19.28 with an exercise period of ten years subject to certain performance and market vesting requirements. On May 11, 2023, the Company entered a Retention Agreement with Ms. Pham, pursuant to which the Company agreed to provide specified retention bonus amounts subject to certain performance conditions in the aggregate amount of up to $240,625 and to accelerate the vesting on her equity awards upon termination. This Agreement replaces the previous Executive Retention Agreement dated April 25, 2022, which was terminated and a release granted in relation thereto. Ms. Pham resigned as Chief Financial Officer effective August 15, 2023.

 

On April 12, 2023, the Company entered an Offer Letter with Thomas R. Szoke, a director of the Company, pursuant to which Mr. Szoke agreed to serve as Chief Technology Officer in consideration of an initial annual salary of $250,000. Mr. Szoke received an initial signing bonus of $20,833 and will be eligible for an annual target bonus of up to $200,000 based on performance milestones. For the period ending March 31, 2024, a bonus amount of $40,000 shall be payable upon our company achieving increments of $1,000,000 in total contract value of all customer agreements less claw backs (“Bookings”) up to an aggregate of $5,000,000 in Bookings. For subsequent years, Mr. Szoke and the Compensation Committee of the Board will mutually agree as to the performance targets to be achieved, to earn the annual bonus. The vesting criteria of Mr. Szoke’s Stock Options to acquire 12,500 shares of common stock previously granted to Mr. Szoke on March 14, 2023 (the “Original Grant”) were amended pursuant to an Amended and Restated Stock Non-Statutory Option Agreement providing for vesting subject to achievement of performance and service conditions. All other terms of the Original Grant were not changed. On June 28, 2023, the Company made an additional grant of options to Mr. Szoke to acquire 50,000 shares of common stock at the exercise price of $5.48 per share for a period of ten years vesting subject to achievement of performance and service conditions.

 

The employment of Mr. Szoke is at will and may be terminated at any time, with or without formal cause. The Company also entered an Executive Retention Agreement with Mr. Szoke, pursuant to which the Company agreed to provide specified severance and bonus amounts and to accelerate the vesting on his equity awards upon termination upon a change of control or an involuntary termination, as each term is defined in the agreement. In the event of a termination upon a change of control or an involuntary termination, Mr. Szoke is entitled to receive an amount equal to 100% of his base salary, the actual bonus earned but unpaid for the previous year and any bonus that was earned but unpaid prior to the termination date. Further, upon termination upon a change of control or an involuntary termination, the Company will reimburse Mr. Szoke for the cost of continuation of health coverage for Mr. Szoke and his eligible dependents pursuant to COBRA until the earlier of 12 months following the termination date, the date Mr. Szoke and his dependents are eligible for health coverage from a new employer or the date Mr. Szoke and his eligible dependents are no longer eligible for COBRA.

 

On July 31, 2023, the Company and Edward Sellitto entered an Offer Letter pursuant to which Mr. Sellitto agreed to serve as Chief Financial Officer of the Company commencing August 15, 2023 in consideration of an annual salary of $250,000. Mr. Sellitto will be eligible for an annual target bonus of up to 60% of base salary based on achievement of performance milestones, as Mr. Sellitto and the Compensation Committee of the Board, will mutually agree for each year. The bonus shall be pro-rated for the year 2023. At the outset of employment, Mr. Sellitto was provided with a grant of options to purchase 50,000 shares of common stock vesting subject to achievement of performance and service conditions at an exercise price of $8.87, with an exercise period of 10 years. The employment of Mr. Sellitto will be at will and may be terminated at any time, with or without formal cause.

 

Board of Directors

 

Messrs. Thomas Thimot, Phillip L. Kumnick, Philip R. Broenniman, Michael A. Gorriz and Ms. Neepa Patel tendered their resignations from the Board of Directors of the Company on March 9, 2023. The Board of Directors appointed Joseph Trelin to the Company’s Compensation and Audit Committees. On March 9, 2023, the Board of Directors appointed Rhon Daguro, Ken Jisser, Michael Thompson and Thomas Szoke as additional directors of the Company and reduced the size of the Board of Directors from 8 directors to 7 directors. The Company granted Messrs. Jisser, Thompson and Szoke 12,500 options each at the exercise price of $2.64 per share.

 

On March 16, 2023, the Company appointed Joseph Trelin as the Chairman of the Board, Michael Koehneman as Chairman of the Governance Committee and appointed Michael Thompson to the Company’s Compensation and Governance Committees.

 

On June 28, 2023, the Company granted 15,625 options each at the exercise price of $5.48 per share to Messrs. Joseph Trelin, Michael Koehneman and Ms. Jacqueline White and 3,125 options each at the exercise price of $5.48 to Messrs. Jisser and Thompson, in accordance with the Company’s compensation policy for non-employee directors. Each such option vests over a period of twelve months.

 

Services Agreements

 

Mr. Ken Jisser joined our Board of Directors on March 9, 2023. Mr. Jisser is the founder and Chief Executive Officer of The Pipeline Group, Inc. (“TPG”), a technology-enabled services company that assists the Company with pipeline generation. On June 6, 2023, the Company entered into a services agreement with TPG. The agreement provides that TPG assist in providing outsourced sales including business development resources for outbound calling, provide support for automated dialing technology, classify customer data and other sales related services. In consideration of the services, the Company will pay TPG $47,000 per month during a one-year term. On October 25, 2023 the Agreement was amended to provide for additional services and for the Company to pay TPG $70,000 per month during the remainder of the term.

v3.23.3
Stockholders' Equity
9 Months Ended
Sep. 30, 2023
Stockholders' Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 8STOCKHOLDERS’ EQUITY

 

On June 26, 2023, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a one-for-eight (1-for-8) reverse split (the “Reverse Split”) of the shares of the Company’s common stock. The Reverse Split became effective on July 7, 2023 (see Note 11 “Subsequent Event”). As a result of the Reverse Split, every eight shares of the Company’s issued and outstanding common stock automatically converted into one share of common stock, without any change in the par value per share, and began trading on a post-split basis under the Company’s existing trading symbol, “AUID”, when the market opened on July 10, 2023. The Reverse Split affected all holders of common stock uniformly and did not affect any common stockholder’s percentage ownership interest in the Company, except for de minimis changes as a result of the elimination of fractional shares. A total of 62,816,330 shares of common stock were issued and outstanding immediately prior to the Reverse Split, and 7,874,962 shares of common stock were issued and outstanding immediately after the Reverse Split. No fractional shares will be outstanding following the Reverse Split. Any holder who would have received a fractional share of common stock received an additional fraction of a share of common stock to round up their holding to the next whole share. In addition, effective as of the Reverse Split, proportionate adjustments were made to all then-outstanding options and warrants with respect to the number of shares of common stock subject to such options or warrants and the exercise prices thereof, as well as to the conversion price under the remaining Convertible Notes. The impact of this change in capital structure has been retroactively applied to all periods presented herein.

 

Common Stock

 

During the nine months ended September 30, 2023, shares of common stock were issued as a result of the following transactions:

 

  On May 26, 2023, pursuant to Securities Purchase Agreements, the Company issued 1,989,676 shares of common stock for cash gross proceeds of approximately $7.3 million (or approximately $6.4 million, net of offering costs).

 

  On May 26, 2023, pursuant to a Securities Purchase Agreement, Mr. Garchik capitalized the outstanding principal balance of $900,000 under the Initial Promissory Note, into 245,634 shares of common stock, respectively.

 

  On May 26, 2023, pursuant to an exchange agreement with Holders of Convertible Notes payable, the Company issued 2,348,347 shares of common stock in exchange for Convertible Notes in the gross principal amount of approximately $8.9 million (approximately $7.9 million, net of debt issuance costs and discount). In addition, the Company recorded approximately $7.5 million of expense on conversion of convertible notes.

 

  The Company issued 111,516 shares of common stock for approximately $388,000 of interest accrued under the Convertible Notes and Credit Facility. See Note 6 “Convertible Notes Payable”.

 

Warrants

 

  On May 12, 2023, in connection with certain recruitment services, the Company issued 187,500 common stock warrants to Madison III, LLC with a term of 5 years and an exercise price of $3.164 per share.

 

  On May 26, 2023, in connection with their placement agent services, the Company issued 156,712 common stock warrants to Madison Global Partners, LLC, with a term of 5 years and an exercise price of $3.664 per share.

 

The following is a summary of the Company’s warrant activity for the nine months ended September 30, 2023 (unaudited):

 

       Weighted   Weighted
       Average   Average
   Number of   Exercise   Remaining
   Shares   Price   Life
            
Outstanding at December 31, 2022   153,683   $36.96   2.21 Years
Granted   344,212   $3.39  
Exercised/cancelled   (9,877)  $39.60    
    488,018   $13.22   3.94 Years

 

Stock Options

 

During the nine months ended September 30, 2023, the Company granted directors a total of 78,125 options at exercise prices ranging from $2.64 to $5.48 per share. During the nine months ended September 30, 2023, the Company granted the Chief Executive Officer 490,000 options at exercise prices ranging from $3.18 to $5.48 per share, the Chief Technology Officer 62,500 options at exercise prices ranging from $2.64 to $5.48 per share and the Chief Financial Officer 50,000 options at an exercise price of $8.87. During the nine months ended September 30, 2023 the Company also granted a total of 75,000 options to certain new employees at an exercise price of $7.36 per share.

 

During the nine months ended September 30, 2023 the Company agreed to accelerate the vesting of 45,190 options for Annie Pham under her Retention Agreement with exercise prices ranging from $6.32 to $19.28 per share. These accelerated options would not otherwise have vested prior to termination of employment according to their Market and Service conditions. Therefore, the Company recalculated the fair value of these options as of her termination date of August 15, 2023 using the Black Scholes method.

 

The Company determined the grant date fair value of options granted for the nine months ended September 30, 2023, using the Black Scholes and Monte Carlo Methods, as applicable, with the following assumptions:

 

Expected volatility  120-124%
Expected term  0.25 - 5 years
Risk free rate  3.52% - 4.36%
Dividend rate  0.00%

 

Activity related to stock options for the nine months ended September 30, 2023 (unaudited), is summarized as follows:

 

       Weighted   Weighted     
       Average   Average   Aggregate 
   Number of   Exercise   Contractual   Intrinsic 
   Shares   Price   Term (Yrs.)   Value 
                 
Outstanding at December 31, 2022   1,291,595   $46.48    6.5   $
-
 
Granted   755,625   $4.81    10.0   $2,218,309 
Exercised   
-
   $
-
    -   $
-
 
Forfeited/cancelled   (361,650)  $52.80    -   $- 
Outstanding as of September 30, 2023   1,685,570   $25.85    6.7   $2,334,011 
Exercisable as of September 30, 2023   1,004,499   $44.36    4.9   $876,503 

 

The following table summarizes stock option information as of September 30, 2023 (unaudited):  

 

       Weighted     
       Average     
       Contractual     
Exercise Price  Outstanding   Term (Yrs.)   Exercisable 
             
Less than or equal $32.00   1,280,216    7.3    709,283 
$32.08 - $56.00   17,917    2.7    17,917 
$56.08 - $80.00   222,792    6.1    131,820 
$80.08 - $127.76   164,645    3.2    145,479 
    1,685,570    6.7    1,004,499 

 

During the nine months ended September 30, 2023, the Company recognized approximately ($0.02) million of stock option based compensation expense. As of September 30, 2023, there was approximately $3.2 million of unrecognized compensation costs related to stock options outstanding that will be expensed through 2026.

 

Revision of Prior Period Information

 

During the review of the Company’s financial statements for the three and nine-month periods ended September 30, 2023, the Company identified errors in the recording of stock-based compensation expense relating to the three months ended March 31, 2023, related to reversing cumulative stock-based compensation recognized on stock awards with market vesting conditions due to Q1 2023 terminations. The Company recorded the following revisions in the nine-month period ended September 30, 2023. The following revisions will also be included to compare the three and six month periods ending March 31 and June 30, 2023 respectively to the 2024 results.

 

   Three Months Ended March 31, 2023   Six Months Ended June 30, 2023 
   As
Previously
Reported
   Adjustment   As Revised   As
Previously
Reported
   Adjustment   As Revised 
Stock-based Compensation  $837,608   $(3,438,613)  $(2,601,005)  $1,895,712   $(3,438,613)  $(1,542,901)
Operating Expenses  $4,458,022   $(3,438,613)  $1,019,409   $7,254,539   $(3,438,613)  $3,815,926 
Loss from Continuing Operations  $(5,220,239)  $3,438,613   $(1,781,626)  $(16,120,559)  $3,438,613   $(12,681,946)
Net Loss  $(5,222,494)  $3,438,613   $(1,783,881)  $(15,901,051)  $3,438,613   $(12,462,438)
APIC  $141,317,627   $(3,438,613)  $137,879,014   $165,593,921   $(3,438,613)  $162,155,308 
Accumulated Deficit  $(145,352,653)  $3,438,613   $(141,914,040)  $(156,031,210)  $3,438,613   $(152,592,597)
Total Stockholders’ Equity (Deficit)  $(3,900,576)  $
-
   $(3,900,576)  $ 9,563,289   $
-
   $ 9,563,289 
Net Loss Per Share from Continuing Operations                               
Basic and Diluted
  $(1.61)  $1.06   $(0.55)  $(3.91)  $0.83   $(3.08)

 

In accordance with the SEC’s Staff Accounting Bulletin Nos. 99 and 108 (“SAB 99” and “SAB 108”), the Company evaluated this error and concluded that although the adjustment to certain areas of the statement of operations was quantitatively material, the cumulative effects were qualitatively immaterial and would not have materially impacted a reasonable investor’s opinion of the Company. This is further supported by the fact that the impact would not have been significant in comparison to prior periods and all errors are of a non-cash nature. Therefore, as permitted by SAB 108 and treated under the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 250, Accounting Changes and Error Corrections, the Company revised previously recorded results for the three months ended March 31, 2023 and the six months ended June 30, 2023, to account for the prior period error in this current filing.

 

As a result, the statement of operations for the three and nine month periods ended September 30, 2023 reflects the revised expenses, loss from continuing operations and net loss.

v3.23.3
Discontinued Operations and Assets Held for Sale
9 Months Ended
Sep. 30, 2023
Discontinued Operations and Assets Held for Sale [Abstract]  
DISCONTINUED OPERATIONS AND ASSETS HELD FOR SALE

NOTE 9 – DISCONTINUED OPERATIONS AND ASSETS HELD FOR SALE

 

The Board of Directors of authID considered it in the best interests of the Company to focus its business activities on providing biometric authentication products and services by means of our proprietary Verified platform.  Accordingly, on May 4, 2022, the Board approved a plan to exit from certain non-core activities comprising the MultiPay correspondent bank, payments services in Colombia and the Cards Plus cards manufacturing and printing business in South Africa.

 

Cards Plus business in South Africa

 

The financial statements of Cards Plus are classified as a discontinued operation and an asset held for sale, as all required classification criteria under appropriate accounting standards were met as of June 30, 2022.

 

On August 29, 2022, the Company completed the sale of Cards Plus for a price of $300,000 of which $150,000 was received and the remaining balance of $150,000 was recorded in other current asset, less $3,272 in costs to sell, and recognized a loss of $188,247 from the transaction. While the Company and Cards Plus continue to actively pursue payment of the remaining balance, which is subject to regulatory approval, management re-evaluated the likelihood of recovery and recorded an allowance for doubtful account in September 30, 2023 related to this receivable.

 

MultiPay business in Colombia

 

The Company exited the MultiPay business in Colombia in an orderly fashion, honoring our obligations to employees, customers and under applicable laws and regulations.  We maintain our customer support and operations team in Bogota, which performs essential functions to support the global operations of our Verified product.

 

As of June 30, 2023, all impacted employees had left the Company. MultiPay finalized the sale of the Company’s proprietary software to its major customer on June 30, 2023 for approximately $96,000 of sale consideration. The Company recorded the receivable under the sale in Other current assets, released foreign currency translation gain of approximately $155,000 and recognized a gain of $216,000 from the transaction. This receivable was collected in September 2023. 

 

The following table summarizes the assets and liabilities of the MultiPay sale and the consideration received (unaudited):

 

   Amount 
Carrying value of net assets sold:     
Property and equipment write-off  $19,528 
Net assets write-off  $19,528 
      
Sale consideration on disposition of net assets:     
Sale consideration  $95,852 
Less: Value added tax   (15,304)
Net Consideration  $80,548 
Foreign currency translation:  $155,049 
Net gain on sale of a discontinued operation  $216,069 

 

The operations of Cards Plus and MultiPay for the three and nine months ended September 30, 2023 and 2022 on a consolidated basis are below (unaudited):

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
Discontinued Operations                
Total Revenues, net  $
-
   $446,643   $29,354   $1,468,199 
                     
Operating Expenses:                    
Cost of Sales   
-
    145,205    
-
    665,269 
General and administrative   
-
    276,866    12,268    1,003,003 
Impairment loss   
-
    -    
-
    143,698 
Depreciation and amortization   
-
    (6,749)   8,066    33,025 
Total operating expenses   
-
    415,322    20,334    1,844,995 
                     
Income (Loss) from operations   -    31,321    9,020    (376,796)
                     
Other Income (Expense):                    
Other income   
-
    12,792    
-
    20,821 
Interest expense, net   
-
    
-
    
-
    (364)
Other income (expense), net   
-
    12,792    
-
    20,457 
                     
Loss before income taxes   
-
    44,113    9,020    (356,339)
                     
Income tax expense   (1,915)   (468)   (7,496)   (7,046)
                     
Income (loss) from discontinued operations   (1,915)   43,645    1,524    (363,385)
Loss (gain) from sale of discontinued operations   -    (188,247)   216,069    (188,247)
Total income (loss) from discontinued operations  $(1,915)  $(144,602)  $217,593   $(551,632)

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
Cards Plus                
Total Revenues, net  $
-
   $380,372   $
-
   $1,263,672 
                     
Operating Expenses:                    
Cost of Sales   
-
    145,205    
-
    665,269 
General and administrative   
-
    21,539    
-
    412,243 
Impairment loss   
-
    -    
-
    143,698 
Depreciation and amortization   
-
    (1,482)   
-
    24,415 
Total operating expenses   
-
    165,262    
-
    1,245,625 
                     
Income (loss) from operations   
-
    215,110    
-
    18,047 
                     
Other Income (Expense):                    
Other income   
-
    2,103    
-
    8,919 
Interest expense, net   
-
    
-
    
-
    (364)
Other income, net   
-
    2,103    
-
    8,555 
                     
Loss before income taxes   
-
    217,213    
-
    26,602 
                     
Income tax expense   
-
    
-
    
-
    (4,681)
                     
Income from discontinued operations   -    217,213    -    21,921 
Loss from sale of discontinued operations   
-
    (188,247)   
 
    (188,247)
Total Income (Loss) from discontinued operations  $-   $28,966   $-   $(166,326)

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
MultiPay                
Total Revenues, net  $
-
   $66,271   $29,354   $204,527 
                     
Operating Expenses:                    
General and administrative   
-
    255,327    12,268    590,760 
Depreciation and amortization   
-
    (5,267)   8,066    8,610 
Total operating expenses   
-
    250,060    20,334    599,370 
                     
Loss from operations   
-
    (183,789)   9,020    (394,843)
                     
Other Income:                    
Other income   
-
    10,689    
-
    11,902 
Other income   -    10,689    -    11,902 
                     
Loss before income taxes   
-
    (173,100)   9,020    (382,941)
                     
Income tax expense   (1,915)   (468)   (7,496)   (2,365)
                     
Income (loss) from discontinued operations   (1,915)   (173,568)   1,524    (385,306)
Gain from sale of discontinued operations   -    
-
    216,069    
-
 
Total Income (loss) from discontinued operations  $(1,915)  $(173,568)  $217,593   $(385,306)

 

As a result of meeting the discontinued operations/assets held for sale criteria for Cards Plus and the MultiPay operations, the cash flow activity related to discontinued operations is presented separately on the statement of cash flows as summarized below (unaudited):

 

   Nine Months Ended 
   September 30, 
   2023   2022 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $1,524   $(363,385)
Adjustments to reconcile net loss with cash flows from operations:          
Depreciation and amortization expense   8,067    42,364 
Impairment of intangible assets   
-
    143,701 
Changes in operating assets and liabilities:          
Accounts receivable   105,194    (14,288)
Other current assets   10,562    186,370 
Inventory   
-
    (78,806)
Accounts payable and accrued expenses   (13,759)   (16,092)
Deferred revenue   
-
    (36,663)
Adjustments relating to discontinued operations   110,064    226,586 
Cash flows from discontinued operations  $111,588   $(136,799)

 

Notes to Financial Statements – Discontinued Operations

 

Revenue Recognition

 

Cards Plus – The Company recognized revenue for the design and production of cards at the point in time when products are shipped, or services have been performed due to the short-term nature of the contracts. Additionally, the cards produced by the Company have no alternative use and the Company has an enforceable right to payment for work performed should the contract be cancelled.

 

MultiPay recognized revenue for variable fees generated for payment processing solutions that are earned on a usage fee over time based on monthly transaction volumes or on a monthly flat fee rate. Additionally, MultiPay also sells certain equipment from time to time for which revenue is recognized upon delivery to the customer.

v3.23.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 10 – COMMITMENTS AND CONTINGENCIES

 

Legal Matters

 

From time to time, the Company is a party to various legal or administrative proceedings arising in the ordinary course of our business. While any litigation contains an element of uncertainty, we have no reason to believe the outcome of such proceedings will have a material adverse effect on the financial condition or results of operations of the Company.

 

Leases

 

The Company rented office space in Long Beach, New York at a monthly cost of $2,500 in 2022. The agreement was month to month and could be terminated on 30 days notice. The lease agreement was terminated in July 2022. The agreement was between the Company and Bridgeworks LLC, an entity principally owned by Mr. Beck, the Company’s former CEO and Director and his family.

 

In July 2022, the Company signed a new lease agreement for one year and moved its headquarters to Denver, Colorado. The office monthly lease cost is approximately $1,500 per month. The Company did not renew the lease agreement after July 2023 and has no remaining lease agreements as of September 30, 2023.

 

Rent expense included in general and administrative on the Consolidated Statements of Operations for the nine months ended September 30, 2023 was approximately $8,000. For the nine months ended September 30, 2022, rent expense was approximately $80,000, inclusive of short-term leases of which $13,000 was for continuing operations and $67,000 for discontinued operations.

v3.23.3
Subsequent Event
9 Months Ended
Sep. 30, 2023
Subsequent Event [Abstract]  
SUBSEQUENT EVENT

NOTE 11 – SUBSEQUENT EVENT

 

Management of the Company has performed a review of all events and transactions occurring after the condensed consolidated balance sheet date and determined there were no events or transactions requiring adjustment to or disclosure in the accompanying condensed consolidated financial statements.

v3.23.3
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Going Concern

Going Concern

As of September 30, 2023, the Company had an accumulated deficit of approximately $156.3 million. For the three and nine months ended September 30, 2023, the Company earned revenue from continuing operations of approximately $0.04 million and $0.12 million, used approximately $2.1 million and $6.2 million to fund its operations, and incurred a net loss of approximately $3.7 million and $16.2 million, respectively.

The continuation of the Company as a going concern is dependent upon financial support from the Company’s stockholders and noteholders, the ability of the Company to obtain additional debt or equity financing to continue operations, the Company’s ability to generate sufficient cash flows from operations, successfully locating and negotiating with other business entities for potential acquisition, and acquiring new clients to generate revenues and cash flows.

During the nine months ended September 30, 2023, the Company has secured additional financing of approximately $6.4 million net, which provides funding for its current operations as it continues to invest in its product, people, and technology. Although there is no guarantee, the Company projects that the investments will lead to revenue expansion thereby reducing liquidity needs. However, in order to further implement its business plan and satisfy its working capital requirements, the Company will need to raise additional capital. There is no guarantee that the Company will be able to raise additional equity or debt financing at acceptable terms, if at all.

There is no assurance that the Company will ever be profitable. These unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. As there can be no assurance that the Company will be able to achieve positive cash flows (become cash flow positive) and raise sufficient capital to maintain operations, there is substantial doubt about the Company’s ability to continue as a going concern.

Reclassification

Reclassification

Certain prior year expenses have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the previously reported loss from continuing operations and management does not believe that this reclassification is material to the consolidated financial statements taken as a whole. Specifically, we reclassified certain expenses from general and administrative expenses to research and development expenses.

 

Net Loss per Common Share

Net Loss per Common Share

The Company computes net loss per share in accordance with FASB ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the statement of operations. Basic EPS is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible notes and stock warrants, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and conversion of convertible notes. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive. The following potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and nine months ended September 30, 2023 and 2022 because their effect was antidilutive:

Security  2023   2022 
         
Convertible notes payable   8,278    325,188 
Warrants   488,018    163,045 
Stock options   1,685,570    1,212,202 
    2,181,866    1,700,435 
Revenue Recognition

Revenue Recognition

Verified Software License – The Company recognizes revenue based on the identified performance obligations over the performance period for fixed consideration and / or variable fees generated that are earned on a usage fee based over time based on user monthly user or transaction volumes or on a monthly flat fee rate. We allocate the selling price in a contract which has multiple performance obligations based on the contract selling price that we believe represents a fair market price for the service rendered based on estimated standalone selling price.

The Company had contract liabilities of approximately $103,000 and $81,000 as of September 30, 2023 and December 31, 2022 respectively for certain revenue that will be earned in future periods. All deferred revenue contract liabilities as of September 30, 2023 are expected to be earned over the next twelve months.

Remaining Performance Obligations

Remaining Performance Obligations

As of September 30, 2023, the Company’s Remaining Performance Obligation (RPO) was $1.87 million, of which $0.10 million is held as deferred revenue and $1.77 million is related to other non-cancelable contracted amounts. The Company expects approximately 34% of the RPO to be recognized as revenue in the twelve months ending September 30, 2024 based on contractual commitments and expected usage patterns. However, the amount and timing of revenue recognition are generally dependent upon customers’ future consumption, which is inherently variable at customers’ discretion. Furthermore, the Company does not have historical information to estimate the recognition of revenue due to its current operations and has approximated such amount based on discussions with the contracted parties.

Deferred Contract Costs – We defer the portion of sales commission that is considered a cost of obtaining a new contract with a customer and amortize these deferred costs over the period of benefit. We expense the remaining sales commissions as incurred. The following table summarizes deferred contract cost activity for the nine months ended September 30, 2023:

   Deferred 
   Contract Costs 
     
Carrying Value at December 31, 2022  $
-
 
Additions   66,300 
Amortization   
-
 
Carrying Value at September 30, 2023  $66,300 

Legacy Authentication Services – The Company historically has sold certain legacy software licenses to customers and revenue is recognized when delivery occurs, and all other revenue recognition criteria have been met. During both quarters ended September 30, 2023 and 2022, the Company provided annual software maintenance support services relating to previously licensed software on a stand-ready basis. These fees were billed in advance and recognized ratably over the requisite service period as revenue.

Revenue Accounting Pronouncement – In June 2016, the Financial Accounting Standards Board issued Accounting Standards Update No. 2016-13, “Financial Instruments – Credit Losses (Topic),” which replaces the current incurred loss impairment methodology for most financial assets with the current expected credit lost, or CECL, methodology. The series of new guidance amends the impairment model by requiring entities to use a forward-looking approach based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. The Company adopted the new standard effective January 1, 2023, which did not have a material impact to the consolidated financial statements.

v3.23.3
Basis of Presentation (Tables)
9 Months Ended
Sep. 30, 2023
Basis of Presentation [Abstract]  
Schedule of Calculation of Diluted Loss Per Share The following potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and nine months ended September 30, 2023 and 2022 because their effect was antidilutive:
Security  2023   2022 
         
Convertible notes payable   8,278    325,188 
Warrants   488,018    163,045 
Stock options   1,685,570    1,212,202 
    2,181,866    1,700,435 
Schedule of Deferred Contract Costs The following table summarizes deferred contract cost activity for the nine months ended September 30, 2023:
   Deferred 
   Contract Costs 
     
Carrying Value at December 31, 2022  $
-
 
Additions   66,300 
Amortization   
-
 
Carrying Value at September 30, 2023  $66,300 
v3.23.3
Other Current Assets and Other Assets (Tables)
9 Months Ended
Sep. 30, 2023
Other Current Assets and Other Assets [Abstract]  
Schedule of Other Current Assets Other current assets consisted of the following at September 30, 2023 (unaudited) and December 31, 2022:
   September 30,   December 31, 
   2023   2022 
         
Prepaid insurance  $295,188   $244,215 
Prepaid third party services   155,052    135,405 
Unamortized credit facility fees   
-
    199,156 
Other   23,938    150,566 
   $474,178   $729,342 
Schedule of Other Assets Other assets consisted of the following at September 30, 2023 (unaudited) and December 31, 2022:
   September 30,   December 31, 
   2023   2022 
         
Unamortized working capital facility fees  $
           -
   $248,945 
Other   
-
    1,438 
   $
-
   $250,383 
v3.23.3
Intangible Assets, Net (Other than Goodwill) (Tables)
9 Months Ended
Sep. 30, 2023
Intangible Assets, Net (Other than Goodwill) [Abstract]  
Schedule of Intangible Assets The following is a summary of activity related to intangible assets for the nine months ended September 30, 2023 (unaudited):
   Acquired and         
   Developed         
   Software   Patents   Total 
             
Useful Lives   5 Years    10 Years      
                
Carrying Value at December 31, 2022  $435,595   $130,664   $566,259 
Acquisition of intangible assets   16,601    
-
    16,601 
Amortization   (200,100)   (12,351)   (212,451)
Carrying Value at September 30, 2023  $252,096   $118,313   $370,409 
   Acquired and         
   Developed         
   Software   Patents   Total 
Cost  $4,492,872    164,614   $4,657,486 
Accumulated amortization   (4,240,776)   (46,301)   (4,287,077)
Carrying Value at September 30, 2023  $252,096   $118,313   $370,409 
Schedule of Future Expected Amortization of Intangible Assets Future expected amortization of intangible assets is as follows:
2023 (Remainder of the Year)  $51,458 
2024   171,414 
2025   67,111 
2026   19,776 
2027   9,776 
Thereafter   50,874 
   $370,409 
v3.23.3
Accounts Payable and Accrued Expenses (Tables)
9 Months Ended
Sep. 30, 2023
Accounts Payable and Accrued Expenses [Abstract]  
Schedule of Accounts Payable and Accrued Expenses Accounts payable and accrued expenses consisted of the following as of September 30, 2023 (unaudited) and December 31, 2022:
   September 30,   December 31, 
   2023   2022 
         
Trade payables  $426,723   $623,130 
Accrued payroll and related obligations   113,494    145,837 
Other accrued expenses   449,321    385,105 
   $989,538   $1,154,072 
v3.23.3
Convertible Notes Payable (Tables)
9 Months Ended
Sep. 30, 2023
Convertible Notes Payable [Abstract]  
Schedule of the Convertible Notes Payable Outstanding The following is a summary of the Convertible Notes payable outstanding as of September 30, 2023 (unaudited):
9.75% convertible notes due March 31, 2025  $245,000 
      
less:     
Unamortized debt issuance expense   (24,691)
   $220,309 
Schedule of Future Maturities of Convertible Notes Payable Future maturities of Convertible Notes payable as of September 30, 2023:
2025  $245,000 
   $245,000 
v3.23.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2023
Stockholders' Equity [Abstract]  
Schedule of Company’s Warrant Activity The following is a summary of the Company’s warrant activity for the nine months ended September 30, 2023 (unaudited):
       Weighted   Weighted
       Average   Average
   Number of   Exercise   Remaining
   Shares   Price   Life
            
Outstanding at December 31, 2022   153,683   $36.96   2.21 Years
Granted   344,212   $3.39  
Exercised/cancelled   (9,877)  $39.60    
    488,018   $13.22   3.94 Years
Schedule of Grant Date Fair Value of Options Granted The Company determined the grant date fair value of options granted for the nine months ended September 30, 2023, using the Black Scholes and Monte Carlo Methods, as applicable, with the following assumptions:
Expected volatility  120-124%
Expected term  0.25 - 5 years
Risk free rate  3.52% - 4.36%
Dividend rate  0.00%
Schedule of Activity Related to Stock Options Activity related to stock options for the nine months ended September 30, 2023 (unaudited), is summarized as follows:
       Weighted   Weighted     
       Average   Average   Aggregate 
   Number of   Exercise   Contractual   Intrinsic 
   Shares   Price   Term (Yrs.)   Value 
                 
Outstanding at December 31, 2022   1,291,595   $46.48    6.5   $
-
 
Granted   755,625   $4.81    10.0   $2,218,309 
Exercised   
-
   $
-
    -   $
-
 
Forfeited/cancelled   (361,650)  $52.80    -   $- 
Outstanding as of September 30, 2023   1,685,570   $25.85    6.7   $2,334,011 
Exercisable as of September 30, 2023   1,004,499   $44.36    4.9   $876,503 
Schedule of Stock Option The following table summarizes stock option information as of September 30, 2023 (unaudited):
       Weighted     
       Average     
       Contractual     
Exercise Price  Outstanding   Term (Yrs.)   Exercisable 
             
Less than or equal $32.00   1,280,216    7.3    709,283 
$32.08 - $56.00   17,917    2.7    17,917 
$56.08 - $80.00   222,792    6.1    131,820 
$80.08 - $127.76   164,645    3.2    145,479 
    1,685,570    6.7    1,004,499 
Schedule of Revisions The following revisions will also be included to compare the three and six month periods ending March 31 and June 30, 2023 respectively to the 2024 results.
   Three Months Ended March 31, 2023   Six Months Ended June 30, 2023 
   As
Previously
Reported
   Adjustment   As Revised   As
Previously
Reported
   Adjustment   As Revised 
Stock-based Compensation  $837,608   $(3,438,613)  $(2,601,005)  $1,895,712   $(3,438,613)  $(1,542,901)
Operating Expenses  $4,458,022   $(3,438,613)  $1,019,409   $7,254,539   $(3,438,613)  $3,815,926 
Loss from Continuing Operations  $(5,220,239)  $3,438,613   $(1,781,626)  $(16,120,559)  $3,438,613   $(12,681,946)
Net Loss  $(5,222,494)  $3,438,613   $(1,783,881)  $(15,901,051)  $3,438,613   $(12,462,438)
APIC  $141,317,627   $(3,438,613)  $137,879,014   $165,593,921   $(3,438,613)  $162,155,308 
Accumulated Deficit  $(145,352,653)  $3,438,613   $(141,914,040)  $(156,031,210)  $3,438,613   $(152,592,597)
Total Stockholders’ Equity (Deficit)  $(3,900,576)  $
-
   $(3,900,576)  $ 9,563,289   $
-
   $ 9,563,289 
Net Loss Per Share from Continuing Operations                               
Basic and Diluted
  $(1.61)  $1.06   $(0.55)  $(3.91)  $0.83   $(3.08)
v3.23.3
Discontinued Operations and Assets Held for Sale (Tables)
9 Months Ended
Sep. 30, 2023
Discontinued Operations and Assets Held for Sale [Abstract]  
Schedule of Assets and Liabilities of the MultiPay Sale and Consideration Received The following table summarizes the assets and liabilities of the MultiPay sale and the consideration received (unaudited):
   Amount 
Carrying value of net assets sold:     
Property and equipment write-off  $19,528 
Net assets write-off  $19,528 
      
Sale consideration on disposition of net assets:     
Sale consideration  $95,852 
Less: Value added tax   (15,304)
Net Consideration  $80,548 
Foreign currency translation:  $155,049 
Net gain on sale of a discontinued operation  $216,069 

 

Schedule of Operations of Cards Plus and MultiPay The operations of Cards Plus and MultiPay for the three and nine months ended September 30, 2023 and 2022 on a consolidated basis are below (unaudited):
   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
Discontinued Operations                
Total Revenues, net  $
-
   $446,643   $29,354   $1,468,199 
                     
Operating Expenses:                    
Cost of Sales   
-
    145,205    
-
    665,269 
General and administrative   
-
    276,866    12,268    1,003,003 
Impairment loss   
-
    -    
-
    143,698 
Depreciation and amortization   
-
    (6,749)   8,066    33,025 
Total operating expenses   
-
    415,322    20,334    1,844,995 
                     
Income (Loss) from operations   -    31,321    9,020    (376,796)
                     
Other Income (Expense):                    
Other income   
-
    12,792    
-
    20,821 
Interest expense, net   
-
    
-
    
-
    (364)
Other income (expense), net   
-
    12,792    
-
    20,457 
                     
Loss before income taxes   
-
    44,113    9,020    (356,339)
                     
Income tax expense   (1,915)   (468)   (7,496)   (7,046)
                     
Income (loss) from discontinued operations   (1,915)   43,645    1,524    (363,385)
Loss (gain) from sale of discontinued operations   -    (188,247)   216,069    (188,247)
Total income (loss) from discontinued operations  $(1,915)  $(144,602)  $217,593   $(551,632)

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
Cards Plus                
Total Revenues, net  $
-
   $380,372   $
-
   $1,263,672 
                     
Operating Expenses:                    
Cost of Sales   
-
    145,205    
-
    665,269 
General and administrative   
-
    21,539    
-
    412,243 
Impairment loss   
-
    -    
-
    143,698 
Depreciation and amortization   
-
    (1,482)   
-
    24,415 
Total operating expenses   
-
    165,262    
-
    1,245,625 
                     
Income (loss) from operations   
-
    215,110    
-
    18,047 
                     
Other Income (Expense):                    
Other income   
-
    2,103    
-
    8,919 
Interest expense, net   
-
    
-
    
-
    (364)
Other income, net   
-
    2,103    
-
    8,555 
                     
Loss before income taxes   
-
    217,213    
-
    26,602 
                     
Income tax expense   
-
    
-
    
-
    (4,681)
                     
Income from discontinued operations   -    217,213    -    21,921 
Loss from sale of discontinued operations   
-
    (188,247)   
 
    (188,247)
Total Income (Loss) from discontinued operations  $-   $28,966   $-   $(166,326)
   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
MultiPay                
Total Revenues, net  $
-
   $66,271   $29,354   $204,527 
                     
Operating Expenses:                    
General and administrative   
-
    255,327    12,268    590,760 
Depreciation and amortization   
-
    (5,267)   8,066    8,610 
Total operating expenses   
-
    250,060    20,334    599,370 
                     
Loss from operations   
-
    (183,789)   9,020    (394,843)
                     
Other Income:                    
Other income   
-
    10,689    
-
    11,902 
Other income   -    10,689    -    11,902 
                     
Loss before income taxes   
-
    (173,100)   9,020    (382,941)
                     
Income tax expense   (1,915)   (468)   (7,496)   (2,365)
                     
Income (loss) from discontinued operations   (1,915)   (173,568)   1,524    (385,306)
Gain from sale of discontinued operations   -    
-
    216,069    
-
 
Total Income (loss) from discontinued operations  $(1,915)  $(173,568)  $217,593   $(385,306)

 

Schedule of Cash Flow Activity Related to Discontinued Operations As a result of meeting the discontinued operations/assets held for sale criteria for Cards Plus and the MultiPay operations, the cash flow activity related to discontinued operations is presented separately on the statement of cash flows as summarized below (unaudited):
   Nine Months Ended 
   September 30, 
   2023   2022 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $1,524   $(363,385)
Adjustments to reconcile net loss with cash flows from operations:          
Depreciation and amortization expense   8,067    42,364 
Impairment of intangible assets   
-
    143,701 
Changes in operating assets and liabilities:          
Accounts receivable   105,194    (14,288)
Other current assets   10,562    186,370 
Inventory   
-
    (78,806)
Accounts payable and accrued expenses   (13,759)   (16,092)
Deferred revenue   
-
    (36,663)
Adjustments relating to discontinued operations   110,064    226,586 
Cash flows from discontinued operations  $111,588   $(136,799)
v3.23.3
Basis of Presentation (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2024
Dec. 31, 2022
Basis of Presentation [Line Items]            
Accumulated deficit $ (156,310,215)   $ (156,310,215)     $ (140,130,159)
Revenue 43,389 $ 30,023 118,387 $ 261,484    
Fund its operations 2,100,000   (6,224,162) (9,553,050)    
Net loss (3,717,618) $ (6,334,949) (16,180,056) $ (18,208,504)    
Additional financing     6,400,000      
Contract liability 103,000   103,000     $ 81,000
Remaining performance obligation 1,870,000   1,870,000      
Deferred revenue $ 100,000   100,000      
Related to other non-cancelable contracted amounts     $ 1,770,000      
Forecast [Member]            
Basis of Presentation [Line Items]            
Remaining performance obligation percentage         34.00%  
v3.23.3
Basis of Presentation (Details) - Schedule of Calculation of Diluted Loss Per Share - shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares 2,181,866 1,700,435 2,181,866 1,700,435
Stock Options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares 1,685,570 1,212,202 1,685,570 1,212,202
Convertible Notes Payable [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares 8,278 325,188 8,278 325,188
Warrants [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares 488,018 163,045 488,018 163,045
v3.23.3
Basis of Presentation (Details) - Schedule of Deferred Contract Costs
9 Months Ended
Sep. 30, 2023
USD ($)
Schedule Of Deferred Contract Costs Abstract  
Carrying Value at December 31, 2022
Additions 66,300
Amortization
Carrying Value at December 31, 2022 $ 66,300
v3.23.3
Other Current Assets and Other Assets (Details) - Schedule of Other Current Assets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Schedule of Other Current Assets [Abstract]    
Prepaid insurance $ 295,188 $ 244,215
Prepaid third party services 155,052 135,405
Unamortized credit facility fees 199,156
Other 23,938 150,566
Total other current assets $ 474,178 $ 729,342
v3.23.3
Other Current Assets and Other Assets (Details) - Schedule of Other Assets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Schedule of other assets [Abstract]    
Unamortized working capital facility fees $ 248,945
Other 1,438
Total other assets $ 250,383
v3.23.3
Intangible Assets, Net (Other than Goodwill) (Details) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Intangible Assets, Net (Other than Goodwill) [Line Items]    
Amortization expense $ 212,450 $ 642,000
v3.23.3
Intangible Assets, Net (Other than Goodwill) (Details) - Schedule of Intangible Assets
9 Months Ended
Sep. 30, 2023
USD ($)
Finite-Lived Intangible Assets [Line Items]  
Carrying Value at December 31, 2022 $ 566,259
Acquisition of intangible assets 16,601
Amortization (212,451)
Carrying Value at September 30, 2023 370,409
Cost 4,657,486
Accumulated amortization $ (4,287,077)
Acquired and Developed Software [Member]  
Finite-Lived Intangible Assets [Line Items]  
Useful Lives 5 years
Carrying Value at December 31, 2022 $ 435,595
Acquisition of intangible assets 16,601
Amortization (200,100)
Carrying Value at September 30, 2023 252,096
Cost 4,492,872
Accumulated amortization $ (4,240,776)
Patents [Member]  
Finite-Lived Intangible Assets [Line Items]  
Useful Lives 10 years
Carrying Value at December 31, 2022 $ 130,664
Acquisition of intangible assets
Amortization (12,351)
Carrying Value at September 30, 2023 118,313
Cost 164,614
Accumulated amortization $ (46,301)
v3.23.3
Intangible Assets, Net (Other than Goodwill) (Details) - Schedule of Future Expected Amortization of Intangible Assets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Schedule of Future Expected Amortization of Intangible Assets [Abstract]    
2023 (Remainder of the Year) $ 51,458  
2024 171,414  
2025 67,111  
2026 19,776  
2027 9,776  
Thereafter 50,874  
Total $ 370,409 $ 566,259
v3.23.3
Accounts Payable and Accrued Expenses (Details) - Labor Reduction Plan [Member]
$ in Millions
9 Months Ended
Sep. 30, 2023
USD ($)
Accounts Payable and Accrued Expenses [Line Items]  
Severance expenses $ 0.8
Severance cash paid 0.4
Accounts payable and accrued expenses 0.1
Other liabilities as a long term liability $ 0.3
v3.23.3
Accounts Payable and Accrued Expenses (Details) - Schedule of Accounts Payable and Accrued Expenses - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Accounts Payable and Accrued Expenses [Abstract]    
Trade payables $ 426,723 $ 623,130
Accrued payroll and related obligations 113,494 145,837
Other accrued expenses 449,321 385,105
Total $ 989,538 $ 1,154,072
v3.23.3
Working Capital Faciltiy (Details) - USD ($)
3 Months Ended 9 Months Ended
May 25, 2023
May 23, 2023
Mar. 09, 2023
Mar. 08, 2023
Mar. 21, 2022
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Mar. 31, 2023
Working Capital Faciltiy [Line Items]                    
Shares of facility Commitment Fee (in Shares)   24,628                
Loss on debt extinguishment           $ (380,741)  
Original Facility Agreement [Member]                    
Working Capital Faciltiy [Line Items]                    
Unsecured debt         $ 10,000,000          
Shares of facility Commitment Fee (in Shares)         12,500          
Issuance costs                   $ 410,000
A&R Facility Agreement [Member]                    
Working Capital Faciltiy [Line Items]                    
Initial credit facility       $ 900,000            
Aggregate amount       $ 2,700,000            
Issuance costs                   $ 426,000
Unpaid interest $ 929,250                  
Loss on debt extinguishment               $ 381,000    
Garchik [Member]                    
Working Capital Faciltiy [Line Items]                    
Principal Amount     $ 900,000              
v3.23.3
Convertible Notes Payable (Details) - USD ($)
9 Months Ended
Jun. 07, 2023
May 26, 2023
May 23, 2023
Mar. 21, 2022
Sep. 30, 2023
Sep. 30, 2022
Convertible Notes Payable [Line Items]            
Aggregate cash origination fee       $ 200,000    
Issued of common stock origination fee (in Shares)       3,563    
Percentage of convertible note interest rate       9.75%    
Common stock interest           $ 223,000
Common stock warrants (in Shares)         17,836  
Estimated grant date fair value         $ 449,000  
Conversion of convertible notes   $ 7,500,000 $ 7,500,000      
Common Stock [Member]            
Convertible Notes Payable [Line Items]            
Shares of common stock (in Shares)     2,346,105     9,335
Common shares issued (in Shares)         103,533 23,947
Interest amount         $ 358,000 $ 474,000
Convertible Notes [Member]            
Convertible Notes Payable [Line Items]            
Aggregate initial principal amount   8,900,000 $ 8,900,000 $ 9,200,000    
Conversion price per share (in Dollars per share) $ 5.8   $ 3.78 $ 29.6    
Convertible notes maturity date       Mar. 31, 2025    
Accrued interest         388,000  
Net of debt issuance costs and discount   $ 7,900,000 $ 7,900,000   $ 24,691  
Exchange Shares (in Shares) 2,242          
Principal amount $ 13,000          
Outstanding principal amount percentage     66.67%      
Convertible Notes [Member] | Officer [Member]            
Convertible Notes Payable [Line Items]            
Conversion price per share (in Dollars per share)     $ 4.12      
Convertible Notes Payable [Member]            
Convertible Notes Payable [Line Items]            
Principal amount           50,000
Accrued interest           $ 406
Shares of common stock (in Shares)           1,706
v3.23.3
Convertible Notes Payable (Details) - Schedule of the Convertible Notes Payable Outstanding - Convertible Notes Payable [Member] - USD ($)
Sep. 30, 2023
May 26, 2023
May 23, 2023
Debt Instrument [Line Items]      
9.75% convertible notes due March 31, 2025 $ 245,000    
Unamortized debt issuance expense (24,691) $ (7,900,000) $ (7,900,000)
Convertible debt, total $ 220,309    
v3.23.3
Convertible Notes Payable (Details) - Schedule of the Convertible Notes Payable Outstanding (Parentheticals)
Sep. 30, 2023
Convertible Notes Payable [Member]  
Debt Instrument [Line Items]  
Percentage of convertible notes due 9.75%
v3.23.3
Convertible Notes Payable (Details) - Schedule of Future Maturities of Convertible Notes Payable
Sep. 30, 2023
USD ($)
Convertible Notes Payable [Abstract]  
2025 $ 245,000
Future maturities of convertible notes payable, total $ 245,000
v3.23.3
Related Party Transactions (Details) - USD ($)
1 Months Ended 9 Months Ended
Oct. 25, 2023
Aug. 15, 2023
Jun. 28, 2023
May 25, 2023
May 23, 2023
May 11, 2023
May 09, 2023
Apr. 12, 2023
Apr. 10, 2023
Mar. 23, 2023
Mar. 14, 2023
Mar. 09, 2023
Mar. 08, 2023
Mar. 06, 2023
Apr. 25, 2022
Mar. 21, 2022
Mar. 31, 2024
Sep. 30, 2023
Related Party Transaction [Line Items]                                    
Conversion of Stock, Amount Converted         $ 100,000                          
Accrued interest         $ 1,463                          
Conversion shares (in Shares)         24,628                          
Share purchased (in Shares)         12,500                          
Common stock at a price         $ 50,000                          
Amendment amount                           $ 3,600,000        
Grant option purchase (in Shares)                                   755,625
Opetion exercise price (in Dollars per share)                                   $ 4.81
Percentage of base salary                                   100.00%
Bonus amount                             $ 25,000      
Exercise price (in Dollars per share)                       $ 2.64            
Maximum [Member]                                    
Related Party Transaction [Line Items]                                    
Shares of common stock (in Shares)       245,634                            
Minimum [Member]                                    
Related Party Transaction [Line Items]                                    
Shares of common stock (in Shares)       7,983                            
Original Facility Agreement [Member]                                    
Related Party Transaction [Line Items]                                    
Conversion shares (in Shares)                               12,500    
Unsecured amount                               $ 10,000,000    
A&R Facility Agreement [Member]                                    
Related Party Transaction [Line Items]                                    
Initial credit facility                         $ 900,000          
Accrued and unpaid       $ 29,250                            
Mr. Stephen J. Garchik [Member]                                    
Related Party Transaction [Line Items]                                    
Accrued interest         14,625                          
Convertible notes payable         $ 1,000,000                          
Mr. Stephen J. Garchik [Member] | Maximum [Member]                                    
Related Party Transaction [Line Items]                                    
Shares of common stock (in Shares)         264,831                          
Mr. Stephen J. Garchik [Member] | Minimum [Member]                                    
Related Party Transaction [Line Items]                                    
Shares of common stock (in Shares)         3,874                          
Mr. Garchik [Member]                                    
Related Party Transaction [Line Items]                                    
Percentage of outstanding shares         10.00%                          
Mr. Garchik [Member] | A&R Facility Agreement [Member]                                    
Related Party Transaction [Line Items]                                    
Principal amount             $ 900,000                      
Mr. Daguro [Member]                                    
Related Party Transaction [Line Items]                                    
Grant option purchase (in Shares)     183,125           306,875                  
Vesting Period     10 years           10 years                  
Mr. Daguro [Member] | Initial Annual Salary [Member]                                    
Related Party Transaction [Line Items]                                    
Officer Expense                   $ 400,000                
Mr. Daguro [Member] | Bonus [Member] | Maximum [Member]                                    
Related Party Transaction [Line Items]                                    
Officer Expense                   $ 375,000                
Mr. Daguro [Member] | Warrant [Member]                                    
Related Party Transaction [Line Items]                                    
Opetion exercise price (in Dollars per share)     $ 5.48           $ 3.176                  
Chief Financial Officer [Member]                                    
Related Party Transaction [Line Items]                                    
Percentage of base salary                             40.00%      
Annual base salary amount                             $ 275,000      
Ms. Pham [Member]                                    
Related Party Transaction [Line Items]                                    
Grant option purchase (in Shares)                             43,750      
Vesting Period                             10 years      
Exercise price (in Dollars per share)                             $ 19.28      
Ms. Pham [Member] | Bonus [Member]                                    
Related Party Transaction [Line Items]                                    
Officer Expense           $ 240,625                        
Mr Szoke [Member]                                    
Related Party Transaction [Line Items]                                    
Grant option purchase (in Shares)     50,000               12,500              
Exercise price (in Dollars per share)     $ 5.48                              
Percentage of base salary                                   100.00%
Mr Szoke [Member] | Initial Annual Salary [Member]                                    
Related Party Transaction [Line Items]                                    
Officer Expense               $ 250,000                    
Mr Szoke [Member] | Bonus [Member]                                    
Related Party Transaction [Line Items]                                    
Officer Expense               20,833                    
Mr Szoke [Member] | Bonus [Member] | Maximum [Member]                                    
Related Party Transaction [Line Items]                                    
Officer Expense               $ 200,000                    
Mr. Sellitto [Member]                                    
Related Party Transaction [Line Items]                                    
Grant option purchase (in Shares)                                   50,000
Opetion exercise price (in Dollars per share)                                   $ 8.87
Vesting Period                                   10 years
Percentage of base salary                                   60.00%
Mr. Sellitto [Member] | Initial Annual Salary [Member]                                    
Related Party Transaction [Line Items]                                    
Officer Expense   $ 250,000                                
Board of Directors Chairman [Member]                                    
Related Party Transaction [Line Items]                                    
Grant option purchase (in Shares)                       12,500            
Messrs. Joseph Trelin, Michael Koehneman [Member]                                    
Related Party Transaction [Line Items]                                    
Grant option purchase (in Shares)     15,625                              
Exercise price (in Dollars per share)     $ 5.48                              
Ms. Jacqueline White [Member]                                    
Related Party Transaction [Line Items]                                    
Grant option purchase (in Shares)     3,125                              
Exercise price (in Dollars per share)     $ 5.48                              
Forecast [Member]                                    
Related Party Transaction [Line Items]                                    
Officer Expense                                 $ 5,000,000  
Forecast [Member] | Mr. Daguro [Member] | Bonus [Member]                                    
Related Party Transaction [Line Items]                                    
Officer Expense                                 75,000  
Forecast [Member] | Mr. Daguro [Member] | Achieving Increments [Member]                                    
Related Party Transaction [Line Items]                                    
Officer Expense                                 1,000,000  
Forecast [Member] | Chief Executive Officer [Member]                                    
Related Party Transaction [Line Items]                                    
Officer Expense                                 5,000,000  
Forecast [Member] | Mr Szoke [Member] | Bonus [Member]                                    
Related Party Transaction [Line Items]                                    
Officer Expense                                 40,000  
Forecast [Member] | Mr Szoke [Member] | Achieving Increments [Member]                                    
Related Party Transaction [Line Items]                                    
Officer Expense                                 $ 1,000,000  
TPG [Member]                                    
Related Party Transaction [Line Items]                                    
Consideration of the services $ 70,000                                 $ 47,000
v3.23.3
Stockholders' Equity (Details) - USD ($)
9 Months Ended
Jun. 26, 2023
May 26, 2023
May 23, 2023
Mar. 21, 2022
Sep. 30, 2023
Sep. 30, 2022
May 12, 2023
Dec. 31, 2022
Class of Stock [Line Items]                
Common stock issued and outstanding 62,816,330              
Common stock outstanding         7,874,962     3,179,789
Common stock issued         7,874,962     3,179,789
Shares of common stock   1,989,676            
Gross proceeds (in Dollars)         $ 6,321,491 $ 3,146,940    
Shares of common stock in exchange for Convertible Notes   2,348,347            
Conversion of convertible notes (in Dollars)   $ 7,500,000 $ 7,500,000          
Grantes options shares         75,000      
Maximum exercise price (in Dollars per share)         $ 19.28      
Options vested         45,190      
Stock option based compensation expense (in Dollars)         $ (20,000.00)      
Unrecognized stock option based compensation expense (in Dollars)         $ 3,200,000      
Common Stock [Member]                
Class of Stock [Line Items]                
Gross proceeds (in Dollars)   7,300,000            
Net offering cost (in Dollars)   6,400,000            
Equity Option [Member]                
Class of Stock [Line Items]                
Minimum exercise price (in Dollars per share)         $ 6.32      
Directors [Member]                
Class of Stock [Line Items]                
Grantes options shares         78,125      
Minimum exercise price (in Dollars per share)         $ 2.64      
Maximum exercise price (in Dollars per share)         $ 5.48      
Chief Executive Officer [Member]                
Class of Stock [Line Items]                
Grantes options shares         490,000      
Minimum exercise price (in Dollars per share)         $ 3.18      
Maximum exercise price (in Dollars per share)         $ 5.48      
Chief Technology Officer [Member]                
Class of Stock [Line Items]                
Grantes options shares         62,500      
Minimum exercise price (in Dollars per share)         $ 2.64      
Maximum exercise price (in Dollars per share)         5.48      
Exercise price (in Dollars per share)         $ 7.36      
Chief Financial Officer [Member]                
Class of Stock [Line Items]                
Grantes options shares         50,000      
Exercise price (in Dollars per share)         $ 8.87      
Convertible Notes[Member]                
Class of Stock [Line Items]                
Common stock issued         111,516      
Principal amount (in Dollars)   8,900,000 8,900,000 $ 9,200,000        
Net of debt issuance costs and discount (in Dollars)   7,900,000 $ 7,900,000   $ 24,691      
Accrued interest (in Dollars)         $ 388,000      
Mr. Garchik [Member]                
Class of Stock [Line Items]                
Outstanding principal balance (in Dollars)   $ 900,000            
Shares of common stock   245,634            
Madison III, LLC [Member]                
Class of Stock [Line Items]                
Common stock, warrant             187,500  
Maturity term of warrant             5 years  
Warrant exercise price (in Dollars per share)             $ 3.164  
Madison Global Partners LLC [Member]                
Class of Stock [Line Items]                
Common stock, warrant   156,712            
Maturity term of warrant   5 years            
Warrant exercise price (in Dollars per share)   $ 3.664            
v3.23.3
Stockholders' Equity (Details) - Schedule of Company’s Warrant Activity - Warrant [Member]
9 Months Ended
Sep. 30, 2023
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Shares outstanding, Beginning | shares 153,683
Weighted Average Exercise Price, Beginning | $ / shares $ 36.96
Weighted Average Remaining Life, Beginning 2 years 2 months 15 days
Number of share, Granted | shares 344,212
Weighted Average Exercise Price, Granted | $ / shares $ 3.39
Number of shares, Exercised/cancelled | shares (9,877)
Weighted Average Exercise Price, Exercised/cancelled | $ / shares $ 39.6
Number of shares outstanding, Ending | shares 488,018
Weighted Average Exercise Price, Ending | $ / shares $ 13.22
Weighted Average Remaining Life, Ending 3 years 11 months 8 days
v3.23.3
Stockholders' Equity (Details) - Schedule of Grant Date Fair Value of Options Granted
9 Months Ended
Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Dividend rate 0.00%
Minimum [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Expected volatility 120.00%
Expected term 3 months
Risk free rate 3.52%
Maximum [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Expected volatility 124.00%
Expected term 5 years
Risk free rate 4.36%
v3.23.3
Stockholders' Equity (Details) - Schedule of Activity Related to Stock Options
9 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Schedule of Activity Related to Stock Options [Abstract]  
Number of shares outstanding, Beginning (in Shares) | shares 1,291,595
Weighted Average Exercise Price, Beginning $ 46.48
Weighted Average Contractual Term, Beginning 6 years 6 months
Aggregate Intrinsic Value, Beginning (in Dollars) | $
Number of shares, Granted (in Shares) | shares 755,625
Weighted Average Exercise Price, Granted $ 4.81
Weighted Average Contractual Term, Granted 10 years
Aggregate Intrinsic Value, Granted $ 2,218,309
Number of shares, Exercised (in Shares) | shares
Weighted Average Exercise Price, Exercised
Aggregate Intrinsic Value, Exercised (in Dollars) | $
Number of shares, Forfeited/cancelled (in Shares) | shares (361,650)
Weighted Average Exercise Price, Forfeited/cancelled $ 52.8
Number of shares outstanding, Ending (in Shares) | shares 1,685,570
Weighted Average Exercise Price, Ending $ 25.85
Weighted Average Contractual Term, Ending 6 years 8 months 12 days
Aggregate Intrinsic Value, Ending (in Dollars) | $ $ 2,334,011
Number of shares, Exercisable (in Shares) | shares 1,004,499
Weighted Average Exercise Price, Exercisable $ 44.36
Weighted Average Contractual Term, Exercisable 4 years 10 months 24 days
Aggregate Intrinsic Value, Exercisable (in Dollars) | $ $ 876,503
v3.23.3
Stockholders' Equity (Details) - Schedule of Stock Option
9 Months Ended
Sep. 30, 2023
shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Outstanding 1,685,570
Weighted Average Contractual Term (Yrs.) 6 years 8 months 12 days
Exercisable 1,004,499
Less than or equal $32.00 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Outstanding 1,280,216
Weighted Average Contractual Term (Yrs.) 7 years 3 months 18 days
Exercisable 709,283
$32.08 - $56.00 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Outstanding 17,917
Weighted Average Contractual Term (Yrs.) 2 years 8 months 12 days
Exercisable 17,917
$56.08 - $80.00 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Outstanding 222,792
Weighted Average Contractual Term (Yrs.) 6 years 1 month 6 days
Exercisable 131,820
$80.08 - $127.76 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Outstanding 164,645
Weighted Average Contractual Term (Yrs.) 3 years 2 months 12 days
Exercisable 145,479
v3.23.3
Stockholders' Equity (Details) - Schedule of Revisions - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
As Previously Reported [Member]    
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Stock-based Compensation $ 837,608 $ 1,895,712
Operating Expenses 4,458,022 7,254,539
Loss from Continuing Operations (5,220,239) (16,120,559)
Net Loss (5,222,494) (15,901,051)
APIC 141,317,627 165,593,921
Accumulated Deficit (145,352,653) (156,031,210)
Total Stockholders’ Equity (Deficit) $ (3,900,576) $ 9,563,289
Basic (in Dollars per share) $ (1.61) $ (3.91)
Adjustment [Member]    
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Stock-based Compensation $ (3,438,613) $ (3,438,613)
Operating Expenses (3,438,613) (3,438,613)
Loss from Continuing Operations 3,438,613 3,438,613
Net Loss 3,438,613 3,438,613
APIC (3,438,613) (3,438,613)
Accumulated Deficit 3,438,613 3,438,613
Total Stockholders’ Equity (Deficit)
Basic (in Dollars per share) $ 1.06 $ 0.83
As Revised [Member]    
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Stock-based Compensation $ (2,601,005) $ (1,542,901)
Operating Expenses 1,019,409 3,815,926
Loss from Continuing Operations (1,781,626) (12,681,946)
Net Loss (1,783,881) (12,462,438)
APIC 137,879,014 162,155,308
Accumulated Deficit (141,914,040) (152,592,597)
Total Stockholders’ Equity (Deficit) $ (3,900,576) $ 9,563,289
Basic (in Dollars per share) $ (0.55) $ (3.08)
v3.23.3
Stockholders' Equity (Details) - Schedule of Revisions (Parentheticals) - $ / shares
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
As Previously Reported [Member]    
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Diluted $ (1.61) $ (3.91)
Adjustment [Member]    
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Diluted 1.06 0.83
As Revised [Member]    
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Diluted $ (0.55) $ (3.08)
v3.23.3
Discontinued Operations and Assets Held for Sale (Details) - USD ($)
9 Months Ended
Aug. 29, 2022
Sep. 30, 2023
Jun. 30, 2023
Discontinued Operations and Assets Held for Sale [Line Items]      
Sale consideration     $ 96,000
Recognized gain   $ 216,000  
Cards Plus business in South Africa [Member]      
Discontinued Operations and Assets Held for Sale [Line Items]      
Sale of card plus $ 300,000    
Card plus amount received 150,000    
Other assets current 150,000    
Cost of sale 3,272    
Recognized a loss $ 188,247    
MultiPay business in Colombia [Member]      
Discontinued Operations and Assets Held for Sale [Line Items]      
Foreign currency translation gain   $ 155,000  
v3.23.3
Discontinued Operations and Assets Held for Sale (Details) - Schedule of Assets and Liabilities of the MultiPay Sale and Consideration Received - MultiPay [Member]
9 Months Ended
Sep. 30, 2023
USD ($)
Carrying value of net assets sold:  
Property and equipment write-off $ 19,528
Net assets write-off 19,528
Sale consideration on disposition of net assets:  
Sale consideration 95,852
Less: Value added tax (15,304)
Net Consideration 80,548
Foreign currency translation: 155,049
Net gain on sale of a discontinued operation $ 216,069
v3.23.3
Discontinued Operations and Assets Held for Sale (Details) - Schedule of Operations of Cards Plus and MultiPay - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Discontinued Operations [Member]        
Condensed Statement of Income Captions [Line Items]        
Total Revenues, net $ 446,643 $ 29,354 $ 1,468,199
Operating Expenses:        
Cost of Sales 145,205 665,269
General and administrative 276,866 12,268 1,003,003
Impairment loss   143,698
Depreciation and amortization (6,749) 8,066 33,025
Total operating expenses 415,322 20,334 1,844,995
Income (loss) from operations   31,321 9,020 (376,796)
Other Income (Expense):        
Other income 12,792 20,821
Interest expense, net (364)
Other income (expense), net 12,792 20,457
Loss before income taxes 44,113 9,020 (356,339)
Income tax expense (1,915) (468) (7,496) (7,046)
Income (loss) from discontinued operations (1,915) 43,645 1,524 (363,385)
Loss (gain) from sale of discontinued operations   (188,247) 216,069 (188,247)
Total income (loss) from discontinued operations (1,915) (144,602) 217,593 (551,632)
Cards Plus [Member]        
Condensed Statement of Income Captions [Line Items]        
Total Revenues, net 380,372 1,263,672
Operating Expenses:        
Cost of Sales 145,205 665,269
General and administrative 21,539 412,243
Impairment loss   143,698
Depreciation and amortization (1,482) 24,415
Total operating expenses 165,262 1,245,625
Income (loss) from operations 215,110 18,047
Other Income (Expense):        
Other income 2,103 8,919
Interest expense, net (364)
Other income (expense), net 2,103 8,555
Loss before income taxes 217,213 26,602
Income tax expense (4,681)
Income (loss) from discontinued operations   217,213   21,921
Loss (gain) from sale of discontinued operations (188,247) (188,247)
Total income (loss) from discontinued operations   28,966   (166,326)
MultiPay [Member]        
Condensed Statement of Income Captions [Line Items]        
Total Revenues, net 66,271 29,354 204,527
Operating Expenses:        
General and administrative 255,327 12,268 590,760
Depreciation and amortization (5,267) 8,066 8,610
Total operating expenses 250,060 20,334 599,370
Income (loss) from operations (183,789) 9,020 (394,843)
Other Income (Expense):        
Other income   10,689   11,902
Other income (expense), net 10,689 11,902
Loss before income taxes (173,100) 9,020 (382,941)
Income tax expense (1,915) (468) (7,496) (2,365)
Income (loss) from discontinued operations (1,915) (173,568) 1,524 (385,306)
Loss (gain) from sale of discontinued operations   216,069
Total income (loss) from discontinued operations $ (1,915) $ (173,568) $ 217,593 $ (385,306)
v3.23.3
Discontinued Operations and Assets Held for Sale (Details) - Schedule of Cash Flow Activity Related to Discontinued Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $ (1,915) $ 43,645 $ 1,524 $ (363,385)
Depreciation and amortization expense     8,067 42,364
Impairment of intangible assets     143,701
Accounts receivable     105,194 (14,288)
Other current assets     10,562 186,370
Inventory     (78,806)
Accounts payable and accrued expenses     (13,759) (16,092)
Deferred revenue     (36,663)
Adjustments relating to discontinued operations     110,064 226,586
Cash flows from discontinued operations     $ 111,588 $ (136,799)
v3.23.3
Commitments and Contingencies (Details) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Jul. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Commitments and Contingencies [Line Items]        
Rented office monthly cost       $ 2,500
Office monthly lease cost $ 1,500      
Rent expense   $ 8,000 $ 80,000  
Continuing Operations [Member]        
Commitments and Contingencies [Line Items]        
Rent expense     13,000  
Discontinued Operations [Member]        
Commitments and Contingencies [Line Items]        
Rent expense     $ 67,000  

authID (NASDAQ:AUID)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more authID Charts.
authID (NASDAQ:AUID)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more authID Charts.